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AAP23 Amyloid precursor protein-23
AD Alzheimer’s disease
apoE Apoenzyme
Aß Amyloid beta
BODIPY Boron–dipyrromethene
CCD Charged-coupled device
CCK2 Cholecystokinin-2
CEA Carcinoembryonic antigen
CT Computed tomography
CysLT1 Cysteinyl leukotriene-1
Da Dalton
DNA Deoxyribonucleic acid
EGFR Epidermal growth factor receptor
EPR Enhanced permeability and retention 
effect
FDA Food and Drug Administration
fmol Femto mol
FMT Fluorescence-mediated tomography
FRET Fluorescence energy transfer
IC50 Inhibitory concentration of how 
much of a particular drug (inhibitor) 
is needed to inhibit a given biological 
process by half
ICG Indocyanine green
MMP Matrix metalloproteinase
MRI Magnetic resonance imaging
NADPH Nicotinamide adenine dinucleotide 
phosphate
NIR Near-infrared
nM Nanomolar
PBS Phosphate buffered saline
pH Potential of hydrogen (strength of 
hydrogen)
PSMA Prostate-specific membrane antigen
QDs Quantum dots
SPECT Single-photon emission computed 
tomography
TBR Tumor-to-background ratio
uMUC-1 Underglycosylated mucin-1
UV–vis Ultraviolet–visible
VEGF Vascular endothelial growth factor 
receptor
WT Wild type
Zn-DPA Zinc-trisodium-pentetate
μm Micrometer
16.1  Fluorescence Imaging
Ingrid Hilger
This chapter sets out to (a) describe the main 
techniques employed in current preclinical and 
clinical applications of fluorescence imaging, (b) 
define important aspects of using fluorescence 
reporters, and (c) describe current applications to 
diseases with high socioeconomic relevance.
16.1.1  Introduction
Fluorescence is the phenomenon by which cer-
tain molecules under illumination absorb light of 
a specific wavelength and normally react by 
emitting light of a comparatively longer 
wavelength.
This phenomenon relies on the production of 
excited single states. An electron in the excited 
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orbital is paired with a second electron (of oppo-
site spin) in the ground-state orbital (Lakowicz 
1999). A photon is emitted as a result, causing a 
rapid return to the ground state. Compared to 
phosphorescence (i.e., the emission of light from 
triplet excited states), fluorescence emission rates 
are very high, with fluorescence lifetimes in the 
10 ns range.
Fluorescence occurs quite frequently in 
nature, in minerals such as benitoite, gypsum, 
and scapolite, for example. They emit visible 
light upon being illuminated by invisible ultravi-
olet light, X-rays, or electron beams. A number 
of marine animals – for example, lancelets, cor-
als, jellyfish, and marine fish (Sparks et al. 
2014) – are also capable of fluorescing, as are 
some land animals, namely, butterflies, parrots, 
etc.
Humans have exploited fluorescence by con-
structing chemical sensors, biological detectors, 
and cosmic ray detectors as well as by designing 
fluorescent lamps, etc. Fluorescence has also 
entered the field of life sciences and medicine, par-
ticularly for imaging purposes, as in microscopy. 
Initially, during the early twentieth century, this 
technique was primarily used to analyze selected 
tissue and cell samples with  corresponding 
 fixation. About 20 years later, a fluorescent  contrast 
agent, fluorescein, was developed for use in neuro-
surgery applications (Moore et al. 1948) to 
improve the detection of brain tumors in patients. 
Expanding beyond microscopy, fluorescence 
 featured prominently in the development of 
sophisticated mesoscopic and macroscopic optical 
imaging systems. This classification of optical 
imaging modalities from microscopy to macros-
copy was originally proposed by (Ntziachristos 
2010) and was based on the tissue depth at which 
they operate (see below).
The success of fluorescence optical imaging 
methodology is in large part attributable to its (1) 
ease of use, (2) low cost, and (3) high sensitivity 
(up to the fmol range of detected dye molecule, 
depending on the method used) without requiring 
the use of radioactive tracers.
Nevertheless, even with all the technical 
developments of the last years, researchers and 
users still face the basic challenge that all tissues 
scatter light, which also leads to reduced resolu-
tion and difficulties in image formation (Yodh 
and Chance 1995). In particular, when exciting a 
specific optical probe localized within tissue, the 
signal intensity emerging from it will be affected 
by absorption and scattering (Arridge 1999; 
Schotland and Leigh 1992). To be exact, this 
means that the fate of excitation and emission 
photons depends on the tissue’s scatter, anisot-
ropy, and refractive indexes (Alfano et al. 1997). 
Therefore, the detection limits of fluoro-optical 
technologies within tissues are determined by a 
photon’s main free path and the average angles at 
which photons scatter during each scattering 
event as stated by Ntziachristos et al. (2011).
Wavelengths are known to determine the 
degree of absorption and scattering in tissue and 
therefore the penetration depth in tissues. Using 
near-infrared light permits detecting tissue 
structures deeper under the surface than using 
visible light. In particular, near-infrared photons 
(wavelengths between 650 and 900 nm) were 
observed to travel more efficiently through tis-
sues than ones in the visible light spectrum 
(Jobsis 1977). When wavelengths increase (i.e., 
red or infrared region of the optical spectrum), 
absorption and scattering of light in tissue are 
known to diminish. The longer the wavelength 
is, the lower is the delivered energy of the pho-
tons. Absorption is at its lowest between 500 
and 800 nm (Osterman and Schutz-Geschwender 
2007). By contrast, when increasing wavelength 
above 900 nm, increasing absorption by water 
results in markedly reduced transmission of 
light.
In normal tissue, the principal absorbers are 
water, oxyhemoglobin, deoxyhemoglobin, and 
lipids. The extent of absorption depends on the 
molar concentration of each constituent. For 
example, in a tissue with 8 % blood volume and 
29 % lipid content, the dominant absorber will be 
hemoglobin, accounting for 39–64 % of total 
absorption at NIR wavelengths (Lim et al. 2003).
In addition to photon absorption and scatter-
ing in living tissues, tissue autofluorescence can 
also noticeably limit contrast in fluorescence 
optical imaging. The absorption of a photon is 
obtained by summing up all absorbing constitu-
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ents present in tissue. Under visible light, fluores-
cence of intrinsic fluorophores such as NADPH, 
collagen, elastin, and flavin, etc., may occur 
(Frangioni 2003; Kovar et al. 2007), potentially 
interfering with that of xenogen reporters in the 
visible range of the light spectrum. NIR light 
solves this problem by reducing the autofluores-
cence background of intrinsic fluorophores.
With respect to NIR regions, tissue depths of 
several centimeters can be achieved, depending 
on the type of tissue, e.g., 10 cm in the human 
breast (Buehler et al. 2010a).
Most applications in recent years focused on 
preclinical whole-body imaging using near- 
infrared light. In this context, strategies employ-
ing NIR light typically included labeling specific 
high-affinity ligands with NIR fluorochromes, 
nanoparticles, and the like. Depending on the 
macroscopic imaging method used, less than 100 
fmol of an NIR dye can be detected (Ntziachristos 
2011). At present, a growing number of papers 
describe the introduction to the clinical field of 
fluorescence imaging, particularly for intraopera-
tive (van Dam et al. 2011), endoscopic, and lapa-
roscopic imaging applications (van der Poel et al. 
2011) and intra-arterial imaging (Yoo et al. 2011).
16.1.2  In Vivo Fluorescence 
Imaging Systems
In this section, the focus will be on macroscopic 
fluorescence imaging that allows probing tissues 
to depths greater than 1 cm. Macroscopic imag-
ing lets researchers probe organs, tissues, or 
entire small animals. For these applications, mac-
roscopic fluorescence imaging systems have been 
used primarily as stand-alone devices for preclin-
ical imaging. Recently, combining them with 
other imaging methods, such as MRI and CT, has 
also been suggested as a means for correlating 
the fluorescence signals with anatomical infor-
mation. A comprehensive review of the advan-
tages and current limitations of macroscopic 
imaging is found in (Ntziachristos 2010, 2011). 
The main imaging strategies are fluorescence 
reflectance imaging and fluorescence-mediated 
tomography, both of which will be discussed in 
greater detail below.
16.1.2.1  Epi-illumination or 
Reflectance Imaging
Preclinical fluorescence imaging devices include, 
among others, quite basic epi-illumination (pho-
tographic) systems. The typical epi-illumination 
system consists of a sensitive charge-coupled 
device (CCD) camera, a filter system operating at 
defined wavelengths, illumination systems for 
fluorophore excitation, macro lens systems, a 
lighttight imaging chamber, and the software 
needed to control the device. Among CCD cam-
eras, silicon CCD cameras offer the best cost/
performance ratio, but their sensitivity is rather 
poor above 800 nm. Increased sensitivity up to 
900 nm can be achieved with more expensive 
arsenide CCD cameras. Also available are gal-
lium arsenide cameras, but their sensitivity below 
1,000 nm is poor (Frangioni 2003).
Typically, spectral bandwidths – resulting 
from filtering white light or use of a laser source 
or laser diode – are used to excite the fluorescing 
probes. The light source can also be used to pro-
duce an illumination image of an animal. The 
light falling on the surface of the tissue or animal 
will propagate into it for several millimeters (i.e., 
in the NIR) and excite the fluorophores. Similarly, 
the produced fluorescence signals will propagate 
to the surface. Epi-illumination systems can be 
used for both fluorescence and bioluminescence 
imaging.
Characteristic of epi-illumination systems is 
that the components used to illuminate and detect 
emitted fluorescence are lined up on the same 
side of the object of interest. The technique is 
mainly useful in detecting superficial tumors 
(e.g., tumor xenografts) in laboratory animals for 
preclinical research, since, depending on the type 
of tissue, probing is limited to depths of 3–7 mm 
from the tissue surface. In clinical practice, these 
systems are appropriate for open surgery and 
endoscopic procedures. The particular advan-
tages are that the systems are simple to imple-
ment and operate. However, the fluorescence 
images will not exactly reflect probe localization 
since, as mentioned earlier, their fluorescence 
emission will be closely affected by absorption 
and scattering. Absorption and scattering will 
also impair full quantification of fluorescence 
signals (Boot et al. 2008). Therefore, semiquanti-
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tative analysis of the fluorescence intensities is 
often performed to obtain rough approximations, 
particularly when taking repeated images from 
the same animal during the course of the disease 
(Haedicke et al. 2013; Kossatz et al. 2013). With 
this, the relative changes in probe accumulation 
can be deduced. Nevertheless, it must be taken 
into account that areas of high vascularization in 
tumors will certainly favor unspecific probe 
accumulation but will also absorb fluorescence 
emission due to the presence of blood (Huisken 
et al. 2004). The resolution of epi-illumination 
technique is approximately 2–3 mm with sensi-
tivity in the nM to μM range.
16.1.2.2  Fluorescence-Mediated 
Tomography
Another type of fluorescence imaging methods 
utilizes fluorescence-mediated molecular tomog-
raphy (FMT). In this method, the tissue of inter-
est is illuminated from multiple angles, then 
the emitted fluorescence and excitation photons 
that have propagated through the tissue are col-
lected and registered in different spectral bands. 
Using appropriate mathematical processing 
tools on the raw data, this method permits 
 creating  three- dimensional quantitative images 
of  fluorescent probe localizations in the area of 
interest (Ntziachristos 2010). A comparatively 
high resolution can be achieved by illuminating 
the tissue surface with point light sources and by 
applying theoretical models and assumptions of 
photon propagation. In general, the sensitivity is 
in the nM-range, with an in vivo detection limit of 
1 picomol fluorochrome (10 nM) (Ntziachristos 
et al. 2002). The resolution is at least 500 μm, 
and, despite some improvements, photon scat-
tering remains a challenge. Consequently, to 
correlate the fluoro-optical signals with anatomi-
cal localization, the use of hybrid systems has 
been suggested. Feasible combinations include 
FMT with CT or MRI. These combinations can 
also be used to further improve image reconstruc-
tion and visualization (Ale et al. 2013; Gremse 
et al. 2014).
16.1.2.3  Multispectral Imaging
A particular advantage of fluorescence optical 
imaging is its ability to generate multiple images 
using different spectral regions or, alternatively, by 
applying methods for resolving different spectra 
(multispectral imaging). Different multispectral 
decomposition methods suggested can be applied 
either to the excitation light or to the fluorescing 
light. Corrections for absorption characteristics of 
various tissues, scattering variations, and depths 
are feasible. These methods have been summa-
rized in the following review (Ntziachristos 2010). 
The method has been applied to detect more than 
one molecular marker in cancer (Kossatz et al. 
2013), cancer therapeutic efficiency (Haedicke 
et al. 2013) or for in vivo imaging of FRET (Busch 
et al. 2012) in edemas, etc. (Fig. 16.1).
16.1.2.4  Other Fluorescence Imaging 
Methods
Optoacoustic imaging is not based directly on 
fluorescence emissions by fluorophores but 
instead involves the detection of signals via opto-
acoustic impulses (for more details, see Sect. 
16.5). The method allows the identification of 
intrinsic chromophores in tissue, such as oxyhe-
moglobin and deoxyhemoglobin (Allen and 
Beard 2006a; Eghtedari et al. 2007; Kolkman 
et al. 2004; Zemp et al. 2007). Optoacoustic 
imaging can also detect fluorochromes and 
 fluorescent nanoparticles familiar from epi- 
illumination techniques (Razansky et al. 2007). 
Sensitivity is in the nM to μM-range, resolution 
is above 20 nm, the latter being limited by the 
attenuation of acoustic frequencies in the tissue 
(Ntziachristos 2010).
Further details on other fluorescence imaging 
methods such as bioluminescence imaging, opti-
cal coherence tomography, intravital microscopy 
can be seen in the following chapters of these 
book Sects. 16.2, 16.3, 16.4, 16.5, and 16.6.
16.1.3  Contrast Agents 
for Fluorescence Imaging
16.1.3.1  General Features
In addition to the fluorescence imaging devices 
themselves, appropriate contrast agents are an 
important complementary tool needed for prob-
ing organs, tissues, and whole animals. Most of 
the fluorescing contrast agents are aromatic 
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organic molecules (Fig. 16.2). Ideal fluorescence 
reporters should emit fluorescence in the near- 
infrared spectral range, as already noted. The 
fluorescent dyes most in use for in vivo imaging 
range between 550 and 900 nm in the diagnostic 
window. Typical examples are cyanines and their 
derivatives (i.e., Cy5.5 with an emission wave-
length of 695 nm (Kovar et al. 2007), hemicya-
nine dyes (Busch et al. 2012), and others. 
Increasingly popular are also Alexa Fluor 680, 
IRDye 680, and IRDye 700DX as well as the red 
chromophores Alexa 750 and IRDye 800CW 
(Kovar et al. 2007; Panchuk-Voloshina et al. 
1999). Other fluorescent dyes are derivatives of 
squaraines, phthalocyanines, porphyrin, and 
borondipyrromethene analogues (BODIPY). In 
recent years, much attention has been paid to the 
advent of quantum dots (QDs), nanoparticles 
constituted of heavy metals such as cadmium and 
selenite (see below).
A shared characteristic of fluorescent dyes is 
their high applicability potential, since (1) 
 large- scale chemical synthesis is fundamentally 
feasible and (2) they are suited for rapid and 
efficient conjugation with specific molecules, 
such as DNA primers, nucleotides, proteins, 
small molecules, amino acids, etc. Most recently, 
modifications of their basic chemical structure 
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Fig. 16.1 Multispectral fluorescence imaging of apop-
totic cells in tumors via photodynamic therapy. (a) 
Representative composite images of tumor-bearing mice 
injected with a fluorescent annexin V probe at 2 days (left 
column) or 2 weeks (right column) after therapy. (b) 
Semiquantitative analysis of fluorescence signals in tumors 
in treated or non-treated mice up to 48 h postinjection, 2 d, 
2 days, or 2 w, 2 weeks (*p < 0.05). (c) Biodistribution of 
the fluorescent annexin V 5 days after therapy and 3 days 
post probe injection in PDT-treated (black) and non-treated 
(white) mice, ex vivo organ fluorescence, *p < 0.05. (d) 
Biodistribution of the annexin V probe at 3 weeks after 
therapy and 17 days (black bars) and 8 days (dark gray 
bars) after probe injection in treated mice or 17 days (white 
bars) and 8 days (light gray bars) after probe injection in 
non-treated mice, fluorescence signals of the organs, 
*p < 0.05. (e) Cell nuclei of the cryo- frozen tumor slices 5 
days (upper images) and 3 weeks (lower images). Arrow: 
condensed chromatin (Hoechst stain) (From Haedicke 
et al. (2013) with permission from Elsevier)
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have produced improved chemical stability and 
photostability, long fluorescence life, and 
increased solubility with less aggregation pro-
pensity in biological systems (see below). Of par-
ticular significance is their adequate separation 
between excitation and emission wavelengths 
(Stokes shift), permitting effective filtering of 
emitted fluorescence from excitation light.
To be detected properly, fluorescence dyes 
should exhibit high quantum yields. The fluores-
cence quantum yield is defined as the efficiency 
of the fluorescence process. Mathematically, it is 
the ratio of the number of photons emitted to the 
number of absorbed photons. The ideal quantum 
yield is 1.0, indicating that every absorbed pho-
ton leads to a photon emission. In general, one 
can assume that all dyes between the values of 
0.1 and 1 are fluorescent. Accordingly, this holds 
true for most of the NIRF dyes applied for in vivo 
imaging purposes, with values between 0.13 and 
0.27 (Ohnishi et al. 2005). The highest quantum 
yields are achieved with QDs (around 0.50) 
(Frangioni 2003). All compounds below a value 
of 0.1 lack a detectable fluorescence emission. 
The values cited here should be regarded as rough 
estimates of fluorescence detection intensity, 
since the determination of quantum yield is 
highly susceptible to the features of the surround-
ing medium and lack of standardization.
Solubility of fluorescent probes is an impor-
tant characteristic, as it assures an adequate dis-
persion in the body after intravenous application. 
Because of their basic molecular structure, hemi-
cyanine and cyanine dyes lack solubilization. In 
order to boost it, attempts have been made to 
couple polar groups, such as sulfonates and oth-
ers, with the basic configuration. Lack of solubil-
ity can lead to aggregation and agglomeration of 
the dye molecules, resulting in a reduction of the 
quantum yield (see below). As a result, the quan-
tum dots produced initially were fairly insoluble, 
having been constructed with inorganic shells. 
New formulations use polar organic layers to 
make them water soluble. Due to their heavy 
metal constituents leading to low biocompatibil-
ity and degradability, QDs are restricted to pre-
clinical applications.
Photobleaching is another phenomenon that 
needs to be considered in relation to the use of 
fluorescent probes. It is known to be associated 
with the reduction of fluorescence due to the mol-
ecule’s destruction in the presence of light required 
to induce emission of fluorescence. Photobleaching 
is closely linked to the compound’s stability. Most 
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Fig. 16.2 Several of the newly developed NIR fluorescent dyes (From Luo et al. (2011a) with permission from Elsevier)
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of the known fluorophores are susceptible to it, 
although the light emitted by most fluorophores is 
adequate for successful optical imaging applica-
tions. QDs are more resistant to photobleaching 
than ICG and hemicyanine dyes.
Nonspecific binding is another important 
aspect, particularly in connection with detecting 
target-affine fluorescent probes. Nonspecific 
binding can occur as a result of interaction with 
cellular membranes as well as with extracellular 
matrix materials, etc. Nonspecific binding gener-
ally lowers the signal-to-noise ratio. Depending 
on their molecular configuration, most of the cya-
nines and hemicyanines have a tendency to bind 
proteins. For example, four members of the 
DY-67x cyanine family, composed of the same 
main chromophore but substituted with a 
sequentially increasing number of sulfonate 
groups (n 5 1–4; DY-675, DY-676, DY-677, 
DY-678, respectively), were shown to exhibit dif-
ferent bovine serum albumin binding constants: 
that of the most hydrophobic dye, DY-675, was 
18 times higher than that of DY-678, the most 
hydrophilic fluorophore. In vivo biodistribution 
analysis revealed a considerable influence of dye 
hydrophilicity on biodistribution and excretion 
pathways. In this connection, the more hydro-
phobic dyes, DY-675 and DY-676, accumulate 
preferentially in the liver, followed by strong flu-
orescence signals in the bile and gut owing to 
accumulation in feces, while comparatively 
hydrophilic DY-678-COOH accumulates in the 
bladder (Hamann et al. 2011) (Fig. 16.3). QDs 
with a high number of charged surface groups 
exhibit pronounced nonspecific binding behavior 
(Bentzen et al. 2005). In contrast, hydroxyl- 
coated QDs were shown to be involved in a dis-
tinct reduction of nonspecific binding compared 
to carboxylated QDs (Kairdolf et al. 2008).
In order to achieve good signal-to-background 
ratios, fluoro-optical contrast agents should 
basically possess high-target affinity, good 
accessibility to the target molecule, and rapid 
clearance, since any uncleared molecule will 
contribute to the background signal. The com-
monly used dyes ICG, Cy5.5, and Cy7, IRdye800 
CW, etc., are cleared very rapidly from the blood 
(Frangioni 2003). Polar hemicyanine dyes are 
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cleared by renal filtration, nonpolar ones, such 
as ICG and nonpolar hemicyanines via the bile 
(Hamann et al. 2011; Recknagel et al. 2012). QDs 
with diameters over 3.5 nm cannot be cleared by 
renal filtration, which means that they circulate 
longer (Frangioni 2003).
Most fluorescent dyes have been shown to have 
low toxicity. However, so far, ICG is the only fluo-
rescent dye approved by the FDA (Benya et al. 
1989). The toxicity of hemicyanine dyes and ICG 
derivatives, such as Cy5.5, has not been fully eval-
uated. In some studies, the cytotoxicity and toxic-
ity of Cy5.5 and the hemicyanine dyes were found 
to be lower than with ICG (Pauli et al. 2009a). 
QDs might be potentially dangerous because of 
the presence of cadmium and selenium (Hardman 
2006). The features of the fluorescent dyes and 
QDs have been nicely summarized by te Velde 
et al. (2010). For more details, see Sect. 16.6.
16.1.3.2  The Most Popular 
Fluorescent Probes: Cyanine 
Dyes, Their Derivatives, 
and QDs
Cyanine dyes are synthetic dyes belonging to the 
group of polymethines. Other than cyanines with 
open chains, most of the cyanine molecules for 
biomedical applications are characterized by the 
presence of two aromatic heterocycles (symmet-
ric cyanines), each of them containing a nitrogen 
molecule. Both nitrogen molecules can be part of 
a heteroaromatic moiety (e.g., pyrrole, pyridine, 
etc.). The heterocycles are linked by a polyme-
thine bridge. The extension of the molecule by a 
vinylene moiety leads to a shift of absorption/
emission to a longer wavelength (bathochromic 
shift) of about 100 nm (Mishra et al. 2000). In this 
context, mono- and trimethine cyanines absorb 
and emit in the visible region of the light spectrum 
and pentamethines in the near-infrared region.
In general, cyanine dyes and their derivatives 
are associated with a small Stokes shift and some 
aggregation in aqueous media (Landsman et al. 
1976), which leads to rapid elimination from the 
blood through the liver. Despite being approved, 
ICG has in fact recently been reported as induc-
ing transient cytotoxic effects (Ho et al. 2003; 
Ikagawa et al. 2005; Skrivanova et al. 2006). The 
introduction of carboxylic and sulfonic acid 
groups to the basic cyanine structure to address 
its low solubility in water led to a distinct 
improvement (Peng et al. 2005; Zhou et al. 2007). 
Interestingly, the heptamethine cyanine BHmC 
that is made up of two cyanine subunits exhibits 
a distinct increase in fluorescence after protein 
binding in contrast to solubilization in water 
(Kim et al. 2005).
Among currently available cyanines, indocya-
nine green (ICG, Cardiogreen) was already 
approved in 1958 for use in patients. The small 
molecule (775 Da) exhibits a short plasma half- 
life (1–2 min). It is heavily protein bound, has a 
low quantum yield in plasma, and diffuses  readily 
from the vessels into the interstitium. It has been 
used for routine tests in retinal angiography 
(Chang et al. 1995) among others. It is also used 
in liver function testing (Cherrick et al. 1960; 
Weissleder and Ntziachristos 2003), for the iden-
tification of small and macroscopically invisible 
liver cancers in real time (Gotoh et al. 2009; 
Ishizawa et al. 2009), and in rheumatoid arthritis 
(Schafer et al. 2013). Typically, intravenous dos-
ages of 25–50 mg ICG in saline are used. ICG 
has also been used to image the cerebrospinal 
fluid (Sakatani et al. 1997).
Hemicyanines are made up of at least one het-
erocycle instead of the two that are normally 
present in cyanine molecules (asymmetric cya-
nines). The fluorescence quantums of these dyes 
in aqueous solution depend on the substitution 
pattern of the benzopyrylium-type end group, 
which also significantly determines the aggrega-
tion tendency. Sterically demanding substituents 
and negatively charged sulfonate groups reduce 
the aggregation tendency (Pauli et al. 2011).
Squaraines are made up of an oxocyclobuteno-
late core and aromatic heterocyclic components 
at the two ends of the molecule (Volkova et al. 
2007). These molecules present a high molar 
extinction coefficient and good photoconductiv-
ity (Dilek and Akkaya 2000; Oswald et al. 2000). 
However, water solubility is very poor due to 
their planar and hydrophobic molecular struc-
ture. Recently, stable and non-cytotoxic supra-
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molecular adducts of squaraines and the natural 
carrier protein, i.e., serum albumin, have been 
suggested for tumor-targeted imaging and photo-
thermal therapy in vivo (Gao et al. 2014).
Phthalocyanines are porphyrin derivatives 
made up of four pyrrole moieties that were linked 
together through nitrogen atoms. These mole-
cules are thermally and chemically very stable. 
Due to the feasibility of replacing the two central 
hydrogen atoms with metal atoms, plus the added 
possibility of incorporating substituents at the 
periphery and axial positions of the molecules, 
these molecules have been also used in 
 optoelectronics and biomedicine applications 
(Cammidge and Gopee 2002). Of particular 
interest are applications as photosensitizers. 
When illuminated, they produce toxic singlet 
oxygen capable of killing target (tumor) cells 
(Haedicke et al. 2013). Several porphyrin deriva-
tives such as porfimer sodium (Photofrin®), 
5-aminolevulinic acid or ALA (Levulan®), and 
methyl aminolevulinate (Metvix®), chlorin 
(Foscan®), temoporfin, etc., are FDA-approved 
photosensitizers for photodynamic therapy. 
Photofrin is used intravenously for internal can-
cers, while Levulan® and Metvix® are applied in 
skin therapy (MedicineNet).
BODIPY (borondipyrromethene) dyes exhibit 
high quantum yield and excellent thermal and pho-
tochemical stability. However, most BODIPY dyes 
emit from yellow to deep-red emission with low 
extinction coefficients. Recent years have seen sev-
eral attempts to shift the absorption spectrum to the 
NIR region of the spectrum (Rickert et al. 2010).
Quantum dots (QDs) Compared to organic dyes, 
QDs possess a series of interesting features such as 
high-absorption cross section, broadband absorp-
tion, narrow and symmetric luminescence band, 
simultaneous excitation with different emission 
wavelengths using a single excitation wavelength, 
etc. (Bruchez et al. 1998; Chan et al. 2002; Wu 
et al. 2003). Interestingly, by modulating the size of 
QDs made of a given material, different colors can 
be achieved. Doing so might make multiplexed 
imaging with differently sized QDs with the same 
excitation wavelength a versatile tool in preclinical 
imaging approaches. These nanoparticles are made 
up of heavy metal ingredients such as cadmium 
and selenite. To increase suspension in aqueous 
solution, nanoparticles are increasingly being 
coated with an organic material. They exhibit a 
high extinction coefficient combined with a quan-
tum yield comparable to fluorescent dyes. They are 
highly stable (low photobleaching effects). In par-
ticular, QDs are 20 times brighter and 100 times 
more stable than traditional fluorescent reporters 
(Walling et al. 2009). However, their cytotoxicity in 
biological systems remains to be fully clarified. 
Additionally, they are quite expensive to prepare; 
moreover, difficulties in reproducibility and quanti-
fication have also been reported (e.g., (Nikoobakht 
and El-Sayed 2003; Tsung et al. 2006)).
16.1.4  Prospects of Macroscopic 
Fluorescence Imaging
Since it is a macroscopic imaging modality, fluo-
rescence imaging is expected to be limited to the 
noninvasive detection in vivo of fluorescence sig-
nals in preclinical application to whole animals. 
In clinical settings, it has potential for use in 
imaging not only parts of the body with good 
accessibility to light, such as arthritic joints in 
hands, but also abnormalities in the gastrointesti-
nal tract, gynecological cancers, cardiovascular 
diseases using specialized catheters, imaging of 
the eye, and intrasurgical imaging. In addition, it 
may serve as a valuable tool in the following 
applications: drug testing, understanding disease 
mechanisms in basic research, supporting trans-
lation of imaging approaches to clinical practice, 
pre-screening at key points in time during the 
course of diseases, etc.
16.1.4.1  Oncological Imaging
Most of the original preclinical oncological fluo-
rescence imaging approaches aimed at demon-
strating the feasibility of detecting vascular 
permeability and diffusion via nontargeted 
probes by exploiting the enhanced permeability 
and retention effect (EPR) (e.g., Duncan et al. 
2006; Maeda et al. 2009) of tumor microvascula-
ture and also at demonstrating the reliability of 
detecting molecular markers using targeted opti-
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cal probes in whole animals. Active targeting has 
been achieved by conjugating fluorescent dyes 
(mostly cyanines or hemicyanines) with specific 
ligands made up of peptides, proteins, synthetic 
molecules, antibodies, aptamers, and others. 
Higher signal-to-background ratios were 
achieved with this approach when compared to 
nontargeted probes. Disadvantages of using 
target- affine probes in oncological imaging 
include bioconjugation that can affect the fluores-
cence of several dye molecules, impairment of 
ligand specificity because of the presence of 
comparatively large dye molecules when com-
pared to radioactive tracers, and pharmacokinet-
ics of conjugated ligands that may differ from 
those with free molecules. When using nanopar-
ticles instead of small molecules, accessibility to 
the tumor interstitium may be impaired due to 
their comparatively large size (several nm). 
Particularly when imaging structures of the tumor 
interstitium, using small molecules is advanta-
geous because of their high tissue penetrating 
behavior and rapid clearance of non-bound mol-
ecules from the tumor. Typical examples for 
active targeting in oncological fluorescence 
imaging address the tumor cell compartment per 
se, the tumor environment, extracellular compart-
ment, and neovascularization, such as the detec-
tion of PSMA (Liu et al. 2010), folate (Tung et al. 
2002), EGFR (Becker et al. 2000), CEA (Hilger 
et al. 2004), Her-1 and Her-2 (Ogawa et al. 2009), 
CCK2 receptor and Gut-1-receptor (Kossatz 
et al. 2013), apoptotic cells (Haedicke et al. 
2013), uMUC-1 antigen (Pham et al. 2005), 
αvβ3-integrin (Wang et al. 2007a), etc. (Fig. 16.4).
Additional strategies for oncological imaging 
include the utilization of activatable probes that 
fluoresce upon activation or the incorporation 
of fluorescent dyes into (polymeric) nanopar-
ticles with or without targeting moiety. Here, 
the encapsulation of dye molecules in nanopar-
ticles offers the advantage of having a protective 
matrix cover the dyes and the ability to amplify 
the fluorescence signal. Moreover, encapsula-
tion could help improve the stability of the dyes. 
Nevertheless, nanoparticles have a limited poten-
tial for extravasation into the tumor interstitium 
and might be of particular interest when address-
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Fig. 16.4 Fluorescence imaging of the cholecystokinin-2 
receptor in tumors. NIR fluorescence reflectance images 
of CCK2R expression in an A431/CCK2R (right flank) 
and A431/WT (left flank) xenograft model. The left panel 
displays representative intensity-scaled fluorescence 
images for each experimental group at indicated time 
points after probe injection. TBR tumor-to-background 
ratios (From Kossatz et al. (2013) with permission from 
Elsevier)
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ing intravascular targets in the tumor. Numerous 
recent investigations focus on providing nanopar-
ticles with multimodal capabilities for imaging 
and therapy, given that nanoparticles provide a 
good platform for multifunctional approaches. 
Nevertheless, uptake by the mononuclear phago-
cyte system limits specificity in several organs 
(liver, spleen, etc.), and reproducibility and the 
large-scale preparation of such formulations are 
challenging. For these reasons, application has 
been limited to the preclinical stage. Typically, 
silica nanoparticles conjugated with cyanines 
(He et al. 2007; Haedicke et al. 2015), liposo-
mal nanoparticles for tumor imaging via the EPR 
effect in combination with photodynamic therapy 
(e.g., (Bendsoe et al. 2007), chitosan polymers 
(Backer et al. 2005), etc., have been proposed.
The tumor environment specifically has been 
addressed with so-called fluorescent activatable 
probes. The approach exploits the fact that tumor 
cells exhibit a different pH and different enzyme 
activity than normal cells. The corresponding 
probe does not fluoresce unless activated at the 
target site, which emits fluorescence from 
dequenching of the probe’s dye molecules. Probes 
that are pH sensitive are based on the high sensi-
tivity exhibited by chromophores to protonation 
and deprotonation (Wang et al. 2010a). Enzyme-
activatable probes contain at least two chromo-
phores in proximity to each other and connected 
by a specific peptide linker that serves as enzyme 
substrate. Due to the quenching (identical chro-
mophores) or resonance energy transfer (differing 
chromophores) effects, no or very little fluores-
cence emission takes place in the non- activated 
stage. Sample applications include the detection 
of proteases in tumors such as matrix metallopro-
teinases, caspases, cathepsins, etc. (Bremer et al. 
2001a; Messerli et al. 2004; Tung 2004).
16.1.4.2  Imaging of Infections
Infections represent a profound medical challenge 
worldwide, particularly when local infections turn 
into systemic ones. Here (fluorescence) optical 
imaging could help obtain new insights into the 
mechanisms of disease and prevention. For exam-
ple, by utilizing bioluminescence sourced from the 
luc operon (e.g., from the firefly Photinus pyralis 
or the sea pansy Renilla reniformis) or lux operons 
(Photorhabdus luminescens, Xenorhabdus lumine-
scens) on the bacterial strains of interest, their fate 
in the body and the disease mechanisms can be 
tracked via imaging. These operons express the 
luciferase enzyme which is not naturally present in 
mammalian cells. To produce light, the enzyme 
substrate luciferin is applied to the animals. In this 
context, several researchers found that biolumines-
cent bacteria could be tracked in vivo in murine 
models and that the bioluminescence intensity was 
closely related to the number of viable bacteria 
(Contag and Bachmann 2002). More recently, 
in vivo infection with Pseudomonas aeruginosa in 
an acute murine airway infection model was effi-
ciently tracked with bioluminescence imaging 
(Munder et al. 2014). To study the liver stage devel-
opment of malaria in humans and rodents, modi-
fied luciferase containing malaria parasites was 
used to analyze both hepatocytes in culture and in 
the livers of living mice (Ploemen et al. 2009).
In contrast to the analysis via utilization of 
genetic reporters, a more straightforward strategy 
designed for clinical applications is imaging with 
exogenous synthetic probes that target bacteria 
selectively. This methodology has a compara-
tively high potential for clinical translation at least 
for organs with good accessibility to light. In this 
connection, a deep-red fluorescent squaraine 
rotaxane scaffold with two appended (bis(zinc(II)-
dicolylamine) (bis(Zn-DPA)) targeting ligands 
were used to track Gram-positive Staphylococcus 
aureus and Gram-negative Salmonella enterica 
serovar typhimurium in mice. The bis(Zn-DPA) 
ligands of the probe had high affinity for the 
anionic phospholipids and related biomolecules 
that reside within the bacterial envelope, and they 
are known to selectively target bacterial cells over 
the nearly uncharged membrane surfaces of 
healthy mammalian cells. Imaging of localized 
infections was possible, and the signal was inde-
pendent of mouse humoral immune status. The 
probes did not respond to nonbacterial infections 
(White et al. 2010). Similarly, optical nanoprobes 
were designed that were composed of concana-
valin A (Con A) as a bacterial targeting ligand, a 
nanoparticle carrier, and a near-infrared fluores-
cent dye. Using a murine wound and catheter 
infection model, nanoprobes could rapidly detect 
and quantify the extent of bacterial colonization 
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on wounds and catheters in real time (Tang et al. 
2014). Additionally, detection of Staphylococcus 
aureus infection (5×107 cells) in a mouse is pos-
sible using a cationic antimicrobial peptide conju-
gated to a near-infrared dye ICG that targets the 
anionic surfaces of bacteria. This probe selec-
tively accumulates in bacteria (Liu and Gu 2013).
Similarly, it was found that uptake and hepato-
biliary excretion ICG and the hemicyanine dye 
DY635 are altered during sepsis, namely, by con-
sidering different variables including hepatic per-
fusion, hepatocellular energy state, and functional 
integrity of transporter proteins. In particular, with 
respect to hepatocellular transport of both dyes, 
excretion into bile was significantly delayed for 
both dyes and resulted in net accumulation of 
potentially cytotoxic xenobiotics in the liver paren-
chyma. Transcutaneous assessment of ICG fluo-
rescence by whole-body NIRF imaging revealed a 
significant increase starting from the 30th minute 
of ICG fluorescence in the bowel region of the 
abdomen in sham but not in septic animals, con-
firming a sepsis-associated failure of canalicular 
excretion. These results have potential implica-
tions for monitoring liver function, critical care 
pharmacology, and the understanding of drug-
induced liver injury in the critically ill (Recknagel 
et al. 2012; Gonnert et al. 2013) (Fig. 16.5).
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Fig. 16.5 Imaging of sepsis-induced excretory dysfunc-
tion, as visualized by accumulation of the xenobiotic 
indocyanine green and bilirubin. (a) NIRF imaging of 
ICG at 15 h after sepsis induction: ICG is eliminated via 
hepatobiliary excretion into the duodenum in sham ani-
mals, whereas the dye accumulates in the livers of septic 
animals, with an almost absence of fluorescence signal in 
the gut (the dotted line divides upper and lower abdominal 
quadrants for orientation). (b) Subsequent epifluores-
cence microscopic examination of liver surfaces after ICG 
administration in sham and septic animals. Stars: central 
veins (pseudo-colored). (c) ICG fluorescence intensities 
around central veins were significantly higher in septic 
compared to sham-operated animals (*p = 0.031 com-
pared to sham). (d) Micro-Raman images of tissue sec-
tions from liver sections obtained from sham-operated 
and septic rats. In the livers of the septic rats, elevated 
relative intensities of the bilirubin component were found 
in the perivenous region (stars), but only minor local spots 
of bilirubin were observed of control animals. Scale bars: 
50 mm. (e) Raman spectrum of the bilirubin component 
(red trace) with crystalline bilirubin for comparison 
(black trace) (From Recknagel et al. (2012) (open-access 
article))
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16.1.4.3  Preclinical Attempts 
at Alzheimer Imaging
Diagnosis of many neurodegenerative diseases 
continues to pose challenges. For example, a reli-
able discrimination of Morbus Alzheimer from 
other neurodegenerative diseases can only be 
accomplished post-mortem. For this purpose, the 
presence of amyloid plaques and tau fibrils in 
brains of AD patients is assessed. In living 
patients, the utilization of Florbetaben®, an 
18 F-labeled amyloid ligand for image-based 
detection via PET, is currently in a phase III clini-
cal trial (Barthel et al. 2011). The use of optical 
methods would bypass the use of radioactive 
tracers in AD image-based detection, which pres-
ent a challenge given that they require a local 
cyclotron for production of positron-emitting 
radionuclides and a synthesis unit to produce 
radiolabeled agents.
Interestingly, tau and amyloid have been 
detected not only in the brain (e.g., cortex) but 
also in the retina (Koronyo-Hamaoui et al. 2011). 
In contrast to the brain, the eye is easily accessi-
ble to light thanks to its natural functions. 
Therefore, fluorescing small molecules with high 
affinity for aggregated proteins might be used to 
report protein aggregation in the retina. In this 
context, after intravenous injection of a fluores-
cent probe targeting amyloid plaques and/or tau 
fibrils, the subsequent illumination of the eye 
with light of defined wavelengths would presum-
ably reveal the presence of molecular alteration 
in AD. Nevertheless, there are still several chal-
lenges to be overcome with regard to (1) passage 
of the fluorescence reporter to the brain barrier, 
(2) clearance of non-bound reporter molecules 
from the tissue, and (3) demonstrating a verified 
correlation of pathological changes in the brain 
and (cognitive) symptoms with pathological 
abnormalities in the retina. Of interest in this 
connection are several novel probes based on the 
bis(arylvinyl)pyrazine, bis(arylvinyl)pyrimidine, 
and the asymmetric hemicyanine family molecu-
lar structure. Among these, bis(arylvinyl)pyr-
azines represented the most promising UV–vis 
probes in terms of biocompatibility. Regarding 
their affinity to Aβ and tau, defined bis(arylvinyl)
pyrimidines are the best ligands, endowed with 
good prospects for AD detection. Additionally, 
asymmetric hemicyanine exhibited good selec-
tivity for amyloid plaques and tau fibrils at a level 
similar to that of bis(arylvinyl)pyrazines as well 
as low cytotoxic effects on human cell lines 
within the investigated NIR dyes. The data pro-
vides a solid base for further investigations of 
their applicability to image-based detection of 
AD in vivo (Bolander et al. 2012). Moreover, a 
series of rhodanine-3-acetic acids was synthe-
sized and shown to bind to neurofibrillary tangles 
with a comparably high binding affinity (e.g., 
IC50 = 19 nM) (Anumala et al. 2013). Lastly, tri-
methine cyanine dyes bind to tau fibrils (Gu et al. 
2013).
In other studies, oxazine dyes (Hintersteiner 
et al. 2005) have been used to track Aß in AAP23 
transgenic mice, as have thiobarbitals (Okamura 
et al. 2011). The dimethylamine structural signa-
ture seems to favor binding affinity of compounds 
to Aß, and it is likely that this functionality is 
important for Aβ interaction. Dimethylamines 
can be found in chalcones, benzothiazoles, or 
imidazopyridines among others (Eckroat et al. 
2013). In addition, other small-molecule fluores-
cent probes as reporters of amyloid formation, 
including single-molecule determinations such 
as JC-1, DCVJ, ANS derivatives, and lumines-
cent conjugated polymers as well as site-specific 
probes such as pyrenes, have been suggested 
(Bertoncini and Celej 2011).
16.1.4.4  Imaging of Inflammation
Inflammation is basically associated with the 
release of exogenous and endogenous chemical 
mediators after tissue injury. Exogenous media-
tors (e.g., microbial peptides) act as chemoat-
tractants which in turn recruit neutrophils to the 
target site. Typically, their aim is to phagocytize 
invading microorganisms and cellular debris. 
These response functions protect the host and 
normally they are self-limiting. Once the xeno-
gen material has been removed, the inflamma-
tory reaction will be resolved. In this context, 
leukocytes and debris from inflamed sites are 
removed in order to return to homeostasis. This 
tightly regulated biochemical and metabolic 
process can become chronic if the resolution of 
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the inflammation process is altered (Serhan 
et al. 2008).
Inflammation in the body can also be triggered 
by diverse intrinsic pathophysiological alterations 
leading to tissue lesions. A typical example is 
atherogenesis in blood vessels. In such a case, the 
inflammation process is triggered by infiltration 
of atherogenic lipoproteins into endothelial cells. 
This process ultimately leads to the formation of 
plaques. Acute thrombotic closures of coronary 
arteries can occur as a result of ruptures of the 
fibrous cap and exposure of the thrombogenic 
core to the blood (Jackson 2011).
For this reason, special attention was devoted 
to the examination of inflammatory plaques via 
imaging, since early detection and therapy can 
help reduce cardiovascular mortality and morbid-
ity. To this end, fluorescence imaging was related 
to the development of fluorescence cardiovascu-
lar catheters for clinical application and/or to 
unveil important mechanisms of plaque forma-
tion in preclinical research activities designed to 
provide new insights into prevention and therapy. 
Specific fiber systems have been proposed; ini-
tially, they were based on one-dimensional sys-
tems and more recently on rotational ones. These 
developments have been summarized in several 
technical reviews (Jaffer et al. 2007; Lipinski 
et al. 2006; Nahrendorf et al. 2007). From the 
pathobiological point of view, the activity of 
matrix metalloproteinases and cathepsins, which 
are known to play an important role in rupture of 
vulnerable plaques, has been assessed (Chen 
et al. 2002). Subsequently, MMP-2, MMP-9, and 
cathepsin K und S were also efficiently imaged in 
atherosclerotic apoE mice (Jaffer et al. 2007; 
Deguchi et al. 2006; Galande et al. 2006) in pre-
clinical research approaches using FMT, which 
provided deeper tissue penetration capabilities 
compared to epi-illumination techniques. 
Additionally, intensive research on the mecha-
nisms of atherosclerosis and thrombosis forma-
tion is being performed at the high-resolution and 
high-speed intravital microscopic level, as 
reviewed by (Taqueti and Jaffer 2013).
Rheumatoid arthritis, a serious disease which 
can lead to pronounced activity limitation, disabil-
ity, and reduced quality of life, is also known to be 
associated with inflammation. Diagnosis and indi-
vidualized therapies are important factors in the 
fight against this disease. Primarily it is the wrists, 
hands, elbows, shoulder, knees, and ankles that are 
affected. Even with different imaging technologies 
in radiologic routines in use for detecting inflam-
matory arthritis and osteoarthritis, fluorescence 
imaging holds great promise since affected joints 
are located near the body surface and thus are 
mostly well accessible to light. It is expected that 
(fluorescence) optical imaging can contribute to 
detection and quantification of pathomorphologies 
and pathophysiologies in inflammatory rheumatic 
diseases such as angiogenesis, hypervasculariza-
tion, hypoxia, and hypermetabolism – not only in 
the preclinical but also in the clinical stage. To this 
end, different optical modalities, such as spectro-
scopic methods, transillumination imaging, dif-
fuse optical imaging, fluorescence and 
bioluminescence imaging, photoacoustic imaging, 
etc., have been analyzed. These research activities 
have been reviewed by Chamberland 2010. With 
regard to fluorescence optical imaging, the follow-
ing have been studied: folate receptors (Chen et al. 
2005), the F4/80 antigen present on the surface of 
macrophages (Hansch et al. 2004), cathepsin B 
(Lai et al. 2004), fluorescent-labeled leukocytes 
(Simon et al. 2006), perfusion in arthritic joints 
depending on the molecular weight of the probes 
(Dietzel et al. 2013), targeting glycosaminogly-
cans in cartilage degeneration via dipicolylamine 
(DPA) probes (Hu et al. 2014), and E-selectin 
(Jamar et al. 2002; Marshall and Haskard 2002). 
Image-based detection of rheumatoid arthritis in 
patients by using ICG as contrast agent is being 
analyzed in several clinical studies (Schafer et al. 
2013).
In other studies, the mechanisms of inflamma-
tion have been investigated in different animal 
models. These encompassed granuloma forma-
tion using fluorescence-labeled macrophages 
(Eisenblatter et al. 2009), presence of CysLT1 in 
edema models (Busch et al. 2011), selective visual-
ization of liposomal uptake by macrophages upon 
dequenching in endolysosomes) (Tansi et al. 2013), 
the occurrence of FRET upon uptake of two exog-
enous probes in endolysosomes of phagocytes 
(Busch et al. 2012), and others (Fig. 16.6).
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16.1.5  Conclusion
Fluorescence imaging is an active and promising 
area of research and application in the preclinical 
and clinical field. NIRF imaging is especially 
promising thanks to greater tissue penetration 
depths of light and low interference by tissue 
autofluorescence. A wide spectrum of NIR fluo-
rophores is now available. When utilizing con-
trast agents in vivo, several parameters influencing 
signal-to-background ratio are important for 
effective imaging applications. These include 
selection of excitation and emission wavelengths, 
solubility, photobleaching, target affinity, and 
pharmacokinetics, to name a few. Although sev-
eral clinical studies with ICG are under way with 
a focus on detection of rheumatoid arthritis and 
certain tumors, the approval of other fluorescent 
probes, particularly for target-affine reporters, is 
a large undertaking. In this regard, probes with 
applicability in several disease frameworks (e.g., 
vascular targets in inflammation and cancer) will 
be of higher interest to pharmaceutical compa-
nies. With respect to hardware, epi-illumination 
techniques are widely used in preclinical 
research, although substantial advances have 
been made in producing tomographic systems, as 
well as other sophisticated systems (e.g., opto-
acoustic imaging). In the long term, clinical 
research, applications, and discrete fiber and 
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Fig. 16.6 Selective detection of liposomal uptake by 
macrophages upon dequenching endolysosomes. (a) 
Representative in vivo NIR fluorescence imaging of 
edema using quenched liposomes (Lip-Q) or the hemicya-
nine dye DY-676-COOH (concentration equivalent to 
Lip-Q content) or PBS, pH 7.2. (b) Semiquantitative 
 analysis of fluorescence intensities of edema. (c) Bio-
optical ex vivo images of organs from mice 6 h post probe 
application. (d) Semiquantitative analysis of fluorescence 
intensities of organs after ex vivo NIR imaging (From 
Tansi et al. (2013) with permission from Wiley and Sons)
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intraoperative systems will markedly improve the 
accuracy of interventional procedures.
16.2  Bioluminescence Imaging
Frauke Alves and Julia Bode
16.2.1  General Introduction
Optical imaging offers many unique opportuni-
ties in order to study biological processes in 
intact organisms. One option for the measure-
ment of in vivo optical signals is biolumines-
cence. There has been a rapid growth of 
bioluminescence imaging applications in small 
animal models propelled by the approaches in 
technology during the last years.
In general, bioluminescence refers to the pro-
cess of visible light emission in living organisms. 
Light as a form of energy consists of photons 
with different wavelengths. Light is not only the 
visible light that can be seen by the human eye 
with wavelength ranges from around 380 nm 
(violet) to about 740 nm (red), it also means that 
visible light is only a small part of the total elec-
tromagnetic light. This extends from gamma rays 
(10−12 m) through X-rays, ultraviolet, visible, and 
infrared or near-infrared light up to microwaves 
and radio waves (103 m) (Sadikot et al. 2005).
There are two major groups where the emis-
sion of light can be classified in; one is thermal or 
heat radiation, whereas the other class consists of 
nonthermal radiation (Moreno et al. 2014).
16.2.2  Production of Light by Living 
Organisms
A variety of different bioluminescent systems 
have been identified in nature, every single one 
requires a specific enzyme and substrate. Living 
organisms produce light via luminescence. These 
luminescent species can be found across almost 
all major taxonomic groups ranging from bacte-
ria via hydrozoa, fungi, or insects up to higher 
organisms such as fishes. Only few groups exist 
with no known luminescent forms such as spi-
ders, birds, mammals, or flowering plants (Contag 
et al. 1998; Haddock et al. 2005, 2010).
The majority of luminescent organisms is of 
marine origin and indwells the ocean. They can 
be found all over the ocean depth, but the major-
ity lives in the disphotic zone from 200 to 1000 m 
where only a small part of the sunlight from the 
surface reaches this area. The seawater above 
absorbs most wavelengths of light in the range of 
red, orange, and yellow. Only the light with range 
of blue or blue green light with a short wave-
length of about 475 nm and more energy reaches 
the deeper area of the ocean, an almost com-
pletely dark place. That is why many of the 
organisms adapted to life and now have the 
 ability to produce their own light (Warrant and 
Locket 2004). Forms of luminescent terrestrial 
life can be found all over the world where they 
indwell different habitats and where they use 
light for diverse reasons. For example, swarms of 
glowworms or fireflies dance in the dark in order 
to impress the sexual partner with the blinking 
light (Li et al. 2013a; Close et al. 2011).
Armillaria species are other examples for ter-
restrial luminescence that is the most common 
source of foxfire. Out of about 40 known 
Armillaria species, five have been described as 
luminescent. The mycelium of one single 
Armillaria is able to reach tremendous dimen-
sions with cases describing covering an area as 
large as 9 km2 (Zhao et al. 2008; Mendes et al. 
2008; Desjardin et al. 2008; Miller et al. 2005).
16.2.3  Production of Light 
and Mechanisms
In 1885, a French scientist, Raphael Dubois, veri-
fied the idea of bioluminescence being a result of 
a chemical process. He made a paste of the lumi-
nescent material from the clam Pholas and sus-
pended it in cold water leading to the production 
of a glowing solution. Additionally, Dubois was 
able to show that this reaction was repeatable 
with extracts of the click beetle (Pyrophorus). 
Out of his studies, Dubois concluded that biolu-
minescence was chemical in nature and that there 
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is an organic molecule involved. He named this 
molecule luciferin and the responsible enzyme 
luciferase (Poisson 2010; de Wet et al. 1985).
Decades later the biochemical reaction of bio-
luminescence, when energy is converted into light, 
was solved. The substrate luciferin is oxidized by 
molecular oxygen, whereas the enzyme luciferase 
catalyzes the reaction toward a nonreactive prod-
uct and the release of photons. Figure 16.7 shows 
a simplified scheme of the biochemical reaction.
In detail, luciferin is oxidized to oxyluciferin 
by luciferase – oxygen and ATP are needed for 
the reaction as well.
The most commonly used bioluminescent 
reporter for research purposes is luciferase from 
the North American firefly (Photinus pyralis). 
Other useful luciferases have also been cloned 
from jellyfish (Aequorea), sea pansy (Renilla), 
corals (Tenilla), click beetle (Pyrophorus pla-
giophthalamus), and several bacterial species 
(Vibrio fischeri, V. harveyi) (Hastings 1996).
In comparison to firefly and click beetle lucif-
erase, Gaussia luciferase and Renilla luciferase 
use coelenterazine and oxygen. Here ATP is not 
needed since coelenterazine alone is a high- 
energy molecule that offers the energy for the 
reaction (Soling et al. 2004). All reactions have in 
common that they need oxygen.
During the reaction, a peroxyluciferin is built as 
an intermediate that provides energy for excitation. 
The peroxyluciferin holds the energy coming from 
the reaction only for nanoseconds, and afterward 
the energy is released in the form of a photon.
With awareness of this phenomenon, different 
luciferases were generated by inducing mutations at 
important amino acids close to the enzymatic gap in 
order to emit light with different wavelengths. The 
energy conversion efficiency is with more than 
80 % of energy transformed into light that produces 
close to one photon per oxidized luciferin.
Since the differences in luciferin substrate 
utilization result in no crossover reactions, both 
techniques, the D-luciferin system and the coelen-
terazine system, can be used in parallel, for exam-
ple, in the same animal. Each luciferase has its own 
substrate specificity, characteristic wavelength of 
light emission, and its optimal parameters.
Firefly luciferase was cloned in 1985 for the 
first time. Only 3 years later, an assay was 
invented that made it possible to detect luciferase 
activity in mammalian cell lysates. The develop-
ment of this assay became a useful tool in order 
to set up in vivo studies of gene regulation with 
luciferase activity.
One of the many advantages of luciferase is 
that it is a perfect marker for gene expression 
because there is no posttranslational modifica-
tion. Additionally, the halftime of luciferase 
in vivo is approximately 2 h (Ignowski and 
Schaffer 2004). The light emission from this fire-
fly catalyzed luciferin reaction is broad band 
from 530 nm to 640 nm and peaks at 562 nm. The 
spectrum of this emission allows, together with 
the properties of biological tissues, the light to 
penetrate through several centimeters of tissue. 
This is true especially for light with spectral con-
tent of above 600 nm. This special feature can be 
used to detect light that is emitted from internal 
organs in mice expressing luciferase as a reporter.
There are several factors involved affecting 
the sensitivity of detecting internal light sources. 
One major factor is the level of luciferase expres-
sion of cells. Another one is the depth of cells 
expressing luciferase within the body because it 
influences the distance of photons that have to 
travel through the animal tissue. Last is the 
 sensitivity of the detection system used for col-
lecting the light signal.
Another big advantage of this method is 
the commercial availability of luciferin or 
D-luciferin. Several biochemical companies all 
ATP (energy)
luciferase
+ O2 + light
oxyluciferinluciferin
Fig. 16.7 Oxidation of luciferin and catalyzation of the 
reaction through luciferase. The side product light can be 
detected
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over the world sell it for research reasons (e.g., 
Life Technologies, Sigma-Aldrich, PerkinElmer, 
and many more).
For experimental handling, the first step in 
order to start a bioluminescence measurement is 
to place the animals in a dark chamber. To detect 
the light, emitted from the animal, photons are 
collected by a charge-coupled device (CCD) 
camera in combination with a computer for 
image acquisition and analysis of data. These 
CCD cameras first gather and then convert pho-
tons into electrons after striking silicon wafers. 
The intensity of incident photons is encoded into 
electrical charge patterns to generate an image.
During the last years, great advances have 
been made in order to improve detector technol-
ogy to get better sensitivity and image quality. 
The background noise of the bioluminescence 
imaging machine is reduced by supercooling of 
the system and mounting the CCD camera in this 
lighttight dark box as mentioned before.
For the bioluminescence experiment itself, it 
is important that acquisition and analysis param-
eters remain constant when relative photons or 
counts are acquired. This includes, for example, 
the animal position relative to the CCD camera, 
the region of interest, and f-stop (the ration of 
lens focal length to the diameter of the entrance 
pupil). The absolute unit of radiance is photon/s/
cm2/steradian, and it refers to the photons per 
second of light that radiate from the mouse in a 
unit area (1 cm2) and unit angle (1 steradian). 
This unit is more quantitative but enables an eas-
ier comparison of data in an experiment when 
image acquisition parameters are greatly 
different.
The concentration of administered luciferin 
also needs to be kept stable during experiments. 
Using the most commonly used concentration of 
150 mg/kg per body weight for an animal, the 
experiment is cheap (with costs of around 300 
Euro per 1 g D-luciferin), nontoxic for the labo-
ratory animal, and easy to order and storable. The 
D-luciferin solved in PBS can be stored in−20 °C 
for several months up to 1 year.
However, one problem for bioluminescence 
imaging is caused by D-luciferin itself. Since it is 
not produced by rodents, it needs to be injected 
systemically in order to travel through the blood-
stream and needs to pass different membranes or 
barriers before it can reach the point or cells of 
interest. Different types of injections are dis-
cussed in the next chapter in more detail.
In addition, another disadvantage that 
D-luciferin causes itself is that it was first 
believed that for the rapidness of the enzyme 
luciferase, there is no restriction for the used 
D-luciferin. But it was reported that the detected 
in vivo signals correlate with the injected sub-
strate dose, especially if there is a high number of 
cells expressing luciferase in vivo. This phenom-
enon shows that the higher the administered dose 
of D-luciferin in the animal is, the better the 
enzyme luciferase works close to its maximum 
velocity.
Because of the similarity of luciferin to albu-
min, it does not cause an immune response. Even 
though luciferin is able to freely cross the blood 
barrier and the placental barrier, toxicity appears 
low (Tiffen et al. 2010).
16.2.4  Luciferase as a Reporter 
Gene for In Vivo Imaging
The luciferase substrates need to be injected in 
rodents in order to be provided for the biolumi-
nescence reaction in vivo as mentioned. There 
are different choices of injections that the experi-
menter can choose: intravenously and intraperi-
toneally are the most commonly used. 
Additionally, there are subcutaneous injections 
or less frequently used intratumoral injections or 
oral applications (Hiler et al. 2006; Inoue et al. 
2009; Keyaerts et al. 2008, 2012; Wang and 
El-Deiry 2003). One advantage of intraperitone-
ally injections is the straightforwardness because 
the animal does not need to be anesthetized and 
the procedure itself is fast and easy. For injec-
tions in the tumor region, depending on the tissue 
or organ, or intravenously, the animal needs to be 
anesthetized. Before starting an experiment, sev-
eral factors need to be considered. First, the 
injection site of the substrate needs to be dis-
cussed. This depends, for example, on the health 
situation of the animal and the question whether 
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there is an incubation time needed before starting 
a bioluminescence measurement. It takes several 
minutes for the substrate to reach the region of 
interest (ROI); therefore, the times of incubation 
need to be validated for every experimental 
approach. The time that is needed for the lucif-
erin to reach the ROI may differ from tissue to 
tissue and in every experimental setup. For exam-
ple, the incubation time of the substrate can differ 
depending on the organ or tissue where cells 
expressing luciferase are placed: the abdomen, 
neck, or brain of the animal.
To give an example for bioluminescence 
imaging in a tumor model, one excellent example 
for the use of bioluminescence imaging in pre-
clinical research is the detection of brain tumors 
in small rodents. D-luciferin readily crosses the 
blood–brain barrier and allows early examination 
of tumor growth in the brain tissue. Depending 
on the cell line and the strength of luciferase 
expression in the brain, tumor cells can be deter-
mined only hours after cell injection.
In addition to the time that is needed for the 
luciferin to cross the total body of the animal, the 
start point for the bioluminescence measurement 
needs to be determined because the biolumines-
cent signal proceeds over time. Imaging of the 
whole animal can be conducted 5–15 min after an 
intraperitoneally application of D-luciferin, with 
a relatively stable light emission level for 30–60 
min, depending on the experimental conditions. 
Afterward the BLI signals decrease and disap-
pear after a maximum duration of three hours.
The reaction in the animal emerges in no 
background signal for the D-luciferin reactions in 
the absence of the enzyme. For example, for the 
coelenterazine reactions, an auto-oxidation of 
this high-energy molecule occurs at a low veloc-
ity. This results in a low background signal even 
if there is no luciferase present. For in vitro lucif-
erase assays, it is described that with boundless-
ness of ATP, oxygen, and D-luciferin, the 
correlation between enzyme concentration and 
signal intensity is excellent.
In contradistinction to advantages by using 
bioluminescence imaging, the interpretation of 
data obtained from in vivo bioluminescence is 
not always straightforward.
For example, a mouse bearing a massive subcu-
taneous tumor expressing luciferase leads to a bio-
luminescence signal after injection of luciferin. 
This signal can be misinterpreted. Cells in the core 
of the tumor can be apoptotic or parts of the tumor 
necrotic. Necrotic tissue is not able to express 
luciferase or to provide oxygen or ATP. This leads 
to a reduction of the total bioluminescence signal, 
and the signal is not correlated to the real size of 
the tumor. In addition, parts of the tumor region 
that grow deeper in the tissue can lose maximal 
values of counts because of the depth. The emitted 
counts do not display a correlation of tumor cells, 
and therefore it can result in an imbalance between 
signal and real tumor volume. Furthermore, the 
density of vessel density or the leakiness of vessels 
that means reachability of luciferin for the lucifer-
ase expressing cells needs to be kept in mind 
because it can influence the bioluminescence sig-
nal as well. This has to be considered for the mea-
surement of growth rates of brain tumors, for 
example. Questions that can arise while working 
with brain tumors are if the luciferin is crossing the 
blood–brain barrier up to 100 % or if the tumor 
region in the brain is reachable via new developed 
vessels. In general, a highly vascularized tumor, 
independent from the tissue, might even give a 
much higher bioluminescence signal than a tumor 
of the same size with less vessel density.
A major point that is important for the experi-
mental setup and the interpretation of data is the 
approximately tenfold loss of photon intensity 
for each centimeter of tissue depth. Furthermore, 
images are surface weighted meaning that light 
sources closer to the surface of the animal appear 
brighter compared with deeper sources. In addi-
tion, changes in geometry can occur and can 
influence, for example, the growing tumor or scar 
tissue, or the optical properties of tissues can 
affect light scatter or absorption and therefore the 
detected bioluminescent signal.
In literature, there is one commonly used 
D-luciferin concentration described, 150 mg/kg, 
that is nontoxic for the animal and used by many 
researchers. For coelenterazine, a much lower 
concentration of 0.5–4 mg/kg is usually injected 
because of a limitation of solubility of the sub-
strate in aqueous solution.
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There are several parameters that can influ-
ence the sensitivity of bioluminescence imaging. 
Newly developed instruments, for example, with 
a new camera system are more sensitive in detec-
tion of small signals.
As mentioned before, the signal can be weak-
ened by the depth of the tissue. Additionally the 
hair of the rodent can disturb or weaken the sig-
nals as well.
Parameters for imaging, like acquisition time, 
binning, and the positioning of the animal, need 
to be optimized for every experimental approach. 
Also of high importance for the bioluminescence 
experiment is the level of promoter activity con-
trolling the expression of luciferase. In addition, 
the amount of luciferin injected in the animals 
and the diet are sensitive parameters as the gut 
phosphorescence leads to an increase in the back-
ground signal in animals.
But in contrast to other in vivo preclinical 
imaging techniques, bioluminescence imaging is 
a versatile and cost-effective technique with high 
sensitivity. Three to five animals can be measured 
in parallel at the same time during one experi-
ment, and the acquisition of data takes a few sec-
onds up to some minutes. By reducing the amount 
of animals that can be investigated in parallel 
during one measurement and by lowering the dis-
tance to the CCD camera, the sensitivity can be 
increased. Optimizing settings and conditions 
leads to light detection only from areas that con-
tain luciferase, and there is no or minimal back-
ground noise visible.
One critical point in BLI is the half-life time 
of luciferase. The half-life of luciferase activity 
in live cells was measured in real time and was 2 
h (Ignowski and Schaffer 2004).
The enzyme has to be produced continuously 
for the detection of signals. When cells, that 
express the luciferase, die or when the promoter 
elements turn the luciferase “off” or inactivate 
the gene signals from the luciferase, activity 
disappears.
In comparison to other in vivo imaging tech-
niques, the measurement time for biolumines-
cence is significantly less (Zinn et al. 2008). Data 
acquisition with PET, SPECT, or MRI takes 
30–60 min, and only one rodent can be measured 
during that time. Therefore, there is a limitation 
of animals that can be monitored at one single 
day during one experiment. In comparison, five 
mice can be measured in parallel in a biolumines-
cence experiment, and the whole measurement 
takes only some minutes.
This fact increases the amount of animals that 
can be measured at one single day. Additionally 
in comparison to PET, SPECT, or MRI, data 
analysis takes less time for BLI. In PET and 
SPECT, contrast agents are needed, and radiola-
beled probes have to be prepared prior to the 
experiment. PET or SPECT result in background 
signals that reduce the sensitivity or signals in all 
locations, including those compounds that are 
metabolized or excreted by normal routes. 
Bioluminescence imaging can provide 2D and 
3D images. But one major disadvantage of this 
method is the lack of translation to the applica-
tion in humans because of the requirement for 
genetically encoded luciferase and the depen-
dence of light signal on tissue depth.
16.2.5  Functions 
of Bioluminescence
The research that can be performed with biolumi-
nescence imaging can be divided into two major 
parts. One includes routine investigations, in 
which a control element (promoter) for the lucif-
erase that is always active in transfected cells is 
used. It is “on” under all conditions and in all tis-
sue types. A highly active promoter that is often 
used and expressed in all tissue types is the cyto-
megalovirus (CMV) immediate-early promoter. 
Purposes for routine applications in vivo are 
detection of tumors or monitoring of their growth 
in cancer research. Gene therapy studies in com-
bination with targeting of vectors or investigation 
of migration of adoptively transferred cells in cell 
therapy studies are also commonly performed.
For tumor imaging, plasmid or viral tech-
niques are effective for the stable transfection of 
cancer cells with the luciferase reporter construct. 
This constitutive expression of luciferase is one 
strategy to use bioluminescence as a tool. These 
cells that constitutively express luciferase are 
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implanted in syngeneic animals, but in the case of 
human cancer cell lines, immunodeficient mice 
or rats are required and can be monitored over a 
specific time.
Studies in combination with BLI have been 
reported for human cancer cell lines of meningi-
oma, bladder cancer, prostate adenocarcinoma, 
neuroblastoma, hepatocellular carcinoma, breast 
cancer, hematologic malignancy, lung cancer, 
melanoma, and glioma models and moreover 
encompass humanized as well as metastatic mod-
els (Maes et al. 2009).
For example, bioluminescence showed an 
excellent correlation between tumor size and 
light emission when human breast cancer cells, a 
subclone of MDA-MB-231, that stably express 
the luciferase gene under control of the CMV 
promoter, were implanted in the mammary fat 
pad of a mouse model. By bioluminescence 
imaging, the cells were detected in the mammary 
fat pads of nude mice, and later, tumor growth 
rates could be determined. This method has been 
described for the preclinical assessment of the 
effectiveness of novel therapies for ovarian can-
cer and for animal models of prostate cancer 
(Brakenhielm et al. 2007; Kanerva et al. 2003). 
Differences in obtained bioluminescence signals 
correlate with a reduction in tumor size after 
treatment.
One study showed a tumor determination in 
the mammary fat pad of a mouse 19 days after 
injection, but with bioluminescence imaging, 
tumor cells (1 × 106) could be detected 
 immediately after implantation. 15 min after 
intraperitoneal D-luciferin administration, the 
bioluminescent signal could be measured. The 
same study defined the minimum amount that 
could be detected subcutaneously by BLI with 
only 5 × 103 cells (Zinn et al. 2008). This exam-
ple shows the sensitivity of this detection method, 
and one advantage the following: luciferase 
expressing tumor cells can be detected immedi-
ately after implantation in the animal model even 
weeks before the tumor can be detected by man-
ual testing.
In comparison to monitoring a subcutaneous 
tumor that is visible or can be detected with man-
ual testing, detection of metastasis of cancer cells 
within the whole body in rodents is not trivial. 
For this approach, bioluminescence imaging is 
particularly sensitive. Cowey et al. could show 
that immediately after injection of MDA-MB-435 
breast cancer cells in the left ventricle of mouse 
hearts, the cells were detected in the blood pool 
with an overall body scan with BLI (Cowey et al. 
2007). Forty-two days after injection of cells, 
bioluminescence imaging allowed the detection 
of metastases in the spine, joints, and head 
(mandibles).
For the detection of brain tumor growth 
in vivo, one of the best options besides MRI is 
bioluminescence imaging. The luciferin is able to 
cross the blood–brain barrier, and even days after 
tumor cell injection in the brain, signals can be 
measured. There are reports available that 
describe a detection of tumor cells even 7 days 
after injection in the brain.
In order to monitor the increasing luciferase 
expression and therefore increasing proliferation 
of human glioblastoma cells in a mouse model 
in vivo over time, 75,000 U87 MG cells, lentivi-
rally transfected with luciferase, were injected in 
the right hemisphere of mouse brains according 
to Sabag, Bode, and Fink et al. (Sabag et al. 
2012). The first bioluminescence signal was mea-
sured 12 days postinjection. Figure 16.8 shows a 
representative image of a measurement of mice 
each bearing a glioblastoma multiforme. The 
expression of luciferase in the brain was detected 
after an incubation time of ten minutes after 
intraperitoneal injection of D-luciferin (150 mg/
kg KG), exposure time of seven minutes, and bin-
ning of four. No expression of luciferase was 
detected initially after injection of PBS in a 
tumor-bearing mouse (negative control, right 
mouse).
Injection of D-luciferin resulted in biolumi-
nescence signals in the here shown two mice. 
Both mice were injected with the same amount of 
tumor cells at the same day.
The obtained bioluminescence signals demon-
strate the heterogeneity of glioblastoma growth 
in vivo. Mice were then chosen for MRI studies 
using a newly developed contrast agent for the 
detection of brain tumors in mouse models 
in vivo. The goal was to investigate the enrichment 
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of contrast agent in brain tumors with different 
sizes in order to optimize the resolution of MRI 
and to find a correlation with obtained biolumi-
nescence signals.
One disadvantage that we observed during 
this study was the deviation from the location of 
the tumor in the brain and the obtained biolumi-
nescence signal. A tumor grown deeper in the 
brain tissue led to a smaller BLI signal compared 
to a tumor, smaller in size, that grew in a more 
cranial direction. The method is not suitable for 
monitoring treatment effects of brain tumor 
growth in vivo. The reason is the event of default 
of missing the right time of, for example, injection 
of a drug. The brain tumor is only detectable with 
BLI when (i) the size is big enough and (ii) the 
location is not too deep in the tissue.
One advantage of this technique is the fast and 
easy way of monitoring the proliferation of cells 
over time in vivo depending on the location of 
tumor cells in the tissue. It is a technique that 
allows to investigate tumor growth of a cancer 
type that cannot determined easily in vivo.
Noninvasive bioluminescence imaging was 
also applied to monitor preclinically pancreatic 
tumors, a tumor also not visible from the out-
side. Therefore, 1×106 luciferase-transfected 
human pancreatic adenocarcinoma PancTu-I cells 
2.5
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Fig. 16.8 Bioluminescence imaging of nude mice 12 
days after injection of 75,000 luciferase-positive U87 MG 
glioblastoma multiforme cells into the right hemisphere. 
(Left, middle) Luciferin 150 mg/kg bw was given intra-
peritoneally; imaging times of 7 min and a binning of 4 
were kept constantly A brain tumor-bearing mouse as con-
trol after injection of PBS shows no BLI signal (right). 
The pseudo-color scale bar represents the intensity of 
light emission with different colors (Unpublished data: 
T. Krüwel and J. Bode)
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(PancTu-I-luc) were orthotopically injected into 
the head of the pancreas of nude mice. Whole- 
body scans 23 days after cell implantation using 
the IVIS Spectrum in vivo imaging system 
(Fig. 16.9) and 13 min after the i.p. injection of 
150 mg/kg D-luciferin show bioluminescence sig-
nals over the tumor areas corresponding to a dis-
tinct tumor growth and expansion in each mouse.
Another example for an application of biolu-
minescence imaging is the detection of bacteria 
(Burns-Guydish et al. 2005; Siragusa et al. 1999), 
for example, the colonization of Citrobacter 
rodentium in wild-type C57BL/6 mice. It was 
shown that the bacterial colonization of the ani-
mal after inoculation could be monitored over a 
time of over 15 days. The technique demon-
strated that the pathogens are cleared from the 
body at day 9 or 10 post transfection that was 
complete by days 15 to 17. By applying a biolu-
minescent strain of C. rodentium, it could be 
shown that after the removal of the abdominal 
wall and bacterial exposure of the cecum and 
colon, the Citrobacter preferentially colonized 
the cecal lymphoid patch and the mid and distal 
colon. The mice were kept in a chamber in a bio-
safety cabinet. The chamber was sealed to avoid 
bacterial exposure of other animals; therefore, 
bioluminescence signals and the position of bac-
Luminescence
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Fig. 16.9 Representative in vivo 2D bioluminescent 
images of three pancreatic tumor-bearing nude mice, 23 
days after orthotopic implantation of 1 × 106 luciferase- 
transfected PancTu-I cells into the head of the pancreas. 
Bioluminescence signal was measured 13 min after i.p. 
injection of D-luciferin 150 mg/kg (Unpublished data: 
M. Saccomano)
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teria in the animal were sensitively detected 
(Wiles et al. 2004, 2006).
There are specialized research applications for 
reporter constructs which are only active under 
defined conditions. For example, detection of 
apoptosis with bioluminescence signals can be 
realized to evaluate newly developed cancer ther-
apies. In order to unravel gene regulation or to 
study other biological processes, one approach 
using bioluminescence imaging is to generate 
transgenic mice, expressing luciferase during 
developmental processes.
In another transgenic mouse model, fire-
fly luciferase was expressed under the control 
of the VEGFR2 promoter in order to noninva-
sively elucidate the temporal profile of VEGFR2 
expression after stroke as a biomarker for VEGF/
VEGFR2 signaling (Adamczak et al. 2014). In 
their study they described that VEGFR2-related 
signaling is active at least up to 2 weeks after the 
infarct and results in increased vascular volume. 
Furthermore, this study presented a novel strategy 
for the noninvasive evaluation of angiogenesis- 
based therapies.
Bioluminescence imaging detects the expres-
sion of the luciferase as a genetic reporter. There 
are several opportunities to control the expres-
sion based on the activity of the promoter ele-
ment, for example, monitoring the expression of 
luciferase in the liver under specific tissue condi-
tions. The CMV promoter is only “on” or active 
when it is integrated in hepatocytes. A different 
promoter like cyclooxygenase 2 L (cox-2 L) is 
not active under normal conditions in the liver, 
but it is active or “on” in the presence of inflam-
mation (Ishikawa et al. 2006). It was shown that 
the technique is sensitive enough to detect the 
inflammation caused after lipopolysaccharide 
(LPS) injection. After LPS injection, expression 
of luciferase was induced and could be measured. 
No expression in liver tissue was detected ini-
tially (Iyer et al. 2005, 2006).
Another well-characterized application of bio-
luminescence imaging is the investigation of 
tumor hypoxia.
Tumor hypoxia plays an important role in pro-
moting malignant progression and affecting ther-
apeutic response negatively. There is little 
knowledge about in situ, in vivo, tumor hypoxia 
during intracranial development of malignant 
brain tumors because of lack of efficient means to 
monitor it in these deep-seated orthotopic tumors. 
Bioluminescence imaging with a reporter gene 
system under the control of a promoter sequence 
can be used to monitor hypoxic stress in a nonin-
vasive way. Under hypoxic stress, signaling 
responses are mediated mainly via the hypoxia- 
inducible factor-1α (HIF-1α) to drive transcrip-
tion of various genes. For example, Saha et al. 
used a HIF-1α reporter construct, 5HRE-ODD- 
luc, stably transfected into human breast cancer 
MDA-MB231 cells (MDA-MB231/5HRE-ODD- 
luc) to study tumor hypoxia. In vitro, a HIF-1α 
bioluminescence assay was performed by incu-
bating the transfected cells in a hypoxic chamber 
(0.1 % O2) for 24 h before the bioluminescence 
signal measurement, while the cells in normoxia 
(21 % O2) served as a control. Significantly higher 
photon flux observed for the cells under hypoxia 
suggests an increased HIF-1α binding to its pro-
moter (HRE elements), as compared to those in 
normoxia. Cells were injected directly into the 
mouse brain to mimic a breast cancer brain 
metastasis model. In this model, in vivo biolumi-
nescence imaging of tumor hypoxia dynamics is 
initiated 2 weeks after implantation and repeated 
once a week. Bioluminescence reveals increasing 
light signals from the brain as the tumor pro-
gresses, indicating a rise in intracranial tumor 
hypoxia (Saha et al. 2011).
In order to control luciferase expression with 
the help of promoter elements, one approach is to 
synthesize an inactive luciferase enzyme by link-
ing a cleavable protein subunit to luciferase. For 
example, specific sequences within the subunit 
are activated by caspase 3. The caspase activates 
the luciferase, and this is one way to monitor 
apoptosis in vivo (Laxman et al. 2002). The 
application of this reporter in combination with 
bioluminescence imaging was used as an early 
detector of apoptosis (Rehemtulla et al. 2004), 
for example, in response to therapy.
A recently published paper by Cruz- 
Monserrate et al. showed that bioluminescence 
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imaging can be applied knowing that tumor cells 
and the surrounding tissue have different pH val-
ues. They utilized ph-sensitive probes determin-
ing primary tumors and metastasis of human 
pancreatic cancer xenografts (Cruz-Monserrate 
et al. 2014). They applied bioluminescence in 
order to validate signals from fluorescence- 
labeled insertion peptides they used for the local-
ization of primary tumor and metastases in this 
particular mouse model.
Paulmurugan et al. described an inactive lucif-
erase enzyme that responded to a drug to form 
an active luciferase under conditions of specific 
protein–protein interactions. This approach can 
be used to track interactions between proteins 
in living animals or cells (Paulmurugan et al. 
2002).
The generation of transgenic mice, for exam-
ple, can be established as a tool to track naïve 
T-cell populations in real time (Chewning et al. 
2009). This is only one of the examples of trans-
genic mice with luciferase constructs that are 
available in academic research.
In this approach, the firefly luciferase gene 
was cloned into human cd2 genes, limiting the 
constitutive expression to all T-cells. Sorted cell 
populations clearly gave evidence for the T-cell- 
specific expression in CD4+ and CD8+ T-cells. 
In vivo this approach was deployed to image 
intact delineation of primary and secondary lym-
phoid organs.
16.2.6  Conclusions
There are several parameters that influence the 
sensitivity of bioluminescence imaging.
The most important determinants are:
• Instrumentation
• Hair
• Depth in tissue
• Imaging parameters (acquisition time, bin-
ning, animal position)
• Level of promoter activity controlling the 
luciferase expression
• Amount of luciferase substrate injection
• Diet
It is essential to optimize these parameters 
for each experiment. Of primary importance 
are especially the CCD camera and a position 
of the animal close to the camera. Together 
with longer acquisition times and higher bin-
ning, the sensitivity of the measurement can be 
increased.
Bioluminescence imaging is in summary a 
versatile and cost-effective technology that has 
high sensitivity and efficiency. Up to five mice 
can be imaged at the same time with acquisition 
times ranging from some seconds to some min-
utes. That means it is possible to image up to 150 
mice in a single day if needed. By decreasing the 
number of mice in one measurement, the sensi-
tivity can be increased. A simple ROI analyses 
can easily reduce the data.
Using optimal conditions for an experiment, 
light is only detected from areas that contain 
luciferase, and there is minimal or no background 
noise.
Since luciferase has a short biological half- 
life, it must be continuously produced for the 
measurement of signals. In the case of death of 
cells, the signal is lost. In a similar way, changes 
in luciferase levels can be discovered when pro-
moter elements driving luciferase are turned off 
or on.
The majority of bioluminescence experiments 
take advantage of the well-characterized firefly 
luciferase or Renilla luciferase proteins, and 
when used in conjunction with alternate imaging 
technologies, they can provide extremely thor-
ough and sophisticated datasets.
In comparison to other imaging systems such 
as SPECT, PET, or MRI, the cost of biolumines-
cence imaging systems is significantly less.
In future, an advancement of this method can 
lead to a higher sensitivity of tumor cell detection 
in animal models. Further developments could 
help to detect small metastasis and cell clusters in 
order to start treatments of diseases as soon as 
possible.
F. Alves et al.
16.3  Optical Coherence 
Tomography (OCT)
Martin Hofmann, Volker Jaedicke, Peter Cimalla, 
and Edmund Koch
16.3.1  Tissue Properties 
and Ballistic Photons
Optical imaging of biological tissue suffers from 
the strong attenuation of light in the tissue. 
Therefore, standard optical imaging is limited to 
the tissue surface or to transparent tissue, for 
example, the eye. However, under certain cir-
cumstances, the attenuation is mostly not due to 
absorption but due to scattering of light. This 
enables advanced optical imaging technologies 
like optical coherence tomography which allows 
looking into biomedical tissue.
In more detail, the absorption coefficient and 
the scattering coefficient of tissue are shown as a 
function of wavelength in Fig. 16.10 (Roggan 
et al. 1999). The absorption coefficient drops 
from 300 nm to a minimum at 1100 nm and then 
rises again. The scattering coefficient exhibits a 
weaker wavelength dependence and slightly 
decreases from 300 nm to 2100 nm. But obvi-
ously, the scattering coefficient in the wavelength 
regime between 600 and 1300 nm is about two 
orders of magnitude higher than the absorption 
coefficient. Accordingly, light attenuation in tis-
sue in this wavelength range is mostly due to scat-
tering, and absorption plays a minor role. That is 
why this spectral range is also called “optical 
window.”
As a consequence of these optical tissue prop-
erties, approaches for optical imaging in tissue 
have to operate in this optical window and have 
to make use of concepts to suppress or circum-
vent scattering.
To motivate the strategy used in OCT, we now 
look schematically at the scattering processes. 
This is shown schematically in Fig. 16.11.
All inhomogeneities inside the tissue repre-
sent potential scattering centers as indicated by 
the black dots in the schematic picture in 
Fig. 16.11. When photons of light enter the tis-
sue, there is a small but finite probability that 
they propagate through the tissue without any 
scattering event. Of course, this probability drops 
strongly with increasing tissue thickness and 
with increasing density of scatterers. For practi-
cal biomedical tissue, the maximum path length 
or the penetration depth for these unscattered so- 
called ballistic photons (Yoo and Alfano 1990) is 
below 1 mm. More probably, the incoming pho-
tons will be multiply scattered before they leave 
the tissue. In between these extremes, there are 
also a few photons which are only weakly scat-
tered. These are sometimes called “snakelike 
photons”(Yoo and Alfano 1990).
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Fig. 16.10 Absorption coefficient and scattering coefficient of biomedical tissue as a function of wavelength (Roggan 
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If one aims to recover an image of the tissue 
from the transmitted photons, it is clear that the bal-
listic photons would contain the full image infor-
mation. In contrast, the scattered photons would 
carry no image information anymore because of 
their arbitrary statistically distributed propagation 
paths. The snakelike photons may in some cases 
still contain some smeared-out image information.
Unfortunately, due to the high scattering coef-
ficient, the transmitted light will mainly contain 
scattered photons. Any image information 
encoded in the ballistic photons is thus invisible 
by eye or with a standard camera because it is 
superimposed by a more or less unstructured 
background of scattered photons.
Accordingly, image concepts should be devel-
oped that separate the ballistic photons from the 
scattered ones or even suppress the scattered 
photons. Conceptually, one option is based on 
the fact that ballistic photons have a consider-
ably shorter propagation path from the light 
source through the tissue to the detector than the 
multiply scattered photons. Accordingly, the 
ballistic photons have a much faster propagation 
time. If a pulsed light source is used, the ballistic 
photons might be filtered out with a fast enough 
camera that switches off after the arrival of the 
ballistic photons (Hee et al. 1993; Wang et al. 
1991). But in practice, this approach suffers 
from enormous difficulties. For a clear separa-
tion of the ballistic photons, the light source 
should provide pulses considerably shorter than 
a picosecond (10−12s), and the camera should 
detect only in a sub- picosecond time window. 
Though nonlinear optical schemes have been 
demonstrated to enable detection on such short-
time scales (Wang et al. 1991), one fundamental 
problem cannot be overcome: the ultrashort 
pulses are substantially broadened in the tissue 
due to dispersion (i.e., wavelength dependence 
of the refractive index). Thus, the required tem-
poral separation of the ballistic photons would 
not operate sufficiently in real biomedical tissue. 
Therefore, other separation schemes have to be 
implemented. In OCT, the coherence properties 
are used for separation of the ballistic photons 
(Huang et al. 1991). Before introducing the con-
cept used in OCT, we first discuss the coherence 
of light sources.
16.3.2  Coherence, Interferometry, 
and Diffraction
Light is an electromagnetic wave. If its wave-
length is exactly defined, the extension of this 
wave is infinite as indicated in Fig. 16.12a. In this 
case, the light is perfectly coherent that means all 
parts of the infinitely extended plane wave have 
well-defined phase relations to each other. Light 
from practical sources includes statistically dis-
tributed phase jumps as indicated in Fig. 16.12b.
In this case, the perfect phase relation of dif-
ferent parts of the wave is only maintained for the 
intervals in between two phase jumps. 
Accordingly, the perfect coherence is lost. To 
Fig. 16.11 Light scattering in tissue
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quantify the coherence, one defines the coher-
ence length lc of a light source as the average path 
length in between two phase jumps (Wolf 2007). 
Since light propagates with the speed of light c, 
the coherence length lc is equivalent to a coher-
ence time tc given by tc = lc/c.
The coherence length of a light source is 
directly linked to its spectral distribution. As 
mentioned above, an ideal, perfectly coherent 
light source (lc = ¥ ) consists of only one wave-
length. For realistic light sources, the coherence 
length is finite and inversely proportional to the 
spectral width following lc = 0 44
0
2
.
l
lD
 (Wolf 
2007) for a Gaussian-shaped spectrum with cen-
ter wavelength λ0 and spectral width Δλ.
Coherence is usually measured by autocorre-
lating the light source with itself in an interfer-
ometer arrangement, for example, a Michelson 
interferometer (Michelson 1881).
In a Michelson interferometer, a light beam is 
split into two parts with a beam splitter. The two 
parts propagate toward a mirror or retroreflector 
and are backreflected, recombined, and superim-
posed on a detector. The detector measures the 
time-integrated intensity of the superimposed 
light fields. One of the two interferometer arms 
can be changed in length, e.g., with a moveable 
mechanical stage. That means, the path length 
difference Δz or the time delay t  of the two arms 
can be varied. An interferogram corresponds to 
the signal I(t) detected by the detector as a func-
tion of the delay time t .  When I1 and I2 are the 
intensities in the two arms, I(t) is given by
I z I I I I z
z∆ ∆ ∆( ) = + + ( )1 2 1 22
2g p
l
cos ,
 
γ(Δz) being the coherence degree as a function of 
path delay (Hering and Martin 2006).
While I1 and I2 are independent of Δz, the 
third term that depends on Δz is called the inter-
ference term. Interference occurs when the two 
superimposed fields have a defined phase rela-
tion. If there is no phase relation, the time- 
integrated superposition averages out to zero, and 
the interference term disappears. In other words, 
an interference term is only detected if the path 
length difference between the two interferometer 
arms is shorter than the coherence length lc. Thus, 
by measuring the interference signal as a func-
tion of Δz, one can determine the coherence 
length which is half the full width at half maxi-
mum of the coherence degree γ(Δz).
So far, we have discussed the coherence of a 
light source in the propagation direction. This is 
usually called “temporal coherence” (Hecht 
2005). In contrast, “spatial coherence” refers to 
the coherence in lateral direction (Hecht 2005). A 
light source with perfect spatial coherence exhib-
its no phase jumps along the lateral direction, i.e., 
perpendicular to the propagation direction. 
Spatially incoherent light sources are typically 
extended emitters, for example, standard light- 
emitting diodes with weak correlations between 
adjacent emission areas.
The important consequence for OCT is that 
the interference properties of the light source 
may be used to filter out the ballistic photons car-
Fig. 16.12 E(t) in a light 
wave with high (top) and 
low (bottom) temporal 
coherence
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rying the image information. In particular, using 
light with a short coherence time or coherence 
length is advantageous (Huang et al. 1991). Let 
us consider to replace the short pulse light source 
in Fig. 16.11 by a light source with a short coher-
ence length and to position the sample into one 
arm of an interferometer. Still, the ballistic pho-
tons have the shortest propagation path, and the 
multiply scattered photons have much longer 
propagation paths and require more time through 
the tissue. If the time difference between ballistic 
photons and scattered photons is larger than the 
coherence time, the interferometer can be moved 
to a position at which the ballistic photons 
 contribute to the interference signal, while the 
scattered photons do not. This concept referred to 
as coherence filtering is the fundamental idea of 
optical coherence tomography (Huang et al. 
1991). Its practical implementation will be dis-
cussed in the following section.
Before, let us briefly discuss what determines 
the spatial resolution in OCT. The coherence fil-
tering implies that the resolution in propagation 
direction is determined by the coherence length 
of the light source. In a transmission geometry, 
the resolution would directly be given by the 
coherence length, while in the conventionally 
used reflection geometry, the resolution Δz in 
propagation direction or axial direction is given 
by Δz = lc/2. In OCT, the resolution in axial direc-
tion is decoupled from the resolution Δxy in lat-
eral direction. Like in conventional optical 
imaging systems, the resolution Δxy in lateral 
direction, i.e., the minimum distance at which 
two objects can be separated, is given by Abbe’s 
diffraction limit ∆xv n
= =l
a
l
2 2sin NA
, λ being 
the wavelength of illumination, n the refractive 
index, α half the aperture angle of the optics, and NA 
the numerical aperture of the optics (Abbe 1873).
In practice, standard OCT systems provide 
axial resolutions in the range of a few μm, and 
their design usually provides similar values for 
the lateral resolution (Schmitt 1999) (Fig. 16.13).
In comparison to established nonoptical bio-
medical tomographic imaging concepts, OCT 
thus provides a uniquely high spatial resolution, 
while the penetration depth is significantly lower 
than for ultrasound imaging, magnetic resonance 
tomographic imaging (MRT), or computer 
tomography (CT) based on X-ray imaging.
16.3.3  Fundamental Principles 
of Optical Coherence 
Tomography
Practical OCT systems are based on interferome-
ters, typically on Michelson interferometers 
(Huang et al. 1991), but interferometers with dif-
ferent beam splitters for dividing and combining 
the beams allow higher flexibility and may use both 
rays from the second beam splitter, for instance, for 
differential detection. The various OCT concepts 
usually differ in the way the interferograms are 
recorded. The two main categories are time domain 
OCT (TD-OCT) (Huang et al. 1991) and frequency 
domain OCT (FD-OCT) sometimes called Fourier 
domain OCT (Leitgeb et al. 2003a). Both are sche-
matically shown in Fig. 16.14
16.3.3.1  Time Domain OCT
A TD-OCT system consists of 3 main compo-
nents: a broadband light source, the interferome-
ter with sample arm and moveable reference arm, 
and the detector. As the broadband light source, 
one may use femtosecond laser systems (Morgner 
et al. 2000), white light continuum sources (Hartl 
et al. 2001), or superluminescent light-emitting 
diodes (LEDs) (Bayleyegn et al. 2012). 
Femtosecond lasers and white light continuum 
sources offer extremely broad spectra in excess 
of a few hundred nanometers (nm) and thus 
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in comparison to ultrasound imaging, MRT imaging, and 
CT imaging
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enable axial resolutions down to the very few 
micrometer (μm) range (Bouma and Tearney 
2002). But these systems are expensive and com-
plex. In contrast, superluminescent LEDs pro-
vide spectral bandwidths of several tens of nm up 
to about 100 nm (Bayleyegn et al. 2012) and are 
much more compact and cost-effective than the 
other sources. Thus, most standard OCT systems 
use superluminescent LEDs as light sources.
The output beam of the broadband light source 
is coupled into the interferometer where a beam 
splitter divides it into two parts. One part propa-
gates to the sample under investigation where it is 
backreflected and then it propagates back and is 
directed onto the detector. The other part of the 
beam propagates into the reference arm which 
contains a mirror or retroreflector on a moveable 
delay stage. After reflection, it propagates back 
via the beam splitter and is also directed to the 
detector where it interferes with the beam from 
the sample arm (Huang et al. 1991).
The detector is a standard photodetector in the 
easiest realization. Alternatively, photomultipli-
ers or avalanche photodiodes may be used to 
increase sensitivity.
An interferogram is generated when the inter-
ference signal is measured as a function of the 
time delay Δt between reference arm and sample 
arm. When we consider that the sample is 
partially transparent and contains multiple 
reflecting interfaces inside, then the reflections of 
interfaces at different depths will appear at differ-
ent times. Only when the propagation time to the 
corresponding interface and back corresponds 
within the coherence time of the light source to 
the propagation time through the reference arm, 
the backreflection from that interface will con-
tribute to the interference signal. In other words, 
when the length of the reference arm is changed, 
only light reflected back from the sample that had 
the same propagation path length as that through 
the reference arm contributes to the interfero-
gram. Accordingly, the position of the reference 
arm addresses a certain depth in the sample, and 
the strength of the interferogram at this position 
is a measure of the backreflection at that certain 
depth. In particular, interfaces between different 
substances in the sample will create stronger 
backreflections, so-called echoes of light (Drexler 
and Fujimoto 2008). Recording the strength of 
these echoes, i.e., the amplitude of the interfer-
ence signal as a function of delay time or path 
length difference in the interferometer, provides a 
one-dimensional depth scan into the sample or a 
so-called A-scan (Drexler and Fujimoto 2008). In 
practical systems, the scanning of the reference 
Fig. 16.14 TD-OCT (left) and FD-OCT (right). BS: beam splitter
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arm induces a Doppler shift in frequency which 
is used in the signal detection scheme (Drexler 
and Fujimoto 2008).
For a two-dimensional (so-called B-scan) or 
three-dimensional image, mechanical scanning in 
the two directions perpendicular to the axial direc-
tion is required. This might be done with mechani-
cal delay stages or, more practically, with 
galvanometer scanners (Duma et al. 2011) and 
microelectromechanical systems (Sun et al. 2010).
A disadvantage of TD-OCT systems is the 
limited speed, specifying the number of A-scans 
per second. The speed is mostly limited by the 
mechanical scanning of the delay line (Kim and 
Kim 2010). Many efforts have been made by 
using multiple reflections, piezoelectric-driven 
fiber-optic delay lines, and more. The fastest sys-
tems achieve A-scan rates of a few kHz with 
rapid scanning optical delay lines (RSOD) using 
resonantly driven mirror systems (Gao 2007).
16.3.3.2  Frequency Domain OCT
The interference signal represents a correlation 
of the fields from the reference and from the sam-
ple arm. According to the Wiener–Khintchine 
theorem, the Fourier transform of this correlation 
provides the spectral power density (Goodman 
1985). In other words, the interferogram and, 
correspondingly, an A-scan can also be obtained 
when the spectrum of the interference signal is 
recorded and then Fourier transformed. This is 
the principle of Frequency domain or Fourier 
domain OCT which is also referred to as spectral 
radar (Bail et al. 1996). Another explanation is 
that for each wavelength, interference occurs 
independent of the path difference, and the phase 
of the interference depends on the product of path 
difference and wave number (reciprocal value of 
the wavelength) of the light. One advantage of 
FD-OCT over TD-OCT is that no movement of a 
mirror in the interferometer arm is required. On 
the other hand, FD-OCT requires spectrally 
resolved detection. This can either be done with a 
spectrally resolving detector or with a spectrally 
scanning source (so-called swept source OCT) 
(Chinn et al. 1997).
In the first case, the spectrometer is mostly 
realized by a grating for dispersion and a line 
array detector for simultaneous detection of the 
different spectral components (Bail et al. 1996). 
These systems are often called spectral domain 
OCT (SD-OCT). For systems operating in the 
near-infrared range below 1 μm wavelength, this 
concept is well established because cost-effective 
line array detectors based on silicon technology 
are available. For wavelengths considerably 
above 1 μm, the silicon detector arrays have to be 
replaced by InGaAs detectors which are much 
more expensive.
Costly InGaAs line detectors can be avoided 
in the second case. In a swept source OCT sys-
tem, also called optical frequency domain imag-
ing (OFDI), one or two (in the case of differential 
detection) integrating detectors are used, and the 
source wavelength varies over time (Chinn et al. 
1997). So the different wavelengths are detected 
sequentially, and no spectral resolution of the 
detector is required. Recently, extremely fast tun-
able swept sources have been demonstrated 
allowing up to 20 million A-scans per second 
enabling real-time 3D OCT imaging also called 
4D imaging (Gora et al. 2009; Kottig et al. 2012; 
Wieser et al. 2010). Today’s typical FD-OCT sys-
tems using commercially available swept sources 
or fast line scan cameras achieve A-scan rates in 
the range of 100 kHz.
While TD-OCT and FD-OCT systems gener-
ally provide similar physical information about 
the sample, FD-OCT systems have been shown 
to be more sensitive by a factor that scales with 
the square root of the number of spectral points 
(Choma et al. 2003; de Boer et al. 2003; Leitgeb 
et al. 2003a). To enable a fast processing of the 
data, the Fourier transformation is generally 
implemented as a FFT. Because neither the grat-
ing spectrometer nor the tunable source usually 
provides data linear in wave number, lineariza-
tion of the data, often combined with oversam-
pling, is applied before the FFT (Vergnole et al. 
2010). For spectrometer-based systems of 
medium bandwidth, a combination of grating and 
prism can be used for linearization of the spec-
trum instead (Hu and Rollins 2007; Traub 1990). 
A further step in processing FD-OCT data is 
called spectral shaping. As the spectrum of the 
light source in combination with the sensitivity of 
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the detector and the spectral transmission of the 
interferometer is neither flat nor Gaussian, spec-
tral shaping is used to produce a spectral form of 
the interference that leads to moderate artifacts 
after the FFT. Typical window functions used are 
Hanning and truncated Gaussian (Eigenwillig 
et al. 2009).
While TD-OCT detects only the interference 
between light from the reference arm and the 
sample, FD-OCT also detects the interference 
between different reflections within the sample 
arm or other unintended reflections in the optical 
setup. This can lead to ghost images, often caused 
by the strong Fresnel reflex of the first sample 
surface, and fixed pattern structures. Such arti-
facts can be suppressed by implementing enough 
dispersion between reference and sample arm 
(Kottig et al. 2012). While dispersion between 
both interferometer arms, broadening the inter-
ference signal and by this decreasing the axial 
resolution, can be numerically compensated in 
FD-OCT, this is more complicated in TD-OCT 
(Wojtkowski et al. 2004).
For systems with high lateral resolution, 
TD-OCT offers the advantage that the focus posi-
tion can be shifted synchronously to the length of 
the reference arm allowing high lateral resolution 
over a large depth range (Schmitt et al. 1997).
TD-OCT and FD-OCT can be parallelized in 
one or two dimensions by using additional detec-
tor dimensions. Especially in TD-OCT, using 
camera-based systems allows sampling of com-
plete frames which is then called full-field OCT 
(FF-OCT) providing en face images sequentially 
(Dubois et al. 2002). The disadvantage in 
FD-OCT is that due to the longer measurement 
time for the extra dimensions(s), the image will 
be more compromised by movement artifacts 
(Yun et al. 2004). Moreover, all parallel systems 
are more sensitive to artifacts due to multiple 
scattering because of the loss of the confocal 
advantage (Garini et al. 2006).
Besides central wavelength, resolution, speed, 
and measurement range, two more parameters 
are used to characterize OCT systems. The first is 
the sensitivity specifying the minimal reflectivity 
of a plain surface that results in a signal equiva-
lent to the noise level. Because of the interference 
principle, very low levels can be detected and 
typical values of the minimal reflectivity are in 
the range of 10−10 corresponding to a sensitivity 
of 100 dB. Sometimes this parameter is called the 
signal-to-noise ratio (SNR) of the system as well. 
A second parameter is the dynamic range of the 
system which is the largest signal that does not 
saturate the detector or the electronics. Especially 
in FD-OCT, clipping of the signal, often caused 
by Fresnel reflexes, leads to strong artifacts and 
should be avoided. Due to the large dynamic 
range of OCT signals, mostly the logarithmic 
intensity data are visualized on a gray or false 
color map.
While in spectrometer-based FD-OCT sys-
tems, the limited resolution of spectrometers 
leads to a sensitivity roll off at the end of the mea-
surement range of 10–20 dB (Bajraszewski et al. 
2008), a similar degradation in swept source 
OCT systems is often caused by the limited fre-
quency range of the detector and the coherence 
length of the sweeping light source. Additionally, 
the confocal principle leads to a signal drop 
 outside of the focus that depends strongly on the 
used numerical aperture of the probe beam. 
Typical numerical apertures used in FD-OCT are 
therefore in the range of 0.05, yielding transver-
sal resolutions of typically 10 wavelengths.
While alterations by transversal motion in 
images from SD-OCT and OFDI systems are 
similar, both are affected quite differently by 
axial sample motion (Yun et al. 2004). Axial 
motion will lead to fringe washout in the case of 
SD-OCT, while it leads to false positions in the 
case of OFDI. Oblique motion can in general not 
be treated as the sum of both effects (Walther 
et al. 2008).
16.3.4  Extended Functionalities
16.3.4.1  Spectroscopic OCT
Spectroscopic OCT (S-OCT) is an extension of 
the intensity-based backscattering images in 
standard OCT. Since OCT images are recorded 
with broadband light, the spectral distribution of 
the light will be affected by absorption and scat-
tering in the tissue. In other words, if 
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characteristic absorbers or scatterers are present 
in the tissue, they will imprint characteristic fea-
tures into the spectra of the backscattered light. 
These characteristic features may be analyzed to 
add spectroscopic information to the OCT 
images by an additional color map. This may 
enable a kind of “optical histology” including 
digital staining based on absorbing chromo-
phores or characteristic sizes of scatterers 
(Kartakoullis et al. 2010; Robles and Wax 2010; 
Xu et al. 2005) inside the tissue. For example, in 
the near infrared, hemoglobin is a relevant sub-
stance for functional imaging with OCT (Faber 
et al. 2005; Lu et al. 2008; Robles and Wax 
2010) because its state of oxygenation influences 
its spectral properties. Other chromophores in 
the tissue with less pronounced spectral features 
in the optical window include melanin, bilirubin, 
and water (Anderson and Parrish 1981). The 
spectra are also sensitive to scatterers which are 
in the same order as the wavelength of the light. 
This may be used to analyze tissue structures 
below the resolution of the OCT system (Robles 
and Wax 2010; Yi et al. 2013). In addition to the 
existing tissue ingredients, contrast agents for 
S-OCT, for example, dyes (Xu et al. 2004) or 
nanoparticles (Lee et al. 2003; Oldenburg et al. 
2009), may be used.
In principle, there are hardware-based and 
software-based S-OCT concepts. The hardware- 
based concepts use multi-band systems to obtain 
spectrally resolved OCT images in a differential 
manner (Cimalla et al. 2009; Storen et al. 2006). 
Software-based approaches use time-frequency 
distributions that extract the spectroscopic infor-
mation from the raw OCT data, which can be 
recorded with standard OCT systems. In a first 
attempt, Morgner et al. performed spectroscopic 
analysis using a software-based approach on the 
basis of TD-OCT data (Morgner et al. 2000), while 
Leitgeb et al. used a FD-OCT system (Leitgeb 
et al. 2000). In practice, S-OCT still faces seri-
ous challenges. First, spectral features are often 
weak and superimposed by noise-like speckle 
and wavelength-dependent optical aberrations 
of the OCT system (Faber et al. 2005; Kasseck 
et al. 2010). Moreover, using time- frequency 
distributions, there is a tradeoff between spectral 
resolution and spatial resolution that has to be 
considered (Robles et al. 2009). But in spite of 
these difficulties, recent work has demonstrated 
that spectroscopic analysis may add significant 
contrast to the OCT images (Fleming et al. 2013; 
Jaedicke et al. 2013; Robles et al. 2011; Yi et al. 
2014).
16.3.4.2  Polarization-Resolved OCT
In order to get more information or another con-
trast in OCT images, polarization-sensitive OCT 
(PS OCT) was introduced. Aligned structures 
like muscles or fibers show birefringence and 
thereby influence the polarization of the beam 
allowing depth-resolved measurement of the dis-
tribution and orientation of these structures. 
Birefringence of the sample might influence 
images even in normal OCT systems, resulting in 
horizontal stripes, as the polarization of sample 
and reference light from some depth will not be 
aligned, leading to a loss of signal (Cimalla et al. 
2009). Most PS OCT systems detect at least two 
orthogonal linear polarization states of the 
reflected beam. In order to get similar intensities 
in both polarization states of the reference beam, 
a quarter wave plate is inserted into the reference 
arm. Moreover, a second quarter wave plate in 
the sample beam ensures circular polarization on 
the sample. Size and orientation of the birefrin-
gence can be calculated from amplitudes and 
phases of both interference signals (de Boer et al. 
1997; Hee et al. 1992; Hitzenberger et al. 2001). 
While controlling the polarization is relatively 
easy in the case of bulk optics, the higher flexibil-
ity of fiber-coupled scanner heads demands for 
more complicated solutions (Al-Qaisi and Akkin 
2010; Götzinger et al. 2009; Yamanari et al. 
2008). One of the most important applications of 
PS OCT is the visualization of the retina. The 
retinal pigment epithelium (RPE) has the inter-
esting property that it depolarizes the scattered 
light. Therefore, the homogeneity of polariza-
tion, called the degree of polarization uniformity 
(DOPU), is often shown as an additional contrast 
to differentiate this layer. PS OCT is also used to 
differentiate carcinoma and to distinguish 
between normal and burned tissue (Park et al. 
2001).
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16.3.4.3  Doppler-OCT
The visualization and quantification of flowing 
blood are one of the main applications of 
Doppler-OCT (DOCT). DOCT was first intro-
duced in TD-OCT by detecting the frequency 
shift of the interference signal caused by axially 
moving scatterers (Xu et al. 2008). Much higher 
sensitivity to axial movement can be achieved by 
analyzing the phase of the interference signals in 
consecutive A-scans at the same or nearly the 
same position (Leitgeb et al. 2003b). This 
method, called phase resolved Doppler-OCT, is 
today used in TD-OCT and FD-OCT. A high spa-
tial oversampling yielding a great overlap of the 
two beam profiles is beneficial for a good sensi-
tivity of DOCT (Walther and Koch 2009). Other 
methods using phase modulators in the reference 
arm (Bachmann et al. 2007) or changing the 
length of the reference arm to highlight moving 
structures (Wang et al. 2007b) have shown 
remarkable results. As phase data are often very 
noisy, different ways of averaging have been sug-
gested. Most commonly, the phase φ is calculated 
by calculating the phase of the sum of products of 
consecutive A-scans:
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Γj(z) is the complex result of the FFT of the 
A-scan j at depth z and “*” denotes the complex 
conjugate. In the case of low SNR, analyzing a 
set of A-scans using a 2D Fourier transformation, 
called joint spectral and time domain OCT 
(STdOCT), may be beneficial (Szkulmowski 
et al. 2008). More sophisticated strategies for 
averaging Doppler data can be found in Chan 
et al. (2014) and Walther et al. (2014).
Doppler information is mostly visualized by a 
false color map, where the intensity is given by 
the logarithmic intensity of the signal and the 
color from blue over white to red indicates the 
phase in the interval of ±π, with white indicating 
no axial motion. In the case of smooth velocity 
distribution, phase shifts much above ±π can be 
analyzed by unwrapping techniques, but in 
SD-OCT artifacts caused by the detector integra-
tion time may cause huge discrepancies at higher 
flow velocities depending on the angle of the flow 
(Walther et al. 2010).
An example of a phantom measurement, high-
lighting potentials and problems of the flow 
through different capillaries, is shown in 
Fig. 16.15. The different images show human 
blood or 1 % intralipid solution, often used as a 
substitute for blood in Doppler measurements, 
through a rectangular and a circular capillary in 
opposite directions. The angle of both capillaries 
was the same. While the top row shows only the 
intensities, the bottom row is colored as a func-
tion of the phase shift or velocity. To reduce the 
influence of the speckle noise, 256 B-scans are 
averaged. In spite of this averaging, the left 
images without flow still show the granularity of 
blood. The echo from intralipid is quite homoge-
neous as can be seen in the images on the right. 
Vice versa flowing blood shows echoes in the 
form of an hourglass, caused by the circular ori-
entation of erythrocytes in flowing blood (Cimalla 
et al. 2011a). Especially at the backreflections 
from the capillaries in the case of blood, high 
phase shifts can be seen. This effect, called 
Doppler shadow (Bukowska et al. 2010), is attrib-
uted to multiple scattering (Kalkman et al. 2012) 
and is less pronounced in the case of intralipid.
Besides algorithms based on the phase shift, 
intensity-based algorithms evaluating the vari-
ance in repetitive scans have been used especially 
for angiography showing high contrast images of 
blood vessel structure in the hamster skin, for 
example (Liu et al. 2011). A comparison of dif-
ferent methods and their advantages and disad-
vantages is found in (Liu et al. 2012).
An application for Doppler imaging in small 
animals is the observation of blood flow in ves-
sels of mice. Blood flow in these vessels is regu-
lated by the contraction of the vessel muscles in 
the arteries. As the veins have no musculature, 
their diameter will only change passively by 
inner or outer pressure. While vasoconstriction 
may be caused by application of potassium, ves-
sels will dilate after the application of sodium 
nitroprusside (SNP). A dysfunction of this regu-
lation mechanism is associated with arterioscle-
rosis. Due to its advantageous position, imaging 
was performed at the arteria and vena saphena 
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with a dual-band OCT system. The dual-band 
system nicely shows the higher phase changes at 
the smaller wavelength. Quasi M-scans are 
shown in the middle and bottom of Fig. 16.16, 
showing the oscillating blood flow in the artery 
and the almost constant blood flow in the vein. 
The low amplitude of the backscattered signal in 
the center of the vessels is attributed to the align-
ment of the erythrocytes as stated above.
16.3.4.4  Contrast Enhancement 
by Nanoparticles: 
Photothermal OCT 
and Magnetomotive OCT
Compared to other optical imaging techniques 
such as fluorescence microscopy, OCT is a rather 
unspecific modality that provides only general 
information on the tissue structure based on light 
scattering on cells and cellular components such 
as the nuclei and mitochondria. Hence, to improve 
visibility of specific tissues or cells, OCT contrast 
agents are required. Several attempts have been 
made to find a suitable  contrast agent for OCT 
including dyes and plasmon- resonant nanoparti-
cles, which have distinct absorption spectra and 
therefore can be detected by means of spectro-
scopic OCT (Cang et al. 2005; Oldenburg et al. 
2009; Xu et al. 2004; Yang et al. 2004a). However, 
these absorption-based methods always suffer 
from an inherent concentration- path length trad-
eoff. In order to detect a sufficient absorbance, 
either a long propagation length through the 
absorber is required, which consequently degrades 
axial resolution, or a high concentration of absorb-
ing agents is necessary, which is often not toler-
ated by the specimen.
However, since OCT is very sensitive to 
motion due to the coherent nature of the illumi-
nating light, the most promising approaches – 
photothermal and magnetomotive OCT – use 
dynamic contrast agents to enhance visualization 
of specific substances.
In photothermal OCT, gold nanoparticles 
inside the sample are remotely heated by illumi-
nation with intense laser light (>20 mW). For that 
purpose, the emission wavelength of the laser 
is matched to the plasmon resonance absorp-
tion maximum of the particles. The illuminated 
Fig. 16.15 Phantom measurement for Doppler imaging 
with OCT. The upper part on the left side shows the image 
of blood with no flow. Below additional Doppler process-
ing shows no difference. The images in the middle show 
corresponding images for flowing blood. The square cap-
illary and the circular capillary have opposite flow direc-
tions. Echoes behind the structure show the so-called 
Doppler echo which is attributed to multiple reflections. 
The inhomogeneous structure is attributed to the align-
ment of erythrocytes in the flowing blood. The images on 
the right side are taken with intralipid showing less 
Doppler echo and no inhomogeneity. To reduce the 
speckle noise, the images were averaged over 50 B-scans
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particles also heat their immediate vicinity caus-
ing thermal expansion of the microenvironment. 
Hence, resulting sample motion in the submicron 
regime is then detected by OCT using phase 
information (Adler et al. 2008). Sufficient sen-
sitivity is achieved by modulating the laser (turn 
on/turn off periodically) and searching for the 
corresponding frequency in the OCT phase sig-
nal. Photothermal heating can be performed at 
relatively high frequencies of 0.5–20 kHz (Zhou 
et al. 2008), which enables fast image acquisition.
Therefore, among others, photothermal OCT 
was successfully applied for pharmacokinetic 
studies to noninvasively image nanoparticle 
accumulation in mouse mammary tumors 
(Tucker-Schwartz et al. 2014).
Furthermore, photothermal OCT is not neces-
sarily bound to the presence of gold nanoparti-
cles. Also, the absorption profile of endogenous 
chromophores such as hemoglobin can be used 
for imaging (Yim et al. 2014). Since the absorp-
tion spectra of oxy- and deoxyhemoglobin differ, 
photothermal OCT can be applied to assess the 
blood oxygenation level both in vitro (Kuranov 
et al. 2011a) and in vivo, e.g., in the murine brain 
cortex (Kuranov et al. 2011b).
However, attention must be paid to keep sam-
ple temperature below 44 °C to avoid thermal 
damage of biological tissue. Furthermore, photo-
thermal OCT is not suited for imaging of photo-
sensitive tissue such as the retina due to the use of 
intense light.
In magnetomotive OCT, magnetic micro- or 
nanoparticles are used as dynamic contrast 
agents, which are exited into motion by an exter-
nal magnetic field. Contrast enhancement is then 
achieved by quantifying the displacement of the 
elastic tissue next to the particles using the ampli-
tude or phase information of the OCT signal 
(Oldenburg et al. 2005a, 2008).
Fig. 16.16 Top row: single B-scans showing a cross sec-
tion through the artery and vein in mice. Left side control, 
middle vasoconstriction after the application of potas-
sium, right side vasodilatation caused by the application 
of SNP. As stated in the columns, images were taken at the 
same time at center wavelengths of 800 nm and 1250 nm. 
Due to the shorter wavelength, the phase change is larger 
in the 800 nm band. Related to this, a phase wrap (phase 
change more than ± π) is first seen in the 800 nm band. 
Nevertheless, in the case of vasoconstriction, phase wrap 
is seen in both bands. A-scans selected in the center of the 
artery (middle) and vein (bottom), indicated by A and V 
in the upper left part, from sequential B-scans, forming 
a quasi M-scan, highlight the highly pulsating blood flow 
(see arrows) in the artery and the slightly modulated blood 
flow in the vein. The musculature of the artery (M) can be 
nicely seen, especially in the case of vasoconstriction
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In this context, it was shown that magnetomo-
tive OCT is a suitable method for contrast- 
enhanced imaging of single magnetically labeled 
cells in vitro (Oldenburg et al. 2005b). Proof-of- 
principle in vivo magnetomotive imaging was 
demonstrated in African frog (Xenopus laevis) 
tadpole (Oldenburg et al. 2005a) as well as in the 
mouse eye (Wang et al. 2010b). Furthermore, 
similar to photothermal OCT, magnetomotive 
OCT was also successfully applied to image the 
accumulation of targeted magnetic nanoparticles 
in rat mammary tumors (John et al. 2010).
Typically, superparamagnetic iron oxide par-
ticles are used for labeling of biological samples. 
Compared to ferromagnetic materials, these par-
ticles exhibit lower forces in a magnetic field due 
to their smaller magnetization capability. 
However, iron oxide is much better suited in 
terms of biocompatibility since pure iron in 
higher concentrations is cytotoxic.
In contrast to photothermal OCT, modulation 
of the magnetic field in magnetomotive OCT is 
restricted to relatively low frequencies of 
0,1–1 kHz (Kim et al. 2013) since fast switching 
of sufficiently high magnetic fields is technically 
challenging. Furthermore, magnetomotive imag-
ing is limited to small working distances because 
magnetic field strength rapidly degrades with dis-
tance from solenoid.
16.3.5  OCT for Small Animal 
Imaging
16.3.5.1  Retina Imaging
The retina was one of the first samples investi-
gated with OCT, since it has the unique advan-
tage to be visualized through the transparent 
ocular media. In this context, OCT provides 
in vivo cross-sectional visualization of the retinal 
microstructure that cannot be obtained by any 
other noninvasive imaging modality (Drexler and 
Fujimoto 2008). Therefore, the clinical applica-
tion of OCT is mostly developed in ophthalmol-
ogy for the diagnosis, staging, and monitoring of 
ocular diseases primarily macular pathologies 
such as age-related macular degeneration (AMD), 
central serous retinopathy, macular holes and 
edema, Stargardt disease, and retinitis pigmen-
tosa but also optic neuropathies such as glau-
coma. Today, several commercial ophthalmic 
OCT devices are available, which use high-speed 
spectral domain detection. All instruments have 
comparable performance with an axial resolution 
of 4–6 μm operating in the 800 nm wavelength 
range and imaging speeds of 25,000–40,000 
axial scans per second (Wolf-Schnurrbusch et al. 
2009), which enables real-time two-dimensional 
imaging of tissue cross sections.
As an alternative or extension to the conven-
tional ophthalmic imaging at 800 nm, research 
OCT systems operating at 1050 nm have also 
been demonstrated. Due to less absorption of the 
retinal pigment epithelium and reduced tissue 
scattering on the one hand and still sufficiently 
low light absorption by means of the aqueous 
ocular media in front of the retina on the other 
hand, this spectral range allows depth-enhanced 
visualization of the choroid (Povazay et al. 2003; 
Unterhuber et al. 2005) and improved visibility 
of the retina in patients with opaque ocular media, 
i.e., cataract (Povazay et al. 2007).
As stated above, one particular feature of OCT 
is that the axial resolution is decoupled from the 
transverse or lateral resolution. The axial resolu-
tion is mainly given by the coherence length of 
the applied light source, while the lateral resolu-
tion is defined by the numerical aperture of the 
focusing optics, i.e., the beam diameter and the 
focal length, like in conventional microscopy. In 
ophthalmic imaging, the eye’s cornea and lens 
are used as the imaging objective. Therefore, the 
lateral resolution is limited by the pupil size and 
the focal length of the eye and, in practice, even 
further reduced by ocular aberrations. In order to 
overcome this practical limitation, adaptive 
optics – well known in the field of astronomy – is 
applied in research OCT systems to correct ocu-
lar aberrations. These instruments measure the 
wavefront distortion caused by the ocular media 
and correct it by means of deformable mirrors or 
liquid crystal phase modulators. It was shown 
that adaptive optics can significantly improve lat-
eral resolution to 2–3 μm compared to 15–20 μm 
in conventional ophthalmic OCT (Povazay et al. 
2009). Furthermore, this technique increases 
F. Alves et al.
imaging sensitivity especially in the range of the 
photoreceptor layer and reveals single structures 
located at the inner/outer photoreceptor segment 
junction and the posterior tips of the photorecep-
tor outer segments, which are assumed to repre-
sent individual cone cells in humans (Fernández 
et al. 2008; Zhang et al. 2006) as well as in ani-
mal models such as mice (Jian et al. 2013). The 
combination of high axial resolution OCT with 
aberration-correcting adaptive optics is therefore 
often referred to as cellular imaging of the living 
retina.
For the understanding of the mechanisms 
underlying retinal degeneration and trial of 
potential therapeutic strategies, experimental ani-
mal models play an important role. In this con-
text, OCT also enables noninvasive monitoring 
of the retina in small animals like rats (Nagata 
et al. 2009), mice (Horio et al. 2001) and even 
zebrafish (Bailey et al. 2012; Weber et al. 2013). 
The last-mentioned one is of particular interest 
for researchers and vision scientists since the 
zebrafish has the ability to regenerate neuronal 
tissue including the retina – a phenomenon that 
is not observed in mammals. Although animal 
imaging is mostly performed in the 800 nm wave-
length range (Huber et al. 2009; Kocaoglu et al. 
2007; Ruggeri et al. 2007) as in humans, OCT 
of the rodent retina is also reported at 1060 nm 
(Hariri et al. 2009) and 1300 nm (Li et al. 2001). 
It was shown that there is a good correlation 
between OCT data and histology (Huber et al. 
2009), thus enabling OCT to be a valuable tool 
to analyze and monitor microstructural changes 
in the retina for noninvasive time-course studies 
in individual animals.
An example for in vivo OCT imaging and 
monitoring of the mouse retina is depicted in 
Fig. 16.17.
In human retinal imaging, the sample beam is 
conventionally relay imaged onto the pupil by 
means of a lens pair and focused onto the fundus 
by the eye itself, which was also applied for reti-
nal imaging in mice and rats (Kocaoglu et al. 
a
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Fig. 16.17 High-resolution OCT imaging of the mouse 
retina in vivo. (a) OCT fundus projection and representa-
tive OCT cross sections (b, c) of the healthy mouse retina 
(vertical bars, 200 μm). (d) Detailed view of the retinal 
microstructure (abbreviations: RNFL retinal nerve fiber 
layer, GCL ganglion cell layer, IPL inner plexiform layer, 
INL inner nuclear layer, OPL outer plexiform layer, ONL 
outer nuclear layer, ELM external limiting membrane, IS/
OS inner/outer photoreceptor segment junction, RPE reti-
nal pigment epithelium, Ch choroid, Sc sclera). (e) 
Longitudinal OCT monitoring of genetic retinal degener-
ation in one individual rhodopsin-deficient (Rho−/−) mouse 
at different ages (vertical bar, 100 μm). The Rho−/− degen-
eration as a model for recessive inherited retinitis pigmen-
tosa is characterized by a progressive loss of the outer 
nuclear layer (ONL), which represents the nuclei of the 
photoreceptors. At an age of 9 weeks, the ONL has almost 
completely vanished, so that only a minor fraction of pho-
toreceptors is left at this stage. All images were acquired 
with an experimental high-resolution dual-band OCT sys-
tem (Cimalla et al. 2009, 2011b)
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2007; Ruggeri et al. 2007). However, it is rea-
soned by others that this method is not optimal 
for small animals since the small size and short 
focal length of the eye imply a high numerical 
aperture objective lens design in order to cover a 
large measurement area on the retina. In addition, 
the short focal length of the eye increases aberra-
tion, which degrades the OCT signal and reduces 
image quality. Alternatively, a contact lens made 
from a microscope coverslip and hydroxypropyl 
methylcellulose solution is used, which effec-
tively removes the refractive power of the air–
cornea boundary and allows the sample beam to 
be focused directly onto the retina. Due to the 
corresponding enlargement of the eye’s focal 
length, lower numerical aperture lens designs can 
be applied to cover a sufficient measurement area 
on the retina. Furthermore, this technique reduces 
corneal aberrations and prevents the eye from 
dehydration (Kim et al. 2008; Srinivasan et al. 
2006), which would otherwise lead to corneal 
opacity.
Due to their small sizes, it is possible to image 
the entire eyes of mice and zebrafish from the 
cornea to the retina in one single OCT scan. This 
technique allows noninvasive quantitative assess-
ment of biometric parameters such as intraocular 
distances and interface curvatures of ocular 
media, which is of interest in eye development 
research (Wang et al. 2010c; Zhou et al. 2008) 
and eye modeling for improved design of optical 
instruments (Gaertner et al. 2014).
Recent developments in the experimental and 
commercial sector tend toward multimodal imag-
ing of the small animal retina using OCT in com-
bination with other established methods such as 
scanning laser ophthalmoscopy (SLO), fluores-
cence angiography (FA), and fundus autofluores-
cence (FAF), which deliver additional information 
about fundus morphology, blood flow, and 
metabolism (Fischer et al. 2010; Huber et al. 
2009, 2010; Seeliger et al. 2005).
An example for multimodal in vivo imaging 
of the mouse retina using OCT and fluorescence 
angiography is shown in Fig. 16.18.
In addition to the morphological and molecular 
contrast acquired by optical imaging techniques, 
functional information about photoreceptor and 
interneuron activity can be obtained by means of 
electroretinography (ERG). In this context, simul-
taneous OCT and ERG for parallel monitoring of 
the retinal structure and function in experimental 
animal models such as rats (Moayed et al. 2010) 
allows advanced analysis of retinal degeneration 
processes in vivo.
Furthermore, attempts have been made to 
retrieve functional information from the OCT 
signal itself. To that, local changes in the retina’s 
optical properties following to light stimuli are 
detected by means of OCT. These intrinsic opti-
cal signals, which could by now be observed in 
the human retina (Schmoll et al. 2010) as well as 
in chicken (Moayed et al. 2011), were found to 
be restricted to the stimulated fundus region and 
to show some correlation with ERG recordings.
16.3.5.2  Lung Imaging
Due to a lack of imaging technologies having 
sufficient resolution for resolving single alveoli 
and delivering three-dimensional data at high 
frame rates, there is a high interest in using OCT 
for imaging airway wall and alveolar structures 
in animal studies. Lung function in healthy and 
diseased lungs is of high interest for several rea-
sons. Some interest is related to the transport of 
inhaled particles for drug delivery and risk due to 
smoking (Yin et al. 2009). Further airway remod-
eling in connection with asthma may reduce the 
airway distensibility. Moreover, interest in visu-
alization of alveoli and alveolar structures is 
related to the high morbidity of acute respiratory 
distress syndrome (ARDS) and ventilator- 
induced lung injury (VILI), which in spite of 
numerous efforts declines only slowly. A better 
understanding of processes during artificial ven-
tilation might help in improving ventilation 
strategies.
Several strategies have been applied to image 
airway and alveolar structures with OCT. External 
scanning can be applied to isolated lungs visual-
izing the alveolar structure close to the pleura 
(Meissner et al. 2009b; Mertens et al. 2009). 
With some effort, this method can also be applied 
to anesthetized animals by opening the chest or 
by preparing a thoracic window in vivo (Meissner 
et al. 2010a). This method has been applied to 
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mouse and rabbit models to study alveolar sizes 
and the change during ventilation in healthy and 
injured lungs. While in the early systems, gated 
imaging was used to study the dynamic shape 
during the ventilation cycle (Meissner et al. 
2010b), modern high-speed systems capture 
complete alveoli with some tens of frames per 
second, sufficient for breathing rates in the order 
of one per second (Kirsten et al. 2013). In larger 
animals the movement of the lung prevents fol-
lowing single alveoli during the complete venti-
lation cycle. Therefore, lightweight MEMS-based 
probes were developed resting on the lung and 
following the alveolar structures (Namati et al. 
2013).
To access internal regions of the lung, endo-
scopic OCT probes have been used. Typically, 
such probes use radial scanning by rotating the 
entire probe or by using micromechanical motors 
placed in the probe (Yang et al. 2004b). While the 
rotation provides circumferential 2D images, the 
fiber may be retracted while accumulating subse-
quent radial images to provide three-dimensional 
information.
A third strategy uses miniaturized OCT needle 
probes. The needle probe can be inserted through 
the tissue into the region of interest that may be 
located several centimeters below the surface. 
Scanning is again performed by rotating the nee-
dle or the focusing optics inside the needle. 
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Fig. 16.18 Multimodal in vivo imaging of the mouse 
retina. (a) OCT fundus projection and (b) simultaneously 
acquired fluorescence angiography image of the healthy 
mouse retina. (c, d) Representative OCT cross sections 
(vertical bars, 200 μm). For fluorescence angiography, the 
approved in vivo dye fluorescein was used, which has its 
emission maximum in the green visible spectral range. All 
images were acquired with an experimental hybrid imag-
ing system slightly modified to (Cimalla et al. 2012)
AU15
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Although the size of needle probes has been 
reduced to a diameter of about 310 μm, the inser-
tion of the needle will cause some trauma 
(Lorenser et al. 2011). As the needle can hardly 
be translated forth and back, the same tissue can-
not be imaged during different states of the venti-
lation cycle. For repetitive scans, probes 
consisting of an inner part that translates rapidly 
back and forth multiple times per second were 
developed allowing two-dimensional image 
acquisition (McLaughlin et al. 2012).
Imaging alveolar structures is hampered by 
the repetitive refractive index change from air to 
liquid, limiting the useful depth to only one or 
two layers of alveoli. Therefore, several attempts 
have been made to fill the lung with an index 
matching fluid. For ex vivo imaging, the lung can 
be filled completely with saline water (Lorenser 
et al. 2011) or ethanol (Meissner et al. 2009a) 
increasing the useful imaging depth to 5 or more 
alveoli in depth. While these approaches are not 
suited for in vivo imaging, a small amount of 
fluid around the probe can enhance imaging 
without scarifying the animal (Quirk et al. 2014). 
Moreover, liquid ventilation using perfluorocar-
bons having a high transport capacity for oxygen 
and carbon dioxide can be used for ventilation 
allowing enhanced OCT imaging in vivo 
(Schnabel et al. 2013) (see Fig. 16.19).
16.3.6  Discussion and Conclusion
Optical coherence tomography is a contactless 
optical imaging concept enabling three- 
dimensional tomographic imaging with microm-
eter resolution. However, due to the strong 
scattering of light in biological tissue, the pene-
tration depth and thus the image depth are limited 
to a few millimeters in the best case, when light 
in the optical window between 600 and 1300 nm 
is used. The imaging speed of state-of-the-art 
OCT systems is high enough to enable real-time 
video imaging.
Primarily, the contrast in OCT images is gen-
erated by refractive index variations at interfaces 
between different tissues that lead to backscat-
tered light. Additional contrast mechanisms rely 
Fig. 16.19 Transition from an air-filled to a liquid-filled 
region in OCT and intravital microscopy (IVM). These 
pictures show the influence of liquid filling for OCT and 
IVM lung imaging after 18 min of total liquid ventilation. 
While image quality for OCT is considerably increased in 
the liquid-filled area, the contrast for IVM is decreased 
due to the refractive index matching. The depth of tissue 
visualization is nearly tripled in the liquid-filled area due 
to the reduction of scattering loss. The arrows a, b, and c 
in the 3D OCT image (left) were used for a better under-
standing of the OCT and IVM en face view (middle row) 
and the OCT cross section (right). For the 3D image, the 
pleura was hidden to get a look on the first layer of sub-
pleural alveoli. Scale bar is 200 μm (From Schnabel et al. 
(2013) with permission)
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on spectroscopic modifications of the backscat-
tered light by spectrally dependent absorption or 
scattering or on variations of the polarization due 
to birefringence in aligned structures like fibers 
or muscles. Contrast enhancement by adding 
contrast agents like nanoparticles has also been 
demonstrated.
In addition to stationary images of the tissue 
structure, so-called Doppler-OCT also enables 
visualization of movements in the tissue, for 
example, the blood flow.
In terms of small animal imaging, OCT has 
been successfully used for retina imaging. The 
transparence of the ocular media enables nonin-
vasive imaging of the retina not only for humans 
but also for rats, mice, and zebrafish. This imag-
ing is not restricted to stationary morphological 
images but also extends to functional imaging by 
detecting local changes of the retina’s optical 
properties due to light stimuli.
Imaging of vessels has been successfully dem-
onstrated. A particular application is the 
 investigation of traumatic brain injuries or strokes 
in rat models (Osiac et al. 2014). Also, cardiovas-
cular defects in mutant mouse animal models 
have been analyzed by OCT. Even the develop-
ment of whole mouse embryos can be monitored 
in vivo with OCT (Larina et al. 2011). In more 
recent studies, OCT has been successfully 
applied to monitor drug-induced changes of the 
tissue in mouse models (Bell et al. 2013). These 
recent developments demonstrate that OCT has 
become a powerful tool for small animal imaging 
and that its potential for this application is by far 
not completely explored.
16.4  Intravital Imaging in Small 
Animals
Timo Rademakers and Marc A.M.J. van 
Zandvoort
Over the last decades, molecular and cell biology 
has greatly advanced our knowledge of dynamic 
processes at a molecular level, especially by the 
use of (static) in vitro techniques. However, to 
gain an understanding of the in vivo implications 
hereof, a need for translation toward in vivo 
experiments developed, in which dynamic events 
could be studied in real time and in their specific 
microenvironment. Intravital microscopy (IVM) 
is one of the techniques which allow such studies. 
While the technique is (mostly) invasive, it is 
able to (depending on the system) study dynamic 
processes at a resolution of several micrometers 
and therefore has become a widely used tech-
nique in many fields of biomedical research.
The idea of studying (sub)cellular processes 
in small animals in vivo is not new. Already in the 
nineteenth century, the first rudimental intravital 
studies have been described, involving transillu-
mination microscopy of leukocyte behavior in 
the mesentery of a frog (Julius cohnheim 1839). 
From these initial intravital studies using transil-
lumination, the field has developed greatly with 
aid of advances in microscopy, allowing at cur-
rent detailed multicolor study of dynamic pro-
cesses using the newest fluorescent techniques.
The purpose of this chapter is to give an over-
view of IVM techniques and applications, in 
which both classical intravital imaging and 
 state- of- the-art multiphoton intravital imaging 
will be discussed, including examples from dif-
ferent fields of research.
16.4.1  Classical Intravital Imaging
Classical intravital imaging uses regular wide-
field microscopy systems, either using transillu-
mination or fluorescence. These classical systems 
have been in use for several decades and are still 
being used to date. Classical IVM has mostly 
been applied in inflammation research (i.e., leu-
kocyte adhesion and transmigration), but also in 
studies involving hemodynamics (Kiyooka et al. 
2005) or thrombosis (Furie and Furie 2006). 
Classical IVM however has some intrinsic limita-
tions, as will be discussed below.
16.4.1.1  Brightfield Imaging/
Transillumination
The first IVM studies were performed using 
brightfield illumination or transillumination in 
transparent tissues, eventually in combination 
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with the use of differential interference contrast 
(DIC) or phase contrast to enhance visualization 
of various structures within the tissue. The great-
est advantage of this type of IVM is its relative 
ease of use, such that it can be performed on 
many regular light microscopes equipped with a 
high-speed detection system. Moreover, the lat-
eral resolution (i.e., X-/Y-resolution) is generally 
good (±500 nm). One of the most obvious disad-
vantages, however, is the need for transparency in 
the tissue under study, which in most small labo-
ratory animals is very limited. Also, in thicker 
tissues problems with image blurriness arise, 
caused by out-of-focus contributions. This sig-
nificantly reduces image contrast and resolution. 
In practice, only few tissues like the cremaster 
muscle in male animals (Thorlacius et al. 1997) 
or the mesentery are transparent enough to allow 
transillumination. In these tissues, this type of 
IVM has been used to study, e.g., leukocyte adhe-
sion to, rolling along, and transmigration through 
microvasculature. Figure 16.20 shows a typical 
image of a capillary in the cremaster muscle of a 
mouse, in which the capillary wall as well as the 
blood cells may be appreciated after applying a 
DIC filter.
16.4.1.2  Widefield Fluorescence 
and Confocal Microscopy
An approach which is similar to transillumina-
tion IVM is the use of widefield fluorescence 
microscopy. This technique offers a higher con-
trast at comparable resolution, since it only 
detects specifically labeled fluorescent structures 
or cells, while the background – with exception 
of autofluorescent molecules – remains black. In 
addition, since fluorescent markers are available 
in different colors, it is possible to study differen-
tially labeled tissue/cells at the same time using 
dual or triple filters. Moreover, higher contrast 
allows imaging of a multitude of tissues and 
organs, e.g., the liver (Kubes et al. 2002), nonin-
vasive imaging of the capillaries in the murine 
ear (Lammermann et al. 2013), or even larger 
vessels such as the carotid artery (Fig. 16.21) 
(Massberg et al. 2003). However, out-of-focus 
blurriness problems still arise, which in practice 
still limits penetration depth to several microme-
ters in most tissues.
To introduce axial resolution, confocal 
microscopy can be used. In confocal microscopy, 
a laser system is used for excitation of fluoro-
phores at their specific wavelength. Out-of-focus 
emitted light is filtered out by the use of pinholes, 
which reduces blurring of images up to 
50–100 μm of penetration depth depending on 
the type of tissue. Also, XY resolution is 
improved with a factor 2. It is important to note, 
however, that when using line scanning systems, 
the acquisition speed is lower than in widefield 
systems, due to the stepwise buildup of the image, 
instead of direct acquisition of the entire image. 
To again gain imaging speed, systems can be fit-
ted with a line scanning, resonant scanning, or 
Fig. 16.20 IVM time series using transillumination 
microscopy. Thin tissue samples can be imaged by using 
DIC or phase contrast. Here, an erythrocyte (white arrow) 
can be seen passing through a capillary in the cremaster 
muscle. Upon an inflammatory stimulus, transmigration 
of leukocytes may also be determined
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spinning disk system, which however causes 
some reduction in resolution and introduces 
noise. Alternatively, scanning multiple colors at 
the same time also enhances imaging speed, 
although not all systems are equipped for this 
task, as it requires specific fluorescent filters and/
or dual- camera systems. Nevertheless, depending 
on the system setup, high-speed multicolor IVM 
can be achieved.
The applications of these types of IVM are 
numerous, as long as there is the possibility to 
introduce a fluorescent label (either genetically 
or via other means) which is required for detec-
tion. Obviously, these types of IVM can be 
applied to the previously mentioned applications 
in brightfield IVM, i.e., imaging of the microvas-
culature in different tissues. Yet, since transillu-
mination is no longer an issue, larger structures 
such as the macrovasculature can be studied in 
fluorescence-based IVM. Indeed, this technique 
has, e.g., frequently been used to assess leuko-
cyte adhesion to the vessel wall of the carotid 
artery under inflammatory conditions or after 
thrombosis (Massberg et al. 2003), also harbor-
ing the potential to study differentially labeled 
cells at the same time, e.g., wild-type vs. knock-
out cells. The same holds true for confocal IVM 
in, e.g., the cremaster muscle, in which leukocyte 
transmigration can be studied in detail in the 
microvasculature (Woodfin et al. 2011). Similarly 
in other fields like tumor biology, fluorescence- 
based IVM is often used in combination with 
dorsal skin chambers (Endrich et al. 1988; 
Menger et al. 2002).
16.4.2  Intravital Multiphoton 
Imaging
Even though classical intravital imaging is appli-
cable in many cases, the intrinsic limitations with 
regard to axial resolution and penetration depth 
limit the use of these systems. New methods of 
intravital imaging, however, have become avail-
able over the past two decades. As a derivative of 
the confocal imaging systems, multiphoton 
microscopy was introduced early 1990s (Denk 
et al. 1990; Helmchen and Denk 2005). 
Multiphoton (MP) microscopy, mostly two- 
photon microscopy, uses multiple photons of 
higher wavelengths to excite fluorescent probes, 
in contrast to single-photon excitation in regular 
fluorescent techniques. Single-photon excitation 
comprises the transition of an electron in this 
fluorescent molecule to another molecular orbit, 
bringing the molecule from the ground state (S0) 
to the excited state (S1), as is depicted in the 
Jablonski diagram in Fig. 16.22. This transition is 
Fig. 16.21 IVM recording by widefield fluorescence 
microscopy of blood platelet (white, arrow) adhesion and 
aggregation in the common carotid artery of a mouse upon 
vascular injury. Widefield fluorescence IVM can be used 
to assess increases in platelet adhesion and aggregation. 
Nevertheless, axial resolution in widefield fluorescence 
IVM is low (Figure is adapted from Massberg et al. (2003) 
and reprinted with permission)
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only transient, and upon return of the molecule to 
S0, a fluorescent photon will be emitted. Since 
some energy is lost in between absorption and 
emission, the emitted photon has lower energy 
that the absorbed photon, shifting the emission to 
the red (Stokes shift).
Single-photon excitation as used in confocal 
microscopy, however, causes photodamage and 
phototoxicity, while its penetration depth into tis-
sue is limited. Therefore, single-photon excita-
tion is not the most suitable technique to study 
thick and living samples. The use of (near-)infra-
red (IR) light, as used in MP microscopy, can cir-
cumvent these problems. However, near-IR light 
is not capable of exciting the molecule by itself, 
since it lacks the energy to induce the transition 
from S0 to S1. As a result, the molecule will end 
up in the intermediate I1 state. Only if two infra-
red photons arrive virtually simultaneously 
(within 10−18s, i.e., one attosecond) at the mole-
cule, they can together bridge the energy gap 
between S1 and S0. In a continuous laser beam, 
however, the probability of photons to arrive 
simultaneously at the molecule is virtually zero. 
By increasing the photon density, it is possible to 
increase this probability and thus to allow the 
transition from S0 to S1 and, thus, perform deep- 
tissue fluorescence imaging. To achieve this, a 
pulsed laser is used (temporal confinement, 
Fig. 16.23a), which emits femtosecond pulses 
with a high photon density at a high frequency 
(80 MHz). Even under these prerequisites, effec-
tive two-photon excitation will happen only in 
the focal point (spatial confinement, Fig. 16.23b), 
as the probability of two-photon excitation 
decreases with a power of two with increasing 
distance to the focal point.
Especially in the recent 10–15 years, MP 
microscopy has been applied more frequently. At 
first, application was especially focused on deep- 
tissue imaging, since MP microscopy is one of 
the techniques which allows imaging up to 1 mm 
(1000 μm) in, e.g., brain tissue, without requiring 
tissue sectioning or extensive tissue handling 
and/or fixation.
MP microscopy has several advantages over 
confocal microscopy. The most important hereof 
are the use of a pulsed laser system and the use of 
higher excitation wavelengths. The use of a 
pulsed (femtosecond) laser causes less photo-
bleaching and phototoxicity. This is caused by 
the fact that light of higher wavelengths is less 
absorbed by, and as a consequence interacts less 
with, the tissue itself. The reduction in photo-
bleaching can be explained among others by the 
reduction in out-of-focus excitation due to the 
spatial confinement as well as by the relative 
reduced time of excitation of the fluorophore by 
Fig. 16.22 Jablonski diagram showing single-photon 
excitation versus two-photon excitation. Single-photon 
excitation by, e.g., a solid-state laser in confocal setups 
uses a single photon to bring a fluorescent molecule from 
the ground state (S0) to the excited stated (S1), followed by 
fluorescence emission upon return of the electron from S1 
to S0. Fluorescence emission can however also be achieved 
by two-photon excitation, in which two photons are 
required for transition from the ground state (S0) to the 
excited stated (S1) via the intermediate (I1) state
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the temporal confinement compared to continuous 
excitation in regular confocal systems. In addi-
tion, excitation only occurs in focal point (i.e., no 
out-of-focus excitation as in confocal micros-
copy). Additionally, since there is no absorption 
in the out-of-focus plane, a higher penetration 
depth is achieved compared to confocal micros-
copy (Fig. 16.24).
The use of higher (near-)infrared light wave-
lengths also has distinct advantages. Firstly, it 
results in a higher penetration depth as discussed 
above, and, since these wavelengths are less dam-
aging, they are very suitable for vital imaging. 
Moreover, since the two-photon excitation spec-
trum of many fluorescent probes is broader than its 
single-photon counterpart, simultaneous  excitation 
of multiple probes often occurs as a result of off-
peak excitation of these fluorophores using (near-)
infrared light wavelengths. This may however also 
include excitation of autofluorescent molecules.
By combining the characteristics mentioned 
above with methods to allow high-speed image 
acquisition, intravital MP microscopy can be 
achieved. The two most well-established ways of 
achieving high-speed imaging are resonant scan-
ning and multibeam-based imaging (Nielsen 
et al. 2001; Fan et al. 1999; Niesner et al. 2007). 
In resonant scanning, high scanning speeds are 
achieved by the use of resonant galvanometer 
mirrors, which can oscillate with a frequency up 
to 12 kHz. The high speed, however, comes at the 
cost of increased noise levels, which favor the use 
of better detectors which have as little noise as 
possible. An alternative is a multibeam approach, 
in which the excitation laser beam is split into 
multiple (up to 64) beams which can simultane-
ously scan the specimen, allowing a faster scan-
ning time. Here however, there is a loss of 
resolution with increasing penetration depth. 
Alternatively, triggering based on the cardiac 
and/or respiratory cycle can be used as a means to 
compensate for tissue motion, allowing acquisi-
tion of stable images in time but at the cost of 
temporal resolution.
In recent years, the applications of MP-based 
IVM have expanded greatly, and MP microscopy 
a b
Fig. 16.23 Temporal and spatial confinement required 
for achieving fluorophore excitation in multiphoton 
microscopy. By temporal confinement, photon density is 
increased by creating narrow photon-dense pulses. Spatial 
confinement is caused by the focusing capacity of objec-
tive lenses, where, as a result, the photon density is solely 
high enough in the focal plane of the specimen
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has become a powerful technique for studying 
dynamic processes in, e.g., oncology, immunol-
ogy, neuroscience, gastroenterology, urology, 
and cardiovascular research, as is depicted below.
16.4.2.1  Cell Trafficking 
and Hemodynamics
Similar to classic intravital imaging, MP IVM 
imaging has been used to study live process, such 
as vascular permeability, leukocyte adhesion and 
transmigration, blood flow, shear rate, and hema-
tocrit measurements in vivo. Significant progress 
has been made to allow imaging and quantifica-
tion hereof. Nowadays, studies have been real-
ized which are able to assess functional parameter 
in an entire tissue volume (Kamoun et al. 2010). 
By applying differential line scanning tech-
niques, this can be achieved at several locations 
a b
c d e
f g
Fig. 16.24 Effect of penetration depth on the effective 
spatial resolution obtained with multiphoton microscopy 
(a, c, f) and confocal microscopy (b, d, e, g) as studied in 
a mouse carotid artery of which cell nuclei were labeled 
(green). Images are obtained at different depths: a, b, 
15 μm depth; c–e, 40 μm depth; and f–g, 80 μm depth. 
Due to out-of-focus fluorescence in confocal microscopy, 
the effective resolution deteriorates far more with increas-
ing depths as compared with MP microscopy. Confocal 
images obtained with optimal pinhole settings except for 
e in which the pinholes were fully open (Figure is adapted 
from van Zandvoort et al. (2004) and reprinted with 
permission)
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at the same time, allowing the generation of 
velocity maps and comparing the functional 
makeup of a vascular bed (Fig. 16.25). More 
recently, this technology has even been applied in 
tissues suffering from substantial motion arti-
facts, such as atherosclerotic carotid arteries 
(Rademakers et al. 2013), in which functional 
parameters of microvasculature surrounding the 
atherosclerotic lesion were assessed (Fig. 16.26). 
Moreover, heterotopic beating heart models have 
been studied using MP-based IVM, allowing 
intravital imaging of leukocyte transmigration in 
the beating heart (Li et al. 2013b).
Alternatively, by applying triggering for the 
cardiac and respiratory cycle, image resolution 
can be improved. When the residual tissue motion 
can then also be reduced, as was proposed 
recently for carotid artery imaging, spatial and 
temporal resolution are even high enough to per-
mit 4D imaging, i.e., the acquisition of 3D images 
in time (Fig. 16.27) (Chevre et al. 2014).
16.4.2.2  Cell Tracking 
and Photoactivation
As part of intravital MP, new applications for 
dedicated cell tracking have been developed, 
inspired by developments of photoactivatable 
fluorescent probes (Shaner et al. 2007). These 
probes allow otherwise non-fluorescent proteins 
to be specifically activated in a certain cells in a 
piece of tissue or organ, after which these cells 
can be specifically traced. The great advantage of 
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Fig. 16.25 Labeling both the cell-free blood volume and 
erythrocytes, it is possible to measure blood flow veloci-
ties in whole samples, e.g., the brain vasculature in a 
mouse, by using line scanning techniques (a). After image 
processing, involving post-processing of the acquired 
images (b), velocity maps (c), and maps revealing eryth-
rocyte fluxes (d) within the vasculature can be constructed 
(Adapted from Kamoun et al. (2010); reprinted with 
permission)
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this technique is that no injections of labeled cells 
are required, which is especially useful for study-
ing small and delicate tissues which would not 
allow injections. One of the most elegant exam-
ples hereof is depicted below, in which cell traf-
ficking between different compartments within 
the germinal centers of lymph nodes (Fig. 16.28) 
(Victora et al. 2010).
16.4.2.3  Vascular Network Formation 
and Vascular Permeability
Similar to cell tracking, MPM intravital micros-
copy also enables users to track development of 
vascular networks, a tool which is applied regu-
larly in angiogenesis research (Brown et al. 
2001). Transgenic animal models or labeling of 
blood vessels using fluorescent antibodies, 
lectins, or tracers which reside in the blood (e.g., 
high-molecular-weight dextrans) can be used to 
not only track the development of vessels in time 
but also determine properties like angiogenic 
activity, vascular surface area and volume, or vas-
cular permeability. As such, functional parame-
ters can be quantified which can be used to assess 
efficacy of interventions. Similarly, network for-
mation and functionality can also be imple-
mented in different biological systems, e.g., 
neuronal networks (Eichhoff and Garaschuk 
2011; Grewe et al. 2010; Gobel et al. 2007).
16.4.2.4  Cellular Dynamics
Another development is Förster resonance energy 
transfer (FRET) imaging using MP microscopy, 
although FRET imaging has already been a fre-
quently used tool in confocal microscopy. The 
basis of FRET imaging relies on a FRET pair, 
i.e., two fluorescent proteins, which can act as a 
donor-acceptor pair. In such a FRET pair, the 
fluorescent protein with the lowest emission 
wavelength will be excited. When the two fluo-
rescent proteins are in close proximity, their elec-
tron orbits overlap, which causes direct energy 
AU16
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Fig. 16.26 Functional properties of the microvasculature 
can be studied in vivo in tissues suffering from substantial 
motion artifacts, such as atherosclerotic carotid arteries, 
by using resonant scanning MP-based IVM. Here, micro-
vascular permeability for a 70 kDa dextran (green, a,b) 
was studied in local (a) and control (b) microvascular tis-
sue, revealing an increased permeability in the local 
microvasculature in time (c). Moreover, leukocyte adhe-
sion and transmigration could be assessed (d, e), with 
additional in situ z-scans allowing 3D study (f) of the leu-
kocyte (red) transmigration process through the microvas-
cular endothelium (green) (Adapted from Rademakers 
et al. (2013); reprinted with permission)
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transfer from the excited donor to the acceptor 
protein. This fluorescent protein will, as a result, 
emit a fluorescent signal (Fig. 16.29). Since this 
process can only occur when both fluorophores 
are in close proximity to each other, this tech-
nique is well suited for studying receptor-ligand 
binding, protease/kinase activity, and other 
molecular interactions.
FRET imaging has been applied in isolated 
vital tissue (Kapsokalyvas et al. 2014), but 
a
b
Fig. 16.27 Using triggered image acquisition and 
mechanical tissue stabilization, it is possible to greatly 
reduce the motion artifacts occurring during intravital 
imaging, hereby greatly enhancing image resolution (a). 
Such methods also allow imaging of tissue Z-stacks in 
time, i.e., 4D imaging. Maximum projection of time series 
shows the movement GFP+ myeloid cells within a murine 
carotid artery (b) (Figure adapted from Chevre et al. 
(2014) and reprinted with permission)
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recently FRET imaging has been implemented in 
intravital MP microscopy as well. FRET imaging 
in a multiphoton microscope can be performed 
either by measuring differences in fluorescent 
donor lifetime upon FRET activity or simply by 
measuring the emission signal of the FRET 
acceptor molecule relative to the emission signal 
of the donor molecule (i.e., ratio imaging), the 
latter of which is used in intravital FRET imag-
ing. By intravital FRET, it is possible to study 
molecular interactions in tissue in vivo and has, 
e.g., been used to establish kinase activity of Erk 
during neutrophil recruitment under inflamma-
tory conditions in mice (Fig. 16.30) (Mizuno 
et al. 2014).
Other examples of studying cellular dynamics 
are determining calcium fluxes. This technique is 
used, e.g., in neuroscience, to determine neuronal 
activity (Mittmann et al. 2011), but nowadays 
these experiments are also being applied to other 
organs like the kidney, in which podocyte cal-
cium fluxes were determined in vivo (Burford 
et al. 2014).
16.4.2.5  Lineage Tracing
In the last years, novel animal models, genetic 
constructs, and probe developments have led to 
the possibility of mapping cell fate (or lineage 
tracing) by IVM. Here, also photoactivatable or 
photo-switchable probes have been used, while 
other studies rely on the Brainbow approach 
(Mahou et al. 2012) to achieve this. The principle 
of Brainbow technology is based on the stochas-
tic expression of multiple copies of constructs 
which code for different fluorescent proteins 
(Livet et al. 2007). As such, a multitude of color 
combinations can be achieved, and this technique 
has been used especially in neuroscience settings, 
where individual neurons and their mutual con-
nections were studied (Fig. 16.31). Similar 
approaches have been derived from the Brainbow 
principle, including RGB marking (Weber et al. 
2011) or generation of so-called Confetti mice 
(Schepers et al. 2012), and have introduced these 
lineage tracing approaches in other fields of 
research as well.
a b
Fig. 16.29 FRET imaging is based on fluorescent pro-
teins, e.g., cyan fluorescent protein (CFP, blue) and yellow 
fluorescent protein (YFP, yellow), which are linked 
together by a linker domain (a). Upon conformational 
changes (e.g., receptor activation), the two fluorescent 
proteins will come into close proximity, and energy trans-
fer is possible between the two fluorescent proteins. 
Therefore, it is necessary that the emission wavelength (b, 
solid blue line) of the donor (i.e., CFP) overlaps with the 
excitation wavelength (b), dotted yellow line) of the 
acceptor (i.e., YFP)
Fig. 16.28 By using photoactivation in specific regions 
within a tissue, it is possible to study cellular dynamics 
between different tissue compartments, e.g., cell traffick-
ing between the light (LZ) and dark zone (DZ) within the 
germinal centers of lymph nodes (a). After photoactiva-
tion, computational analysis can determine the movement 
of cells in time from DZ to LZ and vice versa (b) (Figure 
adapted from Victora et al. (2010) and reprinted with 
permission)
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16.4.3  Perspectives and 
Considerations
In all, the field of intravital imaging has undergone 
considerable changes, even though to date, even 
the classical intravital approaches are still being 
used to some extent. The type of intravital micros-
copy one would want/need to use will depend on 
several factors (Table 16.1). MP-based IVM on the 
one hand can give an integrated approach of mul-
ticolor, deep-tissue imaging, but the equipment is 
far more expensive and requires considerable tech-
nical expertise. Moreover, often large datasets are 
acquired, which require substantial data processing 
like image deconvolution, because of the increased 
axial point spread function at higher wavelengths 
and increased depth in the tissue. Also data analy-
sis in these larger datasets can be cumbersome. The 
classical techniques on the other hand are generally 
cheaper (depending on the specific setup) and eas-
ier to use and in many cases will be able to answer 
the research question at hand. The choice for the 
exact type of intravital imaging will therefore 
depend greatly on the research question at hand, as 
well as on the tissue/organ studied.
In line with these considerations, several other 
factors will influence the choice for intravital 
imaging, not unimportantly the availability of 
additional tools, e.g., adequate fluorescent 
probes, labeling strategies, or animal models. 
a
b
Fig. 16.30 FRET imaging has also been applied in IVM 
studies in mice, e.g., for studying kinase activity during 
neutrophil recruitment from the circulation to the intestine 
in a model of intestinal inflammation (a). These data can 
be quantified, giving a measure of kinase activity during 
the different phases of neutrophil recruitment (b) (Figure 
adapted from Mizuno et al. (2014) and reprinted with 
permission)
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Especially in multiphoton setups, in which mul-
tiple fluorophores are excited simultaneously, 
there is a need for fluorescent probes with relative 
narrow emission spectra in order to distinguish 
between the fluorophores. Novel probes like 
quantum and carbon dots present promising tools 
(Douma et al. 2009). Next, the ability to label 
specific structures is an important issue 
(Progatzky et al. 2013). Usually, the vasculature 
and cells in circulation can be stained easily by 
intravenous injection of specific fluorescent anti-
bodies, but other cell types are more challenging. 
The development of novel transgenic reporter 
mice as well as, e.g., FRET-sensor knock-in mice 
will provide an elegant tool for this purpose.
Yet, one of the greatest challenges still lies in 
achieving high-resolution imaging in vivo in 
various tissues. In fluorescence-based IVM, 
autofluorescence can significantly hinder proper 
image acquisition and requires careful consider-
ation when selecting fluorescent probes. Worth 
mentioning, autofluorescence can also provide a 
means for label-free imaging. Imaging of, e.g., 
NAD(P)H has been used to assess mitochondrial 
a b
Fig. 16.31 By using a Brainbow approach, stochastic 
expression of multiple copies of constructs which code for 
different fluorescent proteins will lead to a multicolor 
mosaic. The color of a cell is dependent on the expression 
of these proteins, e.g., in the embryonic neural tube (a). In 
time, the growing motor neurons can be imaged (maxi-
mum intensity projections), allowing intravital lineage 
tracing of which cells induce axonal outgrowth (b) (Figure 
adapted from Mahou et al. (2012) and reprinted with 
permission)
Table 16.1 Comparison of the different IVM techniques with regard to acquisition speed, lateral and axial resolution, 
depth penetration into tissue, and possibility of multicolor imaging
Acquisition speed Lateral resolution Axial resolution Depth penetration Multicolor imaging
Brightfield ++ + −− −− −−
Fluorescence
Widefield ++ ++ −− −− +/−
Confocal + ++ ++ +/− +
Spinning disk ++ ++ +/− − +/−
Multiphoton + ++ +/++ ++ ++
Based on Megens et al. (2011)
“−−” very low, “−” low, “+/−” moderate, “+” good, “++” very good
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function in skeletal muscle in vivo (Rothstein 
et al. 2005). Also processes like second and third 
harmonics generation (SHG and THG, respec-
tively) can be used to study different cell types, 
e.g., erythrocyte detection by THG, which can 
be used for label-free determination of hemody-
namic factors (Dietzel et al. 2014).
Beyond autofluorescence, scattering proper-
ties of the tissue will also hinder image acquisi-
tion or limit penetration depth. Even though the 
inherent properties of tissue are not easy to alter, 
ex vivo attempts to induce optical clearing of tis-
sue have proven to be quite successful, especially 
in brain tissue (Chung and Deisseroth 2013). 
First attempts to achieve optical clearing in vivo 
have been successful in, e.g., skin imaging using 
optical coherence tomography in rats (Genina 
et al. 2014), although application on an organ 
level in vivo – especially without altering func-
tion of the organ – remains tentative. Improvement 
of optics, like the development of graded index 
(GRIN) objectives, may however offer another 
way of improving imaging and even allow fiber- 
optic- based imaging, like intravascular or intra-
colon imaging. Also, applications of these 
objectives in brain and kidney imaging in vivo 
have given promising results (Levene et al. 2004; 
Li and Yu 2008).
Taken together, intravital imaging is a vital tool 
for studying dynamic process in small animal mod-
els. Depending on the research question, different 
variants of IVM may be used to answer this ques-
tion. Ongoing and novel technical improvements 
on intravital imaging equipment as well as probes 
and animal models will provide valuable tools for 
many fields of research in the years to come.
16.5  Optoacoustic Imaging
Daniel Razansky
16.5.1  Introduction
The imaging depth limitation of optical micros-
copy related to light scattering in living tissues 
can be generally overcome by means of 
 optoacoustic (OA) techniques (Razansky et al. 
2012). By detecting pressure waves induced via 
transient absorption of short high-energy laser 
pulses, OA methods have recently enabled 
high- resolution imaging with optical contrast at 
depths of several millimeters to centimeters 
(Wang and Hu 2012), orders of magnitude 
deeper than possible with modern microscopy. 
OA sensing and imaging draw its roots from the 
discovery of the photophone by A. G. Bell and 
his assistant C. S. Tainter in 1880, which the 
inventors used as the first practical wireless 
telephony or, in fact, optical communication 
device (Tainter and Bell 1880). However, due to 
lack of appropriate laser sources and ultrasound 
detection technologies, utilization of opto-
acoustics to biomedical applications, such as 
spectroscopy or imaging, was first considered 
in the 1970s (Rosencwaig 1973) with first 
images from living small animals obtained in 
the past decade (Wang et al. 2003). By combin-
ing commercially available pulsed laser tech-
nology in the nanosecond range and sensitive 
acoustic detectors, it was shown possible to 
generate OA responses from tissue that carry 
spatially resolved spectroscopic information on 
the underlying absorption contrast 
(Ntziachristos and Razansky 2010). Nowadays, 
the terms optoacoustic and photoacoustic are 
equally used to describe the effect of acoustic 
wave generation by transient light absorption. 
Due to its hybrid nature combining optical 
excitation and acoustic detection, the OA imag-
ing technology benefits both from the rich and 
versatile optical contrast and high (diffraction-
limited) spatial resolution associated with low-
scattering nature of ultrasonic wave propagation 
as compared to photon propagation (Wang and 
Hu 2012).
The ability to spatially resolve spectral infor-
mation, i.e., location/size of unique tissue struc-
tures containing specific chromophores, provides 
added advantage of OA techniques. Rendering 
images at multiple excitation wavelengths and 
spectral unmixing allow for visualization of 
intrinsic tissue chromophores, such as melanin 
(Krumholz et al. 2011), oxy- and deoxyhemo-
globin (Laufer et al. 2007), and lipids (Jansen 
F. Alves et al.
et al. 2014). Multispectral optoacoustic tomog-
raphy thus holds a great promise for functional 
and molecular imaging, which is highlighted by 
the broad range of emerging biological applica-
tions of optoacoustics, including cardiovascular 
imaging (Taruttis et al. 2010), monitoring of 
organ perfusion and pharmacokinetics (Buehler 
et al. 2010b), targeted studies of inflammation 
and arthritis (Beziere et al. 2014; Vonnemann 
et al. 2014), cancer detection and staging 
(Mehrmohammadi et al. 2013), neuroimaging 
(Nasiriavanaki et al. 2013), and dermatologic 
imaging (Ida et al. 2014).
16.5.2  Principles of Optoacoustic 
Imaging
Optoacoustic (OA) imaging is based on absorp-
tion of light radiation in tissue and conversion of 
the deposited energy into heat, which in turn 
results in thermal expansion and mechanical 
stress propagating in the form of pressure waves 
(Fig. 16.32).
Similarly to most optical imaging modali-
ties, light in the visible or near-infrared spec-
trum (400 nm–1200 nm) is normally used for 
excitation of OA responses due to the relatively 
weak absorption of biological tissues in this 
spectral region. Of particular importance is the 
near- infrared spectral window, which allows 
light penetration of up to several centimeters 
into optically dense tissues (Ntziachristos et al. 
2005). Alternatively, tissue can be excited with 
energy in the radiofrequency and microwave 
spectra (Razansky et al. 2010), which is however 
not included in the scope of this chapter. Large 
variety of chromophores is absorbing at the opti-
cal wavelengths, which further leads to a high 
contrast between different tissues with vary-
ing chromophore concentration. Figure 16.33 
shows absorption spectra of the most domi-
nant intrinsic absorbers in tissue in the vis-
ible and near- infrared range (Yao and Wang 
2014). For biomedical applications, except for 
intrinsic chromophores (e.g., hemoglobin in its 
oxygenated and deoxygenated form, melanin, 
fat), extrinsically administered agents, such as 
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Fig. 16.32 Basic principle of optoacoustic imaging. 
Short pulses of light are absorbed by tissue absorbers, 
generating pressure (acoustic) waves propagating through 
the medium. The latter are recorded by ultrasonic detec-
tors and used to form optoacoustic images by means of 
reconstruction methods
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nanoparticles or fluorophores (Amiot et al. 2008; 
Tong et al. 2009; De La et al. 2008), or geneti-
cally encoded markers (proteins) (Razansky 
et al. 2009), can be additionally employed for 
contrast enhancement.
Vast majority of the modern OA imaging set-
ups utilize lasers that emit ultrashort pulses in the 
nanosecond range, mainly due to good signal-to- 
noise performance and ease of parallelization. 
Under thermal and stress confinement conditions 
(Lutzweiler and Razansky 2013), usually 
assumed with respect to the duration of the laser 
pulse in this regime, the initially induced pres-
sure distribution p0(r) is generally proportional to 
the distribution of the absorbed optical energy 
density H(r) via
 p H0 = ×G ,  (16.1)
where Γ is the dimensionless Grüneisen parame-
ter describing the thermal and mechanical prop-
erties of the imaged tissue. Since Γ it does not 
exhibit significant variations among different soft 
tissues, it is most often assumed to be constant at 
a constant temperature.
The initial goal of optoacoustic imaging and 
tomography is to retrieve the absorbed optical 
energy density inside the object. However, the 
generated pressure fields can normally only be 
measured outside the object, whereas propaga-
tion of pressure waves toward the detection point 
is described by the optoacoustic wave equation 
(Kruger et al. 1995). The way to obtain opto-
acoustic images therefore consists in reconstruct-
ing distribution of the energy density H(r), i.e., 
solving or inverting the optoacoustic wave equa-
tion given the pressure variations measured 
around the imaged object.
For biomedical applications, it is the spatial 
distribution of the optical absorption coefficient 
μa(r) that is usually more directly related to the 
biochemical composition of the imaged tissue 
rather than the absorbed energy density. Both are 
related via
 H a= ×m F  (16.2)
where Φ is the light fluence (or photon density) 
field. Although one may presume that H it is a 
simple product, it in fact depends nonlinearly on 
the absorption coefficient μa. This is because the 
light fluence generally depends on the underlying 
optical properties, including optical scattering 
and absorption coefficients. Thus, it is important 
for image quantification purposes to account for 
the light fluence since it may considerably vary 
as a function of depth.
16.5.3  Multispectral Optoacoustic 
Tomography
While reconstructing distribution of the opti-
cal absorption coefficient may provide valu-
able structural (anatomical) information on the 
underlying tissue contrast, it is the concentra-
tions of different chromophores ci, not the opti-
cal absorption coefficient μa, that are mainly of 
interest from the biological point of view. For 
instance, in many applications, the blood-related 
absorption is of particular interest, providing 
valuable physiological or functional informa-
tion. The relation between concentrations of the 
different chromophores and the optical absorp-
tion coefficient may be expressed via linear 
superposition, namely,
 
m l e l m la
i
i ic( ) = ( ) × + ( )å BG ,
 
(16.3)
where εi(λ) are the wavelength-dependent 
molar extinction coefficients of the different 
intrinsic tissue chromophores or extrinsically 
administered agents and μBG is the residual 
(background) absorption, which might also 
include noise. To differentiate between contri-
butions of different chromophores, their dis-
tinct spectral dependence on wavelength can 
be assessed (Rosencwaig 1973; Kostli et al. 
2000). This multiwavelength imaging approach 
is known as multispectral optoacoustic tomog-
raphy (MSOT) or spectroscopic imaging 
(Laufer et al. 2007; Razansky et al. 2009; 
Sethuraman et al. 2008; Razansky 2012). The 
process of recovering ci from multispectral 
measurements is known as spectral unmixing. 
It can be combined with calculation of the light 
fluence or treated as a separate image process-
ing step.
AU17
AU18
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Due to versatility and wide availability of 
optical molecular agents, sensitive and accurate 
spectral processing to recover concentration of 
extrinsically administered agents may enable 
longitudinal molecular imaging studies. This can 
be done by resolving accumulation of agents 
with specific spectral signatures, such as targeted 
and activatable fluorescent molecular agents, 
nanoparticles, or genetic markers.
Figure 16.34 summarizes the main contribu-
tions to the OA signal generation chain, which 
need to be accounted for when developing accu-
rate image reconstruction algorithms.
16.5.4  Optoacoustic Imaging 
Instrumentation
A typical optoacoustic setup consists of several 
key components. In the pulsed excitation mode, 
the tissue is illuminated by laser emitting mono-
chromatic pulses of light with typical duration of 
some nanoseconds. For deep-tissue imaging 
applications, optical parametric oscillators are 
often used to provide a tunable wavelength in the 
spectrum of interest with pulse repetition rate in 
the order of a few tens of Hertz and per-pulse 
energies in the millijoule range. In optoacoustic 
microscopy and other superficial applications, 
where such high per-pulse energies are not 
required, other types of sources in the microjoule 
and nanojoule range are considered as well, 
including high repetition dye lasers (Song et al. 
2009), laser diodes (Allen and Beard 2006b), and 
fiber lasers (Wang et al. 2011).
For tomographic imaging, the optoacousti-
cally generated pressure profiles are captured 
with detectors surrounding the object. In com-
parison to ultrasound (US) imaging, OA signals 
are broadband (from several tens of kHz up to a 
100 MHz for small structures), while their ampli-
tude is relatively low. Their frequency content is 
mainly dependent on the characteristic size of 
absorbers in the imaged volume. Due to the dom-
inating low-frequency content of OA waves gen-
erated by common biological targets, utilization 
of physical or synthetic aperture focusing may 
turn inefficient. Moreover, while in US the focus-
ing can be done in both transmission and detec-
tion, only the latter is relevant for OA. On the 
other hand, the optical absorption contrast may 
reach more than one order of magnitude for blood 
versus other tissues (Wang 2009) versus up to 
10 % contrast between soft tissue pulse-echo US 
imaging (Duck 1990). As a result of both ineffi-
cient focusing and high-absorption contrast, OA 
image formation using linear phased arrays and 
other focusing techniques suffers from severe 
out-of-focus artifacts, impaired contrast, image 
blurring, and overall lack of quantification abili-
ties (Lutzweiler and Razansky 2013). Thus, in 
contrast to pulse-echo US, correct image recon-
struction in OA imaging is ideally achieved by an 
unfocused detection of OA responses from as 
many tomographic viewing angles as possible 
around the imaged object.
Acoustic coupling between object and detector 
is usually ensured by water or coupling gel. For 
acquisition of spatially resolved data, either a sin-
gle detector is scanned around/along the object or 
multiple detectors acquire the data in parallel. The 
latter further allows for fast data acquisition, e.g., 
rendering images from single laser shots. The sig-
nals are then pre-amplified and digitized by a fast 
data acquisition system. Figure 16.35 illustrates 
the broad variety of OA setups employed for 
small animal imaging, including optical-resolu-
tion microscopy (Hu et al. 2011), endoscopy 
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Fig. 16.34 Schematic representation of the sequence of generation and detection of optoacoustic signals
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Fig. 16.35 Various types of optoacoustic imaging sys-
tems. (a) Optical-resolution photoacoustic microscopy 
(OR-PAM) scanner used for in vivo imaging of mice (Hu 
et al. 2011). Spatial resolution of the system in the lateral 
direction is determined by the size of the optical focus. 
Three-dimensional data is acquired by raster scanning of 
the optical beam along the imaged area. BS beam splitter, 
PD photodiode, CorL correction lens, RAP right-angle 
prism, SO silicone oil, RhP rhomboid prism, US ultra-
sonic transducer (central frequency – 50 MHz). The CCD 
is used to view the imaging region (Reprinted with per-
mission from the Optical Society of America). (b) 
Combined endoscopic system for co-registered US and 
dual-wavelength functional OA imaging in vivo (Yang 
et al. 2012). The endoscope carries out circumferential 
sector scanning by rotating a scanning mirror, which 
reflects both the ultrasonic waves and laser pulses and 
enables static mounting of the associated illumination and 
ultrasonic pulse-generation detection units (Reprinted 
with permission from the Nature Publishing Group). (c) 
Schematic drawing of the real-time whole-body mouse 
scanner including the animal holder, illumination device, 
and transducer array (Razansky et al. 2011). A curved 
array of wide-band and cylindrically focused ultrasound 
transducers enables parallel data acquisition from the 
imaged cross-sectional plane. Optical fibers are used to 
homogeneously illuminate the object. By translating the 
animal holder, three-dimensional data can be acquired 
(Reprinted with permission from the Nature Publishing 
Group). (d) Real-time volumetric imaging system com-
prising of a spherical matrix ultrasound detection array 
with the laser illumination provided via a fiber bundle 
pulled through the center of the array. Rapid acquisition of 
multiwavelength data from an entire imaged volume, 
combined with real-time image reconstruction and spec-
tral unmixing, provides four- and five-dimensional imag-
ing capabilities by rendering volumetric unmixed images 
of individual chromophores in real time (Deán-Ben and 
Razansky 2014) (Reprinted with permission from the 
Nature Publishing Group)
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(Yang et al. 2012), cross-sectional whole-body 
tomography (Razansky et al. 2011), as well as 
real-time volumetric (4D) and 5D imaging sys-
tems (Deán-Ben and Razansky 2014).
16.5.5  Small Animal Imaging 
Applications
Due to its rich optical contrast and high spatio-
temporal resolution, optoacoustics can deliver 
multiple types of contrast from deep tissues. 
Naturally, the best intrinsic tissue contrast at the 
visible and near-infrared wavelengths arises from 
highly absorbing hemoglobin; thus, blood ves-
sels are clearly visible in the optoacoustic images. 
OA microscopy is thus often geared toward 
investigation of vascular structures and neovas-
cularization, providing an excellent intrinsic con-
trast and a high spatial resolution in the order of 
some tens of μm and penetration of several mil-
limeters into scattering tissues. In this way, 
disease- related anatomical changes can be visu-
alized, e.g., development of tumor neovascula-
ture (Laufer et al. 2012) (Fig. 16.36a). While 
images can be generated at a single wavelength, 
multiwavelength illumination and spectral pro-
cessing are necessary for optimally identifying 
the unique spectral signatures of intrinsic tissue 
chromophores, such as hemoglobin, water, and 
lipids. It is therefore natural for OA imaging to 
volumetrically visualize blood oxygenation lev-
els in living tissues by resolving the contribution 
from oxygenated versus deoxygenated hemoglo-
bin. This functional imaging capability is show-
cased in Fig. 16.36b where oxygen saturation 
status of individual blood vessels was visualized 
with the optical-resolution microscopy method 
(Hu et al. 2011).
Preclinical whole-body imaging of small ani-
mals with multispectral optoacoustic tomogra-
phy (MSOT) systems is yet another key 
application of OA imaging. These systems can 
provide tomographic images with a resolution in 
the order of hundred μm for depths between sev-
eral millimeters to several centimeters. Possible 
applications include monitoring of tumor 
hypoxia, drug response, or molecular targets in 
biological model organisms (Herzog et al. 2012; 
Lozano et al. 2014). The ability of MSOT to 
visualize deep-seated fluorescent proteins with 
high resolution has been also demonstrated 
(Razansky et al. 2009). Figures 16.36e, f show 
example of a study on kinetics and biodistribu-
tion of near- infrared contrast agent in a living 
mouse (Taruttis et al. 2012). The uptake of a car-
boxylate dye in separate regions of the kidneys 
was tracked in real time over 30 min post its sys-
temic injection. The images indicate different 
dynamics in different areas of the kidneys, sug-
gesting that two dependent processes are being 
imaged, firstly the filtration of agent in the cortex 
and subsequently the excretion toward the 
ureter.
Finally, Fig. 16.36g, h demonstrates the 
molecular imaging capabilities of MSOT, which 
was employed in this case to detect upregulated 
epidermal growth factor (EGF) receptor in ortho-
topic pancreatic xenografts using a near-infrared 
EGF-conjugated CF-750 fluorescent probe 
(Hudson et al. 2014). The images clearly indicate 
the region where EGF-750 probe has accumu-
lated with high spatial resolution. In comparison, 
fluorescence imaging of the mice also validated 
the accumulation of the EGF-750 probe at 6 h 
with specific accumulation in the lower left quad-
rant of the tumor (Fig. 16.36h). However, due to 
intense light scattering in deep tissues, the fluo-
rescence measurements were only able to pro-
vide diffuse signal pattern with no depth 
resolution.
16.5.6  Conclusions
Owing to its hybrid nature, optoacoustics benefits 
from both the rich and versatile optical contrast 
and high (diffraction-limited) spatial resolution 
associated with the scattering-free nature of 
ultrasonic wave propagation. Much like other 
optical imaging modalities, optoacoustics uses 
safe nonionizing radiation at the visible and near- 
infrared wavelengths. Thus, it provides an excel-
lent platform for multiscale investigations using 
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the same contrast, from microscopic observations 
at the single capillary and cell level to whole- 
body imaging of small animals and deep-tissue 
imaging of humans.
The optoacoustic effect relies on the absorp-
tion of light and is therefore ideally suited for 
vascular imaging since most of intrinsic contrast 
is obtained from high-hemoglobin-containing 
tissues like whole blood. This opens a multitude 
of potential applications in visualization of 
disease- related vascular changes, neovasculariza-
tion, tumor microenvironment, and noninvasive 
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Fig. 16.36 Optoacoustic small animal imaging can pro-
vide multiple indications on in vivo structural, functional, 
kinetic, and molecular tissue profiles with a single modal-
ity. (a–c) show anatomical appearance of proliferating 
subcutaneous 293 T tumor and surrounding vasculature 
from day 7 to day 26 post inoculation (Laufer et al. 2012) 
(Reprinted with permission from SPIE). (d) Optical-
resolution microscopy image representing distribution of 
blood oxygenation in a mouse ear (Hu et al. 2011) 
(Reprinted with permission from the Optical Society of 
America). (e) Time series of cross-sectional whole-body 
mouse images visualizing the biodistribution of IRdye800 
near-infrared contrast agent in green overlaid on the ana-
tomical image (Taruttis et al. 2012). (f) Temporal evolu-
tion of dye signal in the regions of interest highlighted in 
(e), orange showing a region in the renal cortex that dis-
plays early and steep signal pickup and black indicating a 
region in the renal pelvis where probe accumulation is 
delayed and has a smoother profile. Individual multispec-
tral measurements acquired with a rate of approximately 2 
per minute are shown as dots, while the solid line repre-
sents a fit to an analytical function (Reprinted with per-
mission from the Public Library of Science). (g) 
Multispectral optoacoustic tomography (MSOT) detec-
tion of upregulated epidermal growth factor (EGF) recep-
tor in orthotopic pancreatic xenografts using a targeted 
near-infrared EGF-conjugated CF-750 fluorescent probe 
(Hudson et al. 2014). Three-dimensional biodistribution 
of targeted EGF-750 probe is shown in color at 6 h postin-
jection. While MSOT can localize distribution of the 
probe with high resolution and all three dimensions, epi-
fluorescence images (h) from the same animal have highly 
blurred low-resolution appearance with no depth-resolved 
information (Reprinted with permission from the 
American Association for Cancer Research)
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functional diagnostics of blood perfusion and 
oxygenation. Yet, the capacity to image spec-
trally distinctive photo-absorbing agents with 
high spatiotemporal resolution at depths far 
beyond the diffusive limit of light opens unprec-
edented capabilities for functional and molecular 
imaging.
Extensive research is underway to address 
technical challenges associated with the intrigu-
ing and highly promising combination of light 
and sound. Main limitations are currently associ-
ated with the lack of reliable and affordable laser 
and ultrasound detection technology that can 
optimally address the unique needs of optoacous-
tics, such as high per-pulse laser energy or repeti-
tion rate, ultrawideband detection, high detection 
sensitivity, and miniaturization. Multiple fron-
tiers are also open in the algorithmic and inverse 
theory areas, trying to address challenges related 
to artifact removal, image quantification, recon-
struction strategies in the presence of acousti-
cally mismatched areas, real-time operation, and 
multispectral data processing.
All in all, optoacoustic imaging attracts grow-
ing interest from the biological and medical 
research communities, as manifested by the ever- 
increasing number of publications encompassing 
great variety of new applications that exploit the 
unique advantages offered by the technology. It is 
therefore expected to find broad applications in 
biological research and clinical practice in mul-
tiple fields, including cancer research, functional 
brain imaging, cardiovascular imaging, gastroen-
terology, ophthalmology, drug development, and 
treatment monitoring.
16.6  Optical Probes
Kai Licha
16.6.1  Introduction: Optical Probes 
for Animal Imaging
The application of optical imaging technologies 
for drug discovery research and the development 
of novel preclinical animal models have expanded 
with tremendous vigor in the past few years. The 
fact that fluorescent dyes can be detected at low 
concentrations and nonionizing and harmless 
radiation is applied with rather low technical 
effort makes optical techniques attractive for rou-
tine use in the animal imaging laboratory. Novel 
imaging probes and contrast agents have been 
designed in a broad variety addressing the vari-
ous requirements given by the disease problem at 
the preclinical animal imaging stage. Moreover, 
the industry has identified this field as a market 
from the side both the imaging equipment and the 
fluorescent probes applied as readily injectable 
contrast agents or reactive labels for bioconjuga-
tion chemistry.
Imaging devices with powerful and versatile 
capabilities are now commercially available, 
addressing different needs of the customer, such 
as multicolor imaging, time-resolved imaging, 
planar or tomographic geometry, signal quantifi-
cation, spectral unmixing for background correc-
tion, or zooming within macroscopic scale. A 
closer look into these topics is provided else-
where in this book.
The design of fluorescent imaging probes for 
in vivo imaging applications has likewise 
emerged and is reflected by an increasing number 
of commercialized probes and labels. The under-
lying chemistries have been optimized for their 
capability to monitor disease-specific anatomic, 
physiological, and molecular parameters by way 
of directly applicable imaging probes or by spe-
cific reactive labels, which can be used by the 
customer to fluorescently label his own drug can-
didate for further studies or derivatize important 
biological ligands to investigate the basics of a 
given targeting approach.
The main objective of this contribution is to 
provide an overview on the different choices 
available when setting up an imaging protocol 
using optical probes. Hereby, the review sets a 
focus on practical aspects of the application of 
optical probes for animal imaging and drug dis-
covery research. The state of the art of imaging 
probes is first discussed covering nontargeted and 
vascular agents, approaches to generate targeted 
agents via reactive fluorophores, the field of enzy-
matically activatable probes, and imaging agents 
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based on particles. To facilitate the researcher’s 
choice, a selection of relevant parameters is dis-
cussed in the subsequent chapter, discussing 
appropriate examples out of the literature. At this 
point, it is mentioned that examples include pub-
lished work and refer to selected commercial 
compounds and companies as well. The intention 
of this review is neither to provide a comprehen-
sive dataset on these probes nor to accentuate par-
ticular commercial suppliers. Figure 16.37 
summarizes the general parameters that contrib-
ute to the design of optical imaging probes.
16.6.2  State-of-the-Art 
Technologies
16.6.2.1  Basics on Fluorescent Dyes
An efficient fluorescence imaging probe should 
employ a combination of different properties, 
which are (1) a high fluorescence quantum yield 
in the desired wavelength spectrum, (2) sufficient 
biological stability and photostability to permit 
unimpaired image acquisition, and (3) reasonable 
solubility in (most) aqueous environment to 
enable bioconjugation and labeling reactions 
without substantial triggering of aggregation and/
or precipitation. Among the many possible 
organic fluorophore classes, the polymethine 
dyes (e.g., cyanines, hemicyanines, benzopyry-
lium dyes), xanthene dyes (rhodamines and fluo-
resceins), and also some oxazoles and thiazoles 
(e.g., methylene blue, Nile blue) are basically the 
ones that are widely established and have been 
contributing to the majority of scientific results 
(Licha and Resch-Genger 2011, 2014). 
Figure 16.38 illustrates typical absorption and 
fluorescence spectra of these types of fluoro-
phores, thereby showing the wavelength range 
within imaging is possible. While xanthene dyes 
do not reach fluorescence emission far beyond 
700 nm, they exhibit extremely high fluorescence 
quantum yields often close to 100 %. In turn, cya-
nine dyes are capable to cover the entire spec-
trum from VIS to NIR (>900 nm) with high 
extinction coefficients (up to 250,000 L/mol cm), 
but rather moderate fluorescence quantum yields 
(up to 30 %). Other interesting but less frequently 
applied organic dyes include squaraines (Luo 
et al. 2011b) and BODIPYs (Boens et al. 2012). 
Besides organic fluorophores, inorganic semi-
conductor nanoparticles have emerged as alterna-
tive fluorescent reporters (see Chap. 21.2.5).
As further detailed in the subsequent chapters, 
the most relevant applications for these dyes as 
imaging tools are the direct use as injectable con-
trast agents in a nontargeted or passively 
distributing format, the use as reactive fluorophore 
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Fig. 16.37 Basic idea and general parameters for the generation of optical probes
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labels to create targeted conjugates of biological 
or synthetic origin, and the use as quenched com-
ponents or non-fluorescent precursors as activat-
able imaging probes (also named “turn-on” 
probes) to monitor different kinds of enzyme 
activity. Furthermore, pH-responsive fluoro-
phores enabling the sensing of pH in tissues have 
been approached as additional parameter in 
tumor models.
16.6.2.2  Nontargeted and Vascular 
Dyes as Contrast Agents
A variety of fluorescent dyes for passive targeting 
and vascular circulation have been applied as fluo-
rescent imaging probes. These probes, most of 
them carbocyanine dyes, represent the basic chem-
icals for the design of labels and probes. Using 
these dyes as imaging agents by themselves, they 
act by their physicochemical and structural proper-
ties since they do not employ structures designed 
for a specific molecular interaction. However, the 
suitability for animal studies, e.g., the characteriza-
tion of experimental tumor models, has been dem-
onstrated in various publications.
The near-infrared dye indocyanine green (ICG, 
absorption ~780–800 nm) was approved in the 
1960s as a diagnostic drug, was rediscovered in 
the 1990s as an imaging agent, and is today, 
together with fluorescein, frequently applied for 
fluorescence angiography in ophthalmology 
(Richards et al. 1998), as well as increasingly 
used for fluorescence methods in surgery (Alander 
et al. 2012). Similarly, novel cyanine dye deriva-
tives have been created as passively targeted con-
trast agents of simple synthetic availability. 
Examples are the dye SIDAG, which leads to 
enhanced uptake in a variety of tumor models and 
permits differentiation of the degree of angiogen-
esis (Wall et al. 2008). Furthermore, the com-
pound was shown to enable fluorescence imaging 
of inflammation in a model of rheumatoid arthritis 
(Fischer et al. 2006). It therefore provides a pow-
erful tool for the validation of preclinical models, 
imaging equipment, and therapeutic studies 
(TryX750, mivenion). With the IRDyes (LI-COR 
Biosciences) or Cy5.5 (GE Healthcare Life 
Sciences), other examples of nontargeted or con-
trol dyes with published results for animal imag-
ing and human applications, such as lymphatic 
mapping or studies on T-cell migration, accom-
pany ICG (Foster et al. 2008; Rasmussen et al. 
2009). Another class that has recently attracted 
attention is the benzopyrylium- based polyme-
thine dyes (Dyomics) (Pauli et al. 2009b). In 
Fig. 16.39, a panel of selected chromophores is 
depicted. Beyond ICG, which by itself is not 
directly applicable to synthesize reactive deriva-
tives for biolabeling due to the absence of chemi-
cal functionalities, the compounds discussed here 
represent basic structures to create in few further 
steps reactive labels and subsequently any desired 
bioconjugate.
Fig. 16.38 Typical absorption and fluorescence spectra of cyanine dye and xanthenes dyes shown as idealized 
illustration
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Cyanine dye conjugates with substantially 
increased molecular weight have been designed to 
enable the visualization of vascular structures and 
to study effects on the vascularity. For this 
 purpose, the dyes were covalently conjugated to 
macromolecular carriers, such as albumin, 
 dextran, or other biopolymers (Klohs et al. 2009) 
or non-covalently entrapped into dendritic 
 architectures used as passive drug delivery sys-
tems (Quadir et al. 2008). These conjugates have 
been useful for imaging tumors but also to 
 visualize and characterize tissue architecture 
in vivo on a macro- to microscopic imaging level. 
Commercialized are, e.g., streptavidin, ovalbu-
min, protein A, and dextran conjugates with a 
variety of Alex Fluor® labels, marketed under the 
brand SAIVITM (Invitrogen) as imaging probes 
and secondary detection materials. Other avail-
able probes are the Angio Sense® probes (Perkin 
Elmer) based on large, long-circulating macro-
molecules at 250 kD (type of macromolecular 
carrier not published).
16.6.2.3  Reactive Dyes and Labeled 
Targeting Molecules
This chapter addresses the increasing demand for 
fluorescently labeled drug candidates based on 
molecules of synthetic (small organic molecules, 
peptides, oligonucleotides) or biotechnological 
origin, such as engineered proteins, antibodies, 
and novel protein formats. In order to get an 
insight into the targeting capabilities of these 
drugs in vivo, optical imaging is establishing as a 
fast and easy-to-apply technology in the animal 
imaging laboratory. As further outlined in Chap. 
21.3., fluorescence labeling offers the opportu-
nity to study biological and physicochemical 
properties of a desired candidate along the entire 
path from synthesis, in vitro and cellular level to 
the in vivo application in higher organisms.
Generally, optical imaging probes in the for-
mat of bioconjugates range from protein conju-
gates, antibody conjugates, structures based on 
oligonucleotides to receptor-avid peptide conju-
gates. Furthermore, a large panel of small- 
molecule substrates and ligands, such as folate, 
cyanocobalamin, glucose, bisphosphonates, as 
well as rationally designed receptor ligands, has 
been conjugated with fluorophores for in vivo 
studies.
This work has ultimately led to a large variety 
of targeted imaging agents published in the past 
few years. A selection of different reactive dye 
labels and resulting conjugates is depicted in 
Fig. 16.40. Being not the intention of this chapter 
to discuss these versatile approaches in detail, the 
reader is referred to respective reviewing publica-
tions (Licha and and Resch-Genger 2014; 
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Fig. 16.39 Selected near-infrared fluorescent dyes, 
which have been used as nontargeted probes for in vivo 
fluorescence imaging: (a) indocyanine green, (b) SIDAG 
(Wall et al. 2008), (c) IRDye® 800CW (LI-COR, [394]), 
(d) Cy5.5® carboxylic acid (GE Healthcare) and (e) 
DY-750 (Dyomics)
F. Alves et al.
Umezawa et al. 2014). A number of conjugates 
have been made commercially available address-
ing fundamental pathways in cellular uptake, 
angiogenesis, and tumor growth, for instance, 
conjugates with EGF (LI-COR), transferrin, 
annexin V, bombesin, folate, glucose, or certain 
bisphosphonates with bone affinity (Perkin 
Elmer).
Oligonucleotides and small peptides, as 
opposed to, e.g., targeting molecules of biotech-
nological origin, are accessible via solid-phase 
synthesis with the fluorophore conjugation capa-
ble of being implemented into the synthetic 
 protocol. Most of the dyes used have shown to be 
stable enough with respect to the chemical condi-
tions required for peptide cleavage from the resin 
and other interventions (e.g., forming disulfide 
bridges via oxidation). Examples for the synthe-
sis of low-molecular-weight peptide conjugates 
comprising different cyanine or rhodamine dyes 
have been published (Becker et al. 2001; Mier 
et al. 2002). For the 3′ and 5′ labeling of oligo-
nucleotides, conjugation chemistry can be 
applied similarly. A broad set of labels and 
quenchers covering the entire VIS to NIR is, for 
instance, offered with the ATTO dyes 
(ATTO-TEC).
16.6.2.4  Activatable or “Turn-On” 
Probes
Weissleder and coworkers have introduced an 
optical imaging approach, which is of fundamen-
tal difference to the approaches described above 
and utilizes the unique opportunity of modulating 
optical signals through intramolecular fluores-
cence quenching effects (Hilderbrand and 
Weissleder 2010; Weissleder et al. 1999). These 
probes are “activatable” polymeric conjugates 
based on a poly-l-lysine/polyethylene glycol 
graft polymer, which are “switched on” when 
a
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Fig. 16.40 Selected dyes in a reactive format for biola-
beling and published bioconjugates: (a) IRDye® 800CW 
Maleimide (LI-COR), (b) DY-781 NHS-ester (Dyomics), 
(c) Cy5.5-folate conjugate (Moon et al. 2003), and (d) 
indotricarbocyanineoctreotate (Becker et al. 2001)
16 Optical Imaging
single fluorochrome fragments are cleaved from 
the fluorescence-quenched polymeric structure 
by tumor-specific proteolytic enzymes, thus lead-
ing to signal amplification of up to 200-fold. In 
various preclinical disease models, the agents 
have demonstrated the imaging enzymatic activ-
ity and report the in vivo efficacy of enzyme- 
inhibiting drugs (Bremer et al. 2001b). The 
underlying imaging probes are based on cleav-
able graft polymers of high molecular weight and 
are commercialized by VisEn Medical Inc. Under 
different trade names (ProSense®, MMPSense®), 
the compounds are cleaved and activated by 
enzymes such as cathepsins and matrix metallo-
proteinases at spectral ranges of 680 and 750 nm, 
respectively.
Rationally designed conjugates of defined 
chemical structures, activatable photosensitizers 
for photodynamic therapy (Stefflova et al. 2007), 
as well as constructs sensitive to cleavage by other 
enzymes, such as thrombin and caspases (Barnett 
et al. 2009), have expanded this versatile technol-
ogy. More recently, the capability to turn on fluo-
rescence by an enzymatic conversion has been 
implemented into the fluorophore structure itself, 
thereby circumventing the need to employ a cer-
tain number of molecules to generate quenching 
(Kisin-Finfer et al. 2014). The advantage of such 
structures is the extremely low background in the 
switched-off state, simply because this precursor 
does not contain generate  background due to the 
absence of a fully established chromophore.
16.6.2.5  Probes for Sensing of pH 
and Reactive Oxygen 
Species
The establishment and characterization of tumor 
models might benefit from knowledge about cer-
tain physiological parameters, such as tumor pH 
(extracellular or intracellular) and the level of 
oxidative stress (reactive oxygen species), both 
of which being valuable in combination with 
molecular conditions (Licha and Resch-Genger 
2014).
Examples for pH-responsive xanthene dyes are 
BCECF (2´,7´-bis-(2-carboxyethyl)-5-(and-6-)-
carboxyfluorescein) and BCPCF (2´,7´-bis-
(2-carboxypropyl)-5-(and-6)-carboxyfluorescein) 
(see also the Oregon Green series from Life 
Technologies). Beyond fluoresceins and rhoda-
mines, similarly, benzoxanthenes have been syn-
thesized in many versions combining the 
advantages of fluoresceins and rhodamines, such 
as the SNARF and SNAFL dyes (semi- 
naphthorhodafluor and semi-naphthofluorescein 
derivatives, respectively). Typically, these dyes do 
not show significant pH-dependent changes in 
emission. Accordingly, these probes are termed 
dual or ratiometric excitation probes for pH, 
requiring excitation at two wavelengths.
More relevant for imaging purposes are NIR 
cyanine dyes which exhibit responsiveness to 
pH changes by omitting one substituent in the 
indole end groups. Recent examples include the 
commercially available CypHer5E dye label 
(Mathejczyk et al. 2012) and other similarly 
constructed NIR-emissive pH-responsive cya-
nine dyes (Lee et al. 2011), which have been 
applied for in vivo imaging thereby showing 
advantages in tumor detection and background 
suppression.
The term reactive oxygen species (ROS) 
encompasses oxygen radicals and peroxides such 
as •OH−, •O2−, and •OOH which are important 
indicators for the oxidative state of cells, in partic-
ular as a result of certain therapeutic intervention. 
Thus, fluorescent sensors and stimuli-responsive 
fluorophores have emerged as imaging tools. An 
example are so-called hydrocyanines (Selvam 
et al. 2011) which change from a reduced, non-
colored status to the chromophore structure upon 
oxidation in living systems.
16.6.2.6  Fluorescent Particles 
as Imaging Agents
Fluorescent imaging agents based on particles have 
shown great utility, especially for applications on 
cellular staining (in vitro) and vascular imaging 
(in vivo). In principle, there are two different groups 
of nanoparticle probes. On the one hand, nano-
sized materials based on organic and/or inorganic 
chemistry have been equipped with organic fluoro-
phores, by either incorporating the dye molecules 
into the nanoshells or attaching it to surface func-
tionalities (Azar and Intes 2008). Interesting nano-
materials, including semiconductor nanoparticles 
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(quantum dots), gold nanoparticles, and carbon-
based particles (nanotubes), have emerged as 
powerful imaging tools with brilliant optical prop-
erties (Holzinger et al. 2014). Probably in a most 
advanced state of utility are quantum dots which 
consist of atoms such as Cd, Se, Te, S, and Zn. 
The fluorescence emission range depends on the 
diameter of the particles, which can be synthesized 
in a very controlled fashion with respect to size 
and surface modifications (Fig. 16.41). Surfaces 
employing stabilizing polymers as well as target-
ing molecules, such as antibodies and peptides, 
have expanded their applications for in vivo ani-
mal imaging (Bentolila et al. 2009).
Nanoparticles are particularly interesting for 
multimodality imaging purposes due to their 
 modular composition. Magnetic cores for MRI 
imaging can be functionalized with additional 
 fluorophores to allow fluorescent tracking and vice 
versa; fluorescent cores have been combined with 
paramagnetic complexes (Azar and Intes 2008).
16.6.3  The Choice of Parameters
16.6.3.1  Optical Properties
Generally, the choice of the spectral range of 
absorption and fluorescence of the dye deter-
mines whether it is detectable on tissue surfaces 
(UV–vis dyes, 400–700 nm) or from deeper- 
located tissue areas (NIR dyes, >700 nm). A pre-
requisite for sensitive detection of a 
contrast-enhancing dye is a high extinction coef-
ficient at the desired absorption wavelength. If 
fluorescence is recorded within the UV/VIS 
spectral region, both autofluorescence and the 
administered contrast agent will contribute to the 
observed signal, while in the NIR spectral region, 
tissue autofluorescence is negligible due to the 
absence of endogenous NIR fluorophores. In the 
latter case, the detected signal nearly exclusively 
reveals the distribution of the optical imaging 
probe.
The broad availability of fluorophore labels 
allows the selection of probes exactly matching 
the technical parameters of a given analytical 
instrument. Under practical circumstances is the 
application of one particular fluorophore for a 
research program starting at the in vitro level 
with cell microscopy, FACS, and other assays, 
then reaching in vivo imaging studies in animals, 
often not possible. Analytical instruments are 
usually not equipped with excitation and detec-
tion components permitting detection with suffi-
cient sensitivity over the entire spectral range. 
Therefore, a work-around strategy often involves 
the choice of an appropriate series of fluoro-
phores that differ only in minor extent in their 
Fig. 16.41 Typical absorption and fluorescence spectra of quantum dots shown as idealized illustration; principal 
design of targeted quantum dot conjugates
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chemical structures. This strategy minimizes 
unexpected effects on the resulting targeting con-
jugate when changing the fluorophore backbone. 
Here, cyanine dyes with their carbo-, dicarbo-, 
and tricarbocyanine homology are well suited. 
Examples of dyes offered as series are the 
CyDye™ series (GE Healthcare Life Sciences), 
which have been one of the first comprehensive 
product lines for fluorescence labeling (Cy3, 
Cy5, Cy5.5, Cy7).
The Alexa Fluor® Dye series (Invitrogen/
Molecular Probes) have expanded the available 
spectral emission range from approximately 450 
to 800 nm including derivatives (cyanine and 
xanthene) of improved photostability and fluo-
rescence quantum yields. Alexa Fluor 488, Alexa 
Fluor 546, Alexa Fluor 555, and Alexa Fluor 750 
are examples for products (consistently named 
by their excitation maximum). Similarly, highly 
hydrophilic Cy5.5-like pentamethine dyes have 
been reported in comparison to the known Cy5.5 
label (LI-COR and (Pauli et al. 2013)). Another 
group is based on a different chromophore type, 
the borondipyrromethenes, known as BODIPY 
dyes (Invitrogen) (Boens et al. 2012). For a repre-
sentative cyanine dye series, the typical color 
appearance of solutions (approximately 0.1 mM) 
in water is depicted in Fig. 16.42, which might 
facilitate the identification of the correct probe in 
case of some disorientation caused by too many 
flasks at the same time on the bench.
Generally, reactive dyes are offered in differ-
ent version of chemoselectivity (see Chap. 
21.3.3) so that the most reasonable labeling 
chemistry can be applied. The obtained amount 
of conjugate has to match the extent of the 
planned animal imaging study. Typically, fluores-
cent conjugates have been applied at doses in the 
range of 0.1–1 μmol/kg (i.v.), which corresponds 
to approximately 0.1–1 mg/kg amount of fluoro-
phore (calculation based on the molecular weight 
of the fluorophore). Under technical aspects, the 
dose should be chosen such that a reasonable 
enhancement of the overall signal intensity in the 
animal directly after administration is detected 
(e.g., at least tenfold increase compared to back-
ground signal before injection).
16.6.3.2  Pathophysiological 
Paradigm
Viewing the applications of optical imag-
ing probes from the angle of their pathophysi-
ological function, it appears as common sense 
to group the probes into nontargeted or vascu-
lar agents, targeted conjugates, and activatable 
probes. As detailed in the preceding chapter 
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Fig. 16.42 Photograph 
of cyanine dye solutions: 
(a) indocarbocyanine 
with abs/fluor 
550/580 nm,  
(b) indodicarbocyanine 
650/680 nm, and  
(c) indotricarbocyanine 
750/780 nm. 
Concentration of 
solutions approximately 
0.1 mM in water
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on state-of-the- art technologies, a host of com-
pounds have been designed and studied for each 
of these three fundamental strategies. It depends 
on the rationale of the respective scientific prob-
lem to be solved by the application of in vivo 
optical imaging. Vascular or nontargeted fluo-
rophores, as well as circulating fluorescent par-
ticles might be used first when a general imaging 
protocol is to be established, for the character-
ization of novel disease models (growth char-
acteristics, vascularity, tumor sizes, formation 
of metastases, etc.). Other interesting aspects 
refer to the dose finding, detection limits, and 
image acquisition parameters. Targeted conju-
gates permit the imaging of molecular informa-
tion, such as specific cellular expression profile. 
Fluorescently labeled drug candidates can be 
monitored with respect to their in vivo uptake 
into the target tissue and their capability to bind 
the molecular target. The underlying rationale 
is often to study the pharmacokinetic behavior 
of the probe, which has to fulfill certain prop-
erties with respect to their adsorption, distribu-
tion, metabolization, and excretion (ADME) for 
the living organism. Optical imaging can pro-
vide a fast and easy access to semiquantitative 
ADME data; however, a true quantification of 
drug amounts and the fate of metabolites in the 
organs are technically difficult. Here, radioactive 
techniques are a method of choice. Activatable 
probes provide insight into the third level of 
detecting protein function, such as the activity of 
proteolytic enzymes. Here, the injected imaging 
probe is silent until activated by the correspond-
ing enzyme. Accordingly, a concentration ratio 
between diseased tissue and normal areas is not 
necessarily a requirement as long as the circulat-
ing fraction of the probe remains undetectable. 
This technology has shown to be applicable for 
the imaging of enzyme inhibitors in drug screen-
ing protocols (Fig. 16.43).
Probably, the combined exploitation of these 
mechanisms would allow that the deepest insight 
into the physiology and molecular biology of dis-
ease formation and progression be gained. At this 
point, it is worth to emphasize that a particular 
opportunity of fluorescence detection is the prin-
cipal capability of multicolor imaging given that 
the imaging instrumentation permits multiple 
excitation and/or detection wavelengths. To give 
an example, the tumor vascularity would be 
detectable by a long-circulating vascular probe 
(e.g., 680 nm excitation), while the analysis of a 
certain receptor expression could be accom-
plished by a target-specific conjugate working at 
750 or 800 nm.
Fig. 16.43 Illustration of the different mechanisms of 
contrast generation by fluorescent imaging probes. In 
principle, the target-to-background ratios of signals and 
resulting imaging contrasts increase from nonspecific 
optical probes to targeted conjugates and activatable 
probes (Modified with permission from Sonja Vollmer)
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16.6.3.3  Type of Labeling Chemistry
For the labeling of proteins, antibodies, or other 
macromolecules, the type of labeling reac-
tion has to be considered. Generally, different 
residues in the macromolecule are available for 
covalent attachment to reactive fluorophores. The 
most relevant reaction sites are amino groups 
(lysines), thiol groups (cysteine), hydroxyl 
groups (threonine, serine, and glycans), and 
aldehydes (generated from oxidative cleavage of 
glycosylated structures). The principle pathways 
of covalent labeling of amino and thiol groups 
(provided by the amino acids, lysine, and cys-
teine, respectively) are illustrated in Fig. 16.44. 
Labeling of lysines is most established by using 
N-hydroxysuccinimidyl esters of dyes, easily 
accessible from carboxylic acid groups. Another 
approach is the utilization of isothiocyanate 
groups (most prominent is fluorescein isothiocy-
anate, FITC). Labeling of cysteines occurs most 
conveniently with maleimides or with pyridinium 
disulfides. A combined strategy involves the thi-
olation reagent iminothiolane (Traut’s reagent), 
which enables the conversion of an amine group 
into a linker with free thiol group for subsequent 
maleimide labeling (Hermanson 1996).
Labeling usually occurs with high chemose-
lectivity, allowing that cysteines or lysines be tar-
geted independently. In native proteins, labeling 
occurs statistically yielding an average dye-to- 
protein ratio with randomly distributed fluoro-
phores due to the randomly located cysteines or 
lysines in the protein. In this respect, reactions at 
sensitive binding sites or amino acids involved in 
the molecular function can hamper the affinity of 
the biomolecule. Therefore, the labeling approach 
should consider the protein sequence in order to 
select the appropriate labeling reaction.
A complementary approach can be followed 
by employing structures of glycosylation by 
reducing sugar moieties in a way that aldehyde 
functionalities are generated. These aldehyde 
groups react readily with amino groups (forming 
imines) or hydrazine groups (forming hydra-
zones), both of which are acid cleavable but can 
be chemically stabilized by reduction with 
sodium cyanoborohydride (Hermanson 1996).
Thiols are usually accessible by reductive 
breaking of disulfide bonds in the protein. 
However, since these bonds are crucial for pro-
tein folding and stability, denaturation and loss of 
target binding capability can occur. A structurally 
more defined approach can be followed by using 
engineered antibodies with additional cysteine 
residues, which are not involved into protein 
structure and are free to be used for covalent 
labeling (Lee et al. 2008).
As outlined in Chap. 21.2, a host of fluoro-
phores are available for the different bioconjuga-
tion chemistries. In a typical protein-labeling 
protocol, a buffered solution (pH 7.5–8) of the 
protein (1–10 mg/mL) is incubated with a molar 
excess of reactive dye (typically 10–50 moles of 
dye per mole biomolecule) for a few minutes to 
several hours depending on dye reactivity and 
desired labeling ratio. Purification and separation 
from unbound dye can be achieved by separation 
methods such as dialysis, ultrafiltration, or size 
exclusion chromatography. In order to determine 
the quality of the resulting conjugate, suitable 
analytical methods are needed subsequently.
16.6.4  Conclusion and Outlook
Optical imaging has an established role in pre-
clinical research and animal imaging. The appli-
cation of imaging techniques for the detection for 
fluorescence signals in living animals has 
emerged to a powerful routine level and utilizes a 
versatile set of commercially available imaging 
equipment. The detection of fluorophores as 
exogenously applied contrast agents can be 
accomplished with convenient handling and 
without a substantial effort regarding technical 
installation, safety issues, and training. A broad 
variety of fluorescent probes have been created 
and validated for their ability to facilitate the 
setup of imaging protocols, to support the charac-
terization of disease models, and to accompany 
the drug discovery process from drug design, 
in vitro characterization to the in vivo proof of 
concept. Both the selection and application of 
commercially available products optimized for a 
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Fig. 16.44 Illustration of synthetic pathways for selec-
tive labeling of antibodies or other proteins; the fluoro-
phore is simplified as bulb. Depicted are reactions of (a) 
maleimide dye with cysteine, (b) pyridinium disulfide dye 
with cysteine, (c) NHS-ester dye with lysine, (d) isothio-
cyanate dye with lysine, and (d) modification of lysine 
with Traut’s reagent to give thiol, followed by reaction 
with maleimide dye
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specific function as well as the implementation of 
self-induced synthetic chemistry adapting to the 
requirements in a given drug discovery project 
will play a central role in the optical imaging 
laboratory.
16.6.5  Laboratory Protocols
16.6.5.1  Labeling of Antibody 
with Dye NHS-Ester
Generally, antibodies should be used in a buffer 
free of amines. For instance, phosphate, acetate, 
or borate buffers are recommended, whereas 
TRIS and HEPES buffers are less suited. 
Incubation is performed with large excess of dye, 
followed by removal of excess nonreacted dye by 
using gel chromatography, dialysis, or ultracen-
trifugation. The latter two methods bring the dye 
conjugate into contact with material surfaces for 
which precipitation and loss of reaction yield are 
sometimes observed especially when using less 
hydrophilic dyes with tendency to aggregate. The 
following steps are recommended:
• Dissolve antibody or protein to be labeled in 
reaction buffer at concentration of 1–10 mg/
mL depending on solubility (buffers, e.g., 
100 mM sodium phosphate pH 7.4–8.0).
• Dissolve the reactive NHS-ester dye in a small 
amount of DMSO or DMF (concentration 
approximately 10 mM or 1 mg/100 μL). In 
case of high water solubility, the dye can be 
dissolved in buffer but should then be used 
immediately due to starting hydrolysis of the 
NHS-ester group.
• Add the stock solution of dye to the antibody/
protein solution to achieve the desired molar 
excess. For instance, 15-fold molar excess is 
generated by adding 10 μL of dye solution 
(concentration 10 mM) to 1 mL of antibody 
solution (concentration 1 mg/mL, IgG molec-
ular weight 150 kD).
• Incubate for 3–24 h under gentle shaking at 
room temperature and under protection from 
light.
• Remove excess dye by gel filtration, e.g., by 
using desalting columns. Best results are 
obtained when not loading the columns at the 
maximal possible volume, such as using a 
NAP10 column for not more than 0.5 mL.
16.6.5.2  Labeling of Antibody 
with Dye Maleimide
This example describes the labeling of a cys-
teine after reductive generation of free thiol. 
A mild reducing agent is, e.g., TCEP (triscar-
boxyethylphopshine), which reaches surface 
disulfides while leaving deeper bridges in the 
protein backbone intact. Usually, maleimide 
dyes can be used with less molar excess com-
pared to NHS esters. The following steps are 
recommended:
• Dissolve antibody or protein to be labeled in 
reaction buffer at concentration of 1–10  mg/
mL (buffers, e.g., 100 mM sodium phosphate 
pH 6.5–7.0).
• Dissolve TCEP in reaction buffer (concentra-
tion approximately 10 mM).
• Add the TCEP solution to the antibody/pro-
tein solution to achieve a molar excess of 5–10 
molecules TCEP per disulfide to be reduced.
• Incubate for 2 h under gentle shaking at room 
temperature.
• Add the stock solution of dye to the freshly 
reduced antibody/protein solution to achieve 
the desired molar excess (five- to tenfold).
• Incubate for another 2–4 h under gentle shak-
ing at room temperature.
• Remove excess dye by gel filtration, e.g., by 
using desalting columns.
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